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Abstract 
 
Macrophages as professional phagocytes have been considered as prominent participants in 
the response to acute infection and play a significant role in preventing infecting bacteria 
multiplying and damaging the host environment. Macrophages have complex mechanisms 
equipped with specialised receptors to recognise their targets. Upon internalisation of 
receptor-bacterial complex, macrophages initiate killing of the ingested microbes partly 
through the generation of free radicals species. However, the excessive production of 
reactive oxygen species (ROS) and nitric oxide (NO) during phagocytic activity may also 
contribute to the inflammatory process which although is beneficial in killing bacteria may 
result in deleterious consequences, especially following an interaction of NO with 
superoxide radicals to form reactive nitrogen species such as peroxynitrite. 
 
Probiotics are beneficial bacteria which have been shown to activate host innate immune 
response by influencing phagocytic activity of macrophages. This immunomodulatory 
effect has also been shown due to release of a number of soluble proteins by probiotic 
bacteria in the culture medium. However, the mechanism of regulation is not clear. In this 
study, we have therefore evaluated the influence of cell free Lactobacillus rhamnosus GG 
conditioned medium (LGG-CM) on macrophage phagocytosis and also on ROS and NO 
production by the J774 macrophage cell line, and further evaluated the acute effect of 
LGG-CM on NO and ROS production during the process of macrophage phagocytosis of 
E.coli in real time. 
 
Murine macrophage J774 cells were used in the study as these cells are readily activated by 
bacterial lipopolysaccharide (LPS) and produce NO. Gentamicin protection assay was 
employed in order to investigate the effect of LGG-CM on the ingestion and digestion 
phases of macrophages phagocytosis of E. coli HfrC. The cells were exposed to different 
dilutions of LGG-CM in the absence and presence of bacterial LPS, E. coli and the 
inhibitors or scavengers for ROS and NO. The J774 macrophages were loaded with free 
radicals sensitive fluorescent dyes, namely, H2DCFDA for monitoring ROS or with 
DAFFM-DA for NO detection. Acute free radical production was measured using a 
fluorescence microplate reader and changes were analysed by cumulative sum (CuSum) 
calculations. The fluorescence measurements were taken every two minutes for the first 60 
minutes to monitor free radicals production during the ingestion period and from 60 
minutes to 280 minutes to monitor free radicals production during the bacterial digestion 
period. The fluorescence was measured at 485 nm excitation and 528 nm emissions. 
 
The LGG-CM did not have any toxic effect on E. coli or macrophage viability, as 
determined by antibacterial studies and cell proliferation assays. The LGG-CM treated 
macrophages ingested significantly less bacteria both at 30 minutes and 60 minutes of 
incubation (p< 0.05). However, only higher concentrations of LGG-CM (75 % LGG-CM 
and 100 % LGG-CM) significantly increased the bacterial digestion rate of E. coli by the 
macrophages (p< 0.01). The LPS on its own did not have any effect on macrophage 
phagocytosis. The LGG-CM mediated enhanced bacterial digestion was inhibited by ROS 
and NO inhibitors and ROS scavengers. The LGG-CM at higher concentration induced 
increase expression of NADPH oxidase subunits (p47 phox and gp91 phox) at 6 hours (p< 
0.01). 
 
A low concentration of LGG-CM (10 % LGG-CM) or LPS did not cause any significant 
change in the basal levels of ROS or NO production. In contrast, a high concentration of 
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LGG-CM significantly enhanced ROS generation but also significantly reduced the NO 
level in both the ingestion and digestion phases of phagocytosis.  
 
These findings are novel and suggest for the first time that probiotics may release factors in 
culture medium which enhances macrophage digestion capability. The LGG-CM also has 
the capability to increase ROS production and may additionally reduce deleterious effects 
associated with excessive nitrogen species by suppressing the production of NO. These 
events may account, in part, for the beneficial bactericidal and anti-inflammatory actions 
ascribed to probiotics and may be of clinical relevance especially in several pathological 
conditions associated with gut inflammation or bacterial infection and may prove useful in 
improving intestinal homeostasis.  
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1.0. CHAPTER 1 Introduction 
1.1. Microbes and the human body 
The common assumption that- ‘all microbes are harmful’ is disproved by the presence of 
huge microbial population which exceed the number (10 to 1) of our own body cells (Zhu 
et al., 2011). Human body harbours nearly 1013-1014 microorganisms which so far are 
classified in to 30 known genera and around 500 species (Wershil & Furata., 2008; Zhu et 
al., 2011; Purchiaroni et al., 2013).  
 
The human intestinal microbiota is known to play a key role in metabolic, nutritional, 
physiological, psychological and immunological processes (Ottman et al., 2012). The 
human microbiota is established after birth and form a dynamic ecosystem dominated by 
Lactobacillus and Bifidobacteria that stabilizes during the first 2–3 years (Abt et al., 2012; 
Ottman et al, 2012). These microbes are also known as commensal bacteria. There is 
evidence that a stable, intimate, bidirectional interactions between commensal bacteria and 
the host are essential for the host’s normal physiological process (Abt et al., 2012; Ganal et 
al., 2012; Rudin & Lundell, 2012).  These bacteria have been shown to influence directly 
on the host health through modulation of gene expression or by preventing the colonisation 
of infectious bacteria and detoxification of toxic chemicals such as xenobiotics (Ley et al., 
2006; Ottman et al., 2012; Pessione 2012; Honda and Littman, 2012). 
 
A mutual beneficial relationship exists between the commensal bacteria and the host where 
the host provides food and a suitable environment for bacterial growth, and the microbes 
function in tandem with the host’s defences and the immune system to protect against 
pathogen colonisation and invasion (Kraehenbuhl and Corbett, 2004; Winkler et al., 2007; 
Clavel & Haller, 2007; Manichanh et al., 2012).  These microbes are also known to 
perform a number of essential metabolic functions of the hosts. The microbes actively 
metabolize non-digestible dietary carbohydrates, exfoliated epithelial cells, and mucus to 
provide essential nutrients such as short chain fatty acids (SCFA), amino acids and 
vitamins which  profoundly influence host’s intestinal epithelial functions and motility of 
the gut (Hooper and Gordon, 2001).  They also help in the extraction of energy and 
maintain a host-microbial energy balance in the gut (Turnbaugh et al., 2006; Turnbaugh et 
al., 2009). 
 
Alterations in the microbiota can result from exposure to various environmental factors, 
including diet, toxins, drugs, and pathogens. The importance of this indigenous microbiota 
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has been also demonstrated in germ free animals which were found to be more susceptible 
to diseases (Round et al. 2010). Altered intestinal microbial balance (dysbiosis) has been 
demonstrated in patients with several gastrointestinal disorders, including inflammatory 
bowel diseases (IBD), functional dyspepsia, non-alcoholic steatohepatitis and alcoholic 
liver disease. However it is still not clear whether the intestinal dysbiosis is a cause or a 
consequence of a given diseases (Sartor, 2008; Sartor, 2010).   
 
Some of the commensal microbes are now commonly known as probiotic bacteria as they 
are readily available in the consumer market as food supplements. 
 
1.2. Concept of probiotics  
The concept of probiotics can be traced back to the work of Nobel Prize-winning Russian 
scientist Eli Metchnikoff. He first suggested in 1907 that consumption of fermented milk 
products increased the longevity of Bulgarian peasants (Fioramonti et al., 2003). The word 
‘probiotics’ is derived from the Greek words pro and biotos and translated as –‘for life’ 
(Hamilton et al., 2003).  
 
A detailed history, basics and definitions of probiotics has been mentioned in detail by 
Azizpour et al. (2009) and are as follows: Vergin, (1954) had proposed that the imbalance 
in microflora in the body caused by antibiotics could have been restored by a probiotic rich 
diet. However, Lilly and Stillwell (1965) were first to define probiotics as “substances 
produced by one microorganism that promoted the growth of another microorganism”. 
 
Similar to this definition, Sperti (1971) and Fujii and Cook (1973) described probiotics as 
“compounds that either stimulated microbial growth or improved the immune response of 
the host without inhibiting the growth of the culture in vitro”. Another definition offered 
by Parker (1974) resembles more recent descriptions of probiotics (Azizpour et al., 2009). 
Parker (1974) defined them as “organisms and substances, which contribute to intestinal 
microbial balance” (Azizpour et al., 2009).  
 
The most cited definition in the 1990’s is Fuller’s (1992), who defined them as “live 
microbial feed supplement, which beneficially affects the host animal by improving its 
intestinal microbial balance”. This was not a clear statement as it was mostly applicable to 
animals.  
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Salminen et al. (1999) offered their view in incorporating non- viable bacteria in their 
definition. In 2002, Marteau et al. defined probiotics as ‘microbial cell preparation or 
components of microbial cells that have a beneficial effect on health and well-being’.  
Gorbach, (2002) defined probiotics as ‘living organisms which upon ingestion in certain 
numbers exert health benefits beyond inherent general nutrition’.   
 
Following the recommendations of a FAO/WHO, (2002) working group on the evaluation 
of probiotics in food, the suggested definition describes probiotics as “live microorganisms 
which when administered in adequate amounts confer a health benefit on the host”. Until 
today this is the most commonly used definition of probiotics in literature. Howarth in 
2010 entitled the probiotics derived factors as –“probiotoceuticals”. Although literature 
refers back to various terminologies and definitions- all together, in general, any live 
bacteria or probiotic derived factor are termed as probiotics.  
 
1.3. Probiotics and their influence on the immune system. 
 
Lactobacilli and Bifidobacteria are currently the most well-known probiotic species, due to 
their presence being essential for a healthy human microbiota (Arunachalam et al., 2000; 
Kullisaar et al., 2002). These bacteria can survive in the intestine and promote recovery of 
normal gut microbiota. This, in addition to their long and safe history in the manufacture of 
dairy products (Fooks & Gibson, 2002), makes these species an ideal supplement to 
healthy or immune-compromised persons.  
 
Several health benefits of probiotics, including the control of gastroenteritis and irritable 
bowel syndrome, have been previously proposed. Among these, much attention has been 
paid to their immune-regulatory activity (Shida & Nanno, 2008; O’Flaherty et al., 2010). A 
number of animal and human studies have shown the beneficial effects of probiotics on 
health through the maintenance of healthy gut microbiota [Azcarate –Peril et al., 2011; 
Akaza, 2012].  
 
As early as 1907, probiotics were regarded as health promoting to human beings 
(Metchnikoff, 1907). The mechanisms by which these bacteria exert their effects are still 
largely unknown. The impact of probiotics on intestinal microflora was found to be limited 
in some studies as it only brought about a transient alteration in the composition of 
indigenous microflora (Venturi et al., 1999, Tannock et al., 2000). However, there is 
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mounting evidence that probiotics, by some means, directly influence the immune system 
(Cunningham–Rundles et al., 2000; Erickson and Hubbard, 2000). 
 
When an individual gut flora composition fluctuates due to environmental changes in the 
gut, for example a change in the diet, acute diarrhoeal illness or antibiotic treatment 
(Antonopoulos et al., 2009; Sekirov et al., 2010; Willing et al., 2011), use of probiotics 
could shift the ‘balance’ of the bacterial communities back to the normal composition. 
Lactobacilli can out-compete pathogens for resources, or simply not allow pathogens or 
other bacteria to adhere to the epithelial cell wall (Collado et al., 2007).  
 
Probiotics immunomodulatory effect can be derived by its metabolites, DNA and cell wall 
components interaction, with the host epithelial or immune cells (Oelschlaeger, 2010). 
Such recognition, either by cell adhesion or release of soluble factors, can trigger a 
signalling cascade (Oelschlaeger, 2010) which indeed regulates the innate and/or acquired 
immune system. Table 1.1 explains the effect of probiotics on immune functions in healthy 
adults and provides a general overview of the health benefits associated with probiotics.  
 
For the pharmacobiotic approach the probiotics should be selected on the basis of the host 
responses depending upon the host condition. A recent study on human mucosal 
transcriptome responses to probiotics reveals how various cellular pathways are modulated 
by probiotics (van Baarlen et al., 2011). It also reveals a large person to person variation in 
response transcriptomes (set of all RNA molecules transcribed in cells) and large variations 
in genes encoding bioactive molecules.  
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Table 1.1: Effect of probiotics on immune function in healthy adults. [Fluorescein isothiocyanate (FITC),   Multiplicity of infection (MOI), 
Polymorphonuclear cells (PMN)]. 
 
 
Probiotics used Healthy adults  
(Age range) 
Immune function effects Reference 
Lyophilized Enterococcus 
faecium M-74 (single capsule 5× 
109 bacteria day-1) for 6 weeks.  
12 healthy adults  
(aged 44-66 years)  
Decreased superoxide production by peripheral 
neutrophils incubated with zymosan or phorbol 
myristate acetate at the end of supplementation 
then increased 2 weeks after supplementation was 
stopped. 
Mikes et al., (1995) 
L. acidophilus La1 (7x1010 CFU 
day-1) or B.bifidum Bb12 (1x1010 
CFU day-1) for 3 weeks. 
28 healthy adults  
(aged 23-62 years) 
Enhanced phagocytic activity of Escherichia coli 
by granulocytes and monocytes was observed.  
Schiffrin  et al., (1995), 
Schiffrin  et al.,  (1997) 
L.casei Shirota  
(109 CFU day-1) for 4 weeks. 
20 healthy adults  
(aged 40-65 years) 
No effect on percentage of phagocytising 
neutrophils or percentage of neutrophils showing 
oxidative burst. 
Spanhaak  et al., (1998) 
 
L. johnsonii La1 (109 CFU day-1) 
or (≈108 CFU day-1) for 3 weeks. 
42 healthy adults  
(aged 21-57 years) 
Increased leukocyte phagocytosis of FITC–
labelled E.coli and increased respiratory burst 
from leukocytes treated with opsonised unlabelled 
E.coli with ≈109 CFU day-1. No significant effect 
of (≈108 CFU day-1) on phagocytic activity and 
respiratory burst. 
Donnet-Hughes et al., (1999) 
Bifidobacterium lactis HN019 
(1.5 x 1011 CFU day-1) for 6 
weeks. 
25 healthy, elderly adults 
(aged 60-83 years) 
Increased number of PMN cells showing 
phagocytic activity of Staphylococcus aureus. 
Arunachalam et al., (2000) 
Bifidobacterium lactis HN019  
109 CFU B. Lactis twice daily. 
50 healthy adults       
(aged 41-81 years) 
Increase in percent PMN cell phagocytosis. Chiang  et al., (2000) 
L. rhamnosus HN0001 DR20 TM 
(5 x 1010 CFU day-1) for 3 weeks. 
13 healthy, elderly adults 
(aged 62- 77 years) 
Increases phagocytosis of   fluoresceinated 
Escherichia coli by PMN cells and monocytes. 
Gill  et al.,( 2001)a 
 L. rhamnosus, L. plantarum,       
L. Salivarius and  B. bifidum  
(2 × 109 CFU day-1) for 8 weeks.        
10 healthy adults  
(aged 24-54 years) 
Increased percentage of phagocytic monocytes and 
neutrophils of fluorescent labelled E.coli K12. 
Berman  et al., (2006) 
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1.4. Lactobacillus rhamnosus GG (LGG) 
 
Lactobacillus rhamnosus GG (LGG), ATCC 53103, a probiotic strain of human origin is 
by far the most thoroughly explored Gram-positive lactic-acid bacteria with widely 
evidenced health effects (Saxelin, 1997; Sheil, 2007). The LGG is known to influence 
immune response, both specifically by stimulating antibody production (Kaila et al., 1992) 
and non-specifically by impacting on phagocytic activity (Pelto et al., 1998). The LGG 
modulating various signalling pathways in macrophages and intestinal epithelial cells are 
shown in Table 1.2. The LGG was first isolated from a healthy person stool while 
screening bacterial strains that were stable to acid and bile (Silva et al., 1987; Lee and 
Salminen, 1995). Since its isolation, LGG has become one of the clinically best-
documented probiotic strains (Doron et al., 2005). In vivo studies have shown the good 
persistence capacity of LGG in the human gastrointestinal tract (Alander et al., 1999) and 
are known to produce antimicrobial substance (Silva et al., 1987).  
 
The LGG has shown to increase secretion of mucosal immunoglobulin A (IgA) levels in 
the gut (Malin et al., 1996), improve intestinal permeability and reduce disease activity 
when administered to children with Crohn’s disease (Gupta et al., 2000). A double blind 
study performed on 105 infants aged 0 to 2 months when given enriched probiotic formula 
containing milk-based spray-dried powder and 107 CFU g-1 of LGG showed enhanced 
weight and size (Vendt et al., 2006). The LGG has previously shown to protect host tissues 
against the attachment, overgrowth and action of pathogenic microorganisms (Miettinen et 
al., 2000; Matsuguchi et al., 2003; Servin, 2004; Cotter et al., 2005; Deshpande et al., 
2011; Yan and Polk, 2012).  
 
 
 
 
 
 
 
 
 
7 
 
Table 1.2: The LGG modulation of signalling pathways. [Protein kinase B (Akt / P13K), 
heat shock proteins (hsp), intestinal epithelial cells (IEC), Nuclear factor of kappa light polypeptide 
gene enhancer in B-cells inhibitor, alpha (IkBα), Jun N-terminal kinase (JNK), mitogen activated 
protein kinase (MAPK), nuclear factor kappa B (NFkβ)]. 
 
1.5. LGG derived factors 
 
This section reviews the current knowledge on the effect of LGG components on the 
macrophages and the intestinal epithelial cells, which is a vital, interacting site for host-
pathogen interactions.  
1.5.1. Introduction to the role of LGG derived factors 
 
A large number of experimental and clinical studies published in recent years have 
highlighted the beneficial effects of live probiotics (Malin et al., 1996; Sheil et al., 2007). 
The transition from the era of using live probiotics to the era of using probiotic 
components for the pharmacobiotic approach is still in the juvenile state. There are reports 
and concerns of bacteraemia and sepsis cases when live probiotics were used (De Groote et 
al., 2005; Kunz et al., 2004; Boyle et al., 2006). However, these reports were from 
immunocompromised patients or premature infants, for example from a child suffering 
from short gut syndrome ending up with bacteraemia after consuming LGG capsule (De 
Groote et al., 2005; Kunz et al., 2004; Besselink et al., 2008). These emerging concerns 
regarding the safety problems of using live probiotics have enhanced the opportunity to 
utilise the non- viable probiotic components as an alternative (Sanchez et al., 2010; Caselli 
 
Signalling 
pathway 
 
Cell Model 
 
Effect of probiotic 
 
Reference(s) 
NFkβ Macrophages Induces NFkβ binding activity. Miettinen et al., 
(2000) 
MAPK IEC ↑ Phosphorylation of p38 and 
JNK. 
↑ of MAPK regulated genes. 
Di Caro et al., (2005) 
Tao et al., (2006) 
Lin et al., (2008) 
NFkβ IEC Prevents IkBα ubiquitination and 
degradation. 
Zhang et al., (2005) 
Kumar et al., (2007) 
Lin et al., (2009) 
Apoptosis IEC Activates Akt / P13K. Yan and Polk, (2002) 
Yan et al., (2007) 
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et al., 2011; Caselli et al., 2013). The use of probiotic components rather than whole live 
bacteria prevents the risk of bacterial translocation and infection (De Groote et al., 2005; 
Kunz et al., 2004; Boyle et al., 2006). 
 
 Literature review shows that not only the whole living bacteria, but also the probiotic 
components demonstrate a beneficial effect on host immune activity. These factors 
includes bacterial cell wall components, such as peptidoglycans and lipoteichoic acid 
(Matsuguchi et al., 2003; Pena and Versalovic, 2003), whole genomic DNA from lactic 
acid bacteria (Iliev et al., 2005; Lammers et al., 2003; Meier and Steuerwald., 2005), short 
DNA sequences containing unmethylated, phosphate-linked pairs of cytosine plus guanine, 
so-called CpG motifs (Bohle et al. 1999; Helwig et al. 2006; Hessel et al. 2005; Kline et 
al. 1998; Klinman et al. 1996), heat killed LGG (Li et al., 2009) and secreted proteins from 
probiotic supernatant and conditioned media  (Hessel et al., 2005;  Helwig et al., 2006; 
Vincenti, 2010; Hand et al., 2012; Rudin and Lundell, 2012;Yoda et al.,2012; Villena and 
Kitazawa, 2014). 
  
The aim of this section is to gather together the current information and provide an 
overview of the scientific literature concerning studies which have employed both the 
structural and non-structural components (dead LGG, LGG components such as DNA, 
secreted proteins and cell wall) of Lactobacillus rhamnosus GG. Particular attention will 
be given to the downstream responses and the mechanisms by which the LGG components 
exert their effect. The role of various extracellular proteins secreted by LGG is reviewed 
and is listed in table 1.3.  
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Table 1.3: Role of various extracellular proteins secreted by LGG [Young adult mouse 
colonic epithelial cells (YAMC), heat shock proteins (HSP), Human colorectal adenocarcinoma 
cells (Caco-2)]. 
 
 
 
 
 
 
Active component 
secreted from LGG 
Role Reference 
Unknown low 
molecular weight 
compound resistant to 
various proteases. 
Active against broad range of 
Gram positive and Gram negative 
organisms including Lactic acid 
bacteria but non-inhibitory to 
lactobacilli. 
Silva et al.,(1987) 
Secreted proteins of 
approximate size 42 
and 80 kDa 
Prevents cytokine induced 
apoptosis in YAMC cells. 
Yan &Polk, (2002) 
Unidentified secreted 
proteins 
Increased production of HSP25 
and HSP 72 in YAMC cells. 
 
Tao et al., (2006) 
Unidentified proteins 
from  probiotic 
supernatant 
Increase of luminal chloride/ 
hydroxyl exchange activity in 
Caco-2 cells. 
Borthakur et al.,   (2008) 
p40 and p75 proteins Intestinal epithelial cell growth 
promotion in both human and 
murine colon epithelial cells (HT-
29 and YAMC cells). Inhibited 
epithelial cell apoptosis induced 
by cytokines. 
 
Yan et al., (2007) 
p40 and p75 proteins Attenuation of transepithelial 
resistance decrease induced by 
hydrogen peroxide & reduction in 
TNF-α induced injuries. 
 
Seth et al., (2008) 
Peptide NPSRQERR 
and PDENK 
Antimicrobial activity exerted 
against both Gram positive 
(Staphylococcus aureus) and 
Gram negative bacteria 
(Escherichia coli EAEC 042 and 
Salmonella typhi). 
Lu et al., (2009) 
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1.5.2. LGG-conditioned medium and Cell free LGG supernatant 
 
The components by which LGG exert their beneficial health effects are not clear. 
However, there is evidence that a number of low molecular weight proteins secreted by 
LGG might be responsible for these beneficial effects (Yan et al., 2007; Seth et al., 2008). 
The extracellular proteins secreted by these beneficial bacteria can be divided into two 
groups (Sanchez et al., 2010). These include proteins that contain a signal peptide, which is 
located in the N-terminal, part of the sequence to direct the protein to protein export 
machinery and the surface protein shredded off normally as a part of cell wall turn over 
(Sanchez et al., 2008).   
 
Study by Pena and Versalovic. (2003) showed that LGG-CM could reduce the production 
of potent proinflammatory cytokine TNF-α in LPS activated RAW 264.7 murine 
macrophages. Their study identified that the putative immunomodulatory soluble factors in 
the conditioned medium might contain a peptide or protein component that inhibits TNF-α     
production from macrophages. 
 
A study by Roselli et al. (2006) examined the effect of the LGG supernatant on E. coli 
induced inflammatory response in Caco-2 cells. Their study demonstrated that the LGG 
supernatant demonstrated the ability to reduce the inflammation associated with human 
intestinal Caco-2 cells as a response to enterotoxigenic E. coli K88. This was achieved by 
partly reducing pathogen adhesion, preventing increased expression of proinflammatory 
cytokines like IL1β, TNF-α and also by the inhibition of neutrophil migration. 
 
Studies by Yan & Polk, (2002) demonstrated that products recovered from LGG-CM 
showed a concentration dependent activation of Akt (Protein Kinase B) - an apoptotic 
cellular process regulator and inhibitor of cytokine induced apoptosis. The LGG-CM 
activated antiapoptotic AKt/protein kinase B and inhibited p38 MAPK in cytokine (TNF, 
IL1α, IFNγ) stimulated human colonic epithelial carcinoma cell line (HT-29) and Young 
adult mouse colon cell line (YAMC).  This process did not require bacterial- intestinal cell 
contact. The immunomodulin proteins identified from LGG-CM were of approximately 80 
and 42 kDa based on SDS-PAGE. In the subsequent experiments the proteins were purified 
from LGG-CM and identified as p40 and p75 (40 and 75 kilodaltons respectively) (Yan et 
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al. 2007). These purified proteins from the LGG-CM reduced TNF-α, induced epithelial 
damage and activated Akt in a phosphatidyl inositol-3’-kinase (PI3K) dependent manner 
and prevented apoptosis which is consistent with their previous findings. Thus, proteins in 
LGG-CM regulate both anti and pro apoptotic signal transduction pathways and are 
beneficial for the gut epithelium.  
In a similar study by Tao et al. (2006), LGG-CM protects murine intestinal epithelial cells 
(YAMC) against oxidative damage induced by NH2Cl. As a stress response, LGG induced 
the production of heat shock proteins (hsp) by activating various signalling pathways. The 
hsp are induced during environmental stress conditions like heat, heavy metals and 
pathophysiological stress conditions like microbial infections. Inducible hsp like hsp25 and 
hsp 72 productions occurs as a response to LGG-cell free conditioned medium. Evidence 
indicates that even exposure of LGG-CM to intestinal epithelial cells for a few minutes 
triggered the production of heat shock proteins. The hsp-25 expression was seen after 18-
20 hours of LGG-CM exposure while hsp 72 expressions began as early as 4-6 hours. The 
hsp72 is well known for stabilising and preventing denaturation of cellular proteins while              
hsp-25 acts as an actin stabilising agent by binding to actin filaments and fortifying 
filamentous actin (Tao et al., 2006).   
1.5.3. Lactobacillus rhamnosus GG DNA 
Iliev et al. (2005) found that the chromosomal DNA from LGG demonstrated beneficial 
properties (at a concentration of 50 µg ml-1) by inducing a strong proliferation response in 
murine B-lymphocytes. Further they also demonstrated that both chromosomal DNA and 
derived TTTCGTTT oligodeoxynucleotide ID35 not only induced B- cell proliferation but 
also increased the expression of CD86 (proteins expressed on antigen presenting cells that 
provide costimulatory signals for cell-mediated immunity)  in B-cells.  
A study by Donato et al. (2010) carried out experiments utilising live LGG, heat killed 
LGG or LGG in presence of antibiotic chloramphenicol (20 µg ml-1) and investigated their 
effect on proinflammatory cytokines induced epithelial barrier disruption on Caco-2bbe 
epithelial cell integrity. Their study showed that live LGG preserves epithelial barrier 
function against the effects of proinflammatory cytokines IFN-γ and TNF-α (which are 
known to disrupt epithelial cell integrity). However, heat killed LGG or antibiotic addition 
to culture medium abolished the protective response even when 10-fold more LGG was 
used. Thus, they concluded that heat killing might have denatured the LGG DNA, and 
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thereby the protective effect of LGG in preserving epithelial integrity is compromised. In a 
similar study by Yan & Polk, (2002), heat killed LGG did not demonstrate a role in 
maintaining epithelial cell integrity in both human colonic epithelial carcinoma cell line 
(HT-29) and Young adult mouse colon cell line (YAMC). This further fortifies that DNA 
denaturation attenuates the beneficial property of LGG. 
Another study by Ghadimi et al., (2010) using HT-29 and T-84 cells (Human colonic 
adenocarcinoma cell-line) demonstrated that apically applied LGG DNA reverses the loss 
of epithelial integrity resulted by TNF-α treatment. As previously known, TNF-α applied at 
the apical surface leads in decreased trans-epithelial electrical resistance (TER), opening of 
the tight junction barrier, translocation of TNF-α from apical to basolateral surface and 
subsequent access to chemoreceptors. This access followed by recognition leads in to 
degradation of Ikβ and phosphorylation of p38. Once NFkβ is activated it translocates from 
cytoplasm to nucleus and transcribes various proinflammatory genes including 
proinflammatory cytokines. This epithelial damage is prevented by apically applying LGG 
DNA. The LGG DNA prevents TNF-α induced NFkβ activation by reducing Ikβ 
degradation and p38 MAP kinase phosphorylation.  
1.5.4. Dead LGG 
Most of the studies investigating the effect of dead LGG have either heat killed (Zhang et 
al., 2005) or UV-inactivated (Lopez et al., 2008) or glutaraldehyde fixed LGG (Miettinen 
et al., 1996). Miettinen et al., 1996 had demonstrated that glutaraldehyde fixed LGG were 
not as efficient as live bacteria in the production of TNF-α from human peripheral blood 
mononuclear leukocytes. They interpreted that glutaraldehye fixed LGG had undergone 
structural changes, as glutaraldehyde itself is a cross-linking agent. They concluded that 
this glutaraldehyde fixation process might have denatured the LGG structural proteins and 
therefore failed to produce any stimulatory effect. 
Zhang et al. (2005) showed that heat-killed LGG decreases IL-8 (a proinflammatory 
cytokine) production from TNF-α induced Caco-2 intestinal cell-line. However, a high 
dose of live LGG actually increased the IL-8 production in their study. This effect of 
increase in IL-8 was much less pronounced with a high dose of heat-killed LGG indicating 
that the use of heat-killed LGG might be a safer option in certain situations. The 
mechanism of the decrease in IL-8 production was via the inhibition of translocation of 
NFkβ to the nucleus and the associated decrease in Ikβ. In a more recent study by Lopez et 
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al. (2008), uv-inactivated LGG was as effective as live LGG in down regulating IL-8 
production from Caco-2 cell line stimulated with flagellin from Pseudomonas aeruginosa.  
A similar conclusion was also seen from Li et al. (2009) where heat-killed LGG provided 
by the enteral route in infant rats decreased LPS-induced proinflammatory intermediaries 
and increased anti-inflammatory mediators (Li et al., 2009). Studies have also been  carried 
out with human trophoblast cells where the heat killed LGG stimulates IL-4, IL-10 (anti-
inflammatory cytokines) expression and reverses LPS induced TNF-α (a proinflammatory 
cytokine) release from human trophoblast cells without affecting basic trophoblast 
functions (Bloise et al., 2010).  
1.5.5. Summary of LGG and its derived products 
In this literature review, attention has been given to only LGG (our model probiotic 
bacteria); however in the literature, the same study might have employed several other 
probiotics. In this literature review, a range of effects for a single probiotic strain LGG has 
been observed. Several clinical studies have explained the multiple immunological actions 
of LGG in various medical conditions. For example, the LGG appeared to modulate the 
non-specific immune response differently in healthy and hypersensitive subjects. The LGG 
upregulated the phagocytic markers in healthy individuals but down-regulated the same 
markers in milk hypersensitive subjects (Pelto et al., 1998). These clinical studies using 
live LGG are significant but the answer for the varied responses remains unexplained.  
Currently, the knowledge just supports that both live LGG and their structural or secreted 
components are beneficial (Sanchez et al., 2008; Kataria et al., 2009; Taverniti & 
Guglielmetti, 2011; Adams, 2010; Caselli et al., 2013). The utility and potential for 
LGG/LGG components is clear but in depth, further investigations are ultimately essential. 
Several studies have described the soluble component secreted by the probiotics exhibiting 
the beneficial property is a protein (Yan & Polk, 2002; Pena & Versalovic, 2003; Yan et 
al., 2007; Yan et al., 2011). Contradictorily, early studies by Silva et al. (1987), showed 
that the component exhibiting the antibacterial activity was of a low molecular weight 
(<1,000) compound and retained activity even after treatment with various proteases such 
as trypsin, proteinase K, α-chymotrypsin, bromelain and carboxypeptidase A. The LGG 
beneficial activity had a preference of acidic pH range suggesting that it might be a sort of 
short chain fatty acid (Silva et al., 1987).   
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1.6. Macrophages and their defence mechanism 
The host response to microbial pathogens is conventionally divided into two distinct but 
complementary and interactive parts. It comprises the innate immunity which protects the 
hosts in an earlier stage of infection primarily through the activity of neutrophils and 
macrophages. These mechanisms, however, are not driven by specific antigen interaction 
but might significantly protect the host in the first few hours, at least in significantly 
preventing the infected bacteria to multiply within the host environment. This response 
feeds directly into the initiation of adaptive immune response which culminates in lasting 
specific immunity by also establishing immune memory (Karupiah et al., 2000). 
 
Macrophages are the phagocytic cells which are the key regulators of immunity. 
Phagocytosis is the process where the macrophages engulf the foreign particles and 
degrade them (Aderem and Underhill, 1999) (see Section 1.7). After bacterial recognition 
macrophages ingest bacteria. Ingested microbes are then killed within phagolysosome. The 
two main antimicrobial systems of these phagocytes involve:  
1. NADPH Phagocyte oxidase [Responsible for the production of superoxide (O2-.) and 
other oxygen derived intermediates termed Reactive oxygen species (ROS)] 
2. Inducible nitric oxide synthase (iNOS) [Responsible for the generation of nitric oxide 
(NO) and its derivatives termed Reactive nitrogen species (RNS)]. 
1.6.1. Nicotinamide adenine dinucleotide phosphate-oxidase (NADPH-
oxidase) 
Macrophages constitute one of the most powerful means of host defence against invading 
pathogens (Segal, 2005; Nathan, 2006). During infection, phagocytes recognize and engulf 
the pathogen and activate the release of reactive oxygen species such as superoxide anion, 
hydrogen peroxide, hydroxyl radical and hypochlorous acid used for defensive purposes as 
microbicidal agents (Bylund et al., 2010). The ROS are produced by phagocytes in a 
powerful "oxidative burst", characterized by a rapid increase in oxygen uptake and high 
glucose utilization and rapid ROS release. The enzyme responsible for O2
•- production is 
the multicomponent NADPH oxidase or respiratory burst oxidase and is located on plasma 
membrane and membrane of phagosomes (El-Benna et al., 2005; El-Benna et al., 2009; 
Bylund et al., 2010).  
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The phagocyte NADPH oxidase activation can be induced by a large number of soluble 
and particulate agents. Two of the subunits, p22phox (phox for phagocyte oxidase) and 
gp91phox (also known as NOX2), form a membrane bound, heterodimeric 
flavohemoprotein known as cytochrome b (cytochromeb558). The NADPH oxidase is 
dormant in the absence of cellular activation. Upon cellular activation, the cytosolic 
components, namely p40phox, p47phox, and p67phox translocate to the membrane and 
associate with cytochrome b to from a functional NADPH oxidase (Figure 1.1). The whole 
process is highly regulated involving one or more cofactors. In human phagocytes the 
predominant cofactor is Rac2 and in murine phagocytes it’s Rac1. When activated, 
NADPH oxidase transfers electrons from intracellular NADPH to extracellular (or 
intraphagosomal) oxygen forming O2
. - anion (Bylund et al., 2010).  
 
 
 
   
 
 
 
 
 
 
Figure 1.1: Phagocyte NADPH oxidase subunits in its active and resting state. Under 
normal conditions, gp91phox and p22phox are primarily found on the membrane of intracellular 
vesicles. Upon activation, there is an exchange of GDP to GTP on Rac cofactor leading to its 
activation. Phosphorylation of cytoplasmic p47phox results in the conformational changes allowing 
the interaction with p22phox. The p67phox and p40phox also moves to the membrane along with 
p47phox to form active enzyme complex. This active NADPH oxidase enzyme complex transfers 
electrons from cytoplasmic NADPH to extracellular or phagosomal oxygen to produce superoxide. 
[Guanosine diphosphate (GDP), Guanosine triphosphate (GTP), GTPase (Rac)]. Adapted from 
Bedard & Krause, 2007; Bylund et al., 2010). 
The ROS are critical components of the antimicrobial repertoire of macrophages. The 
multi-subunit phagocyte oxidase (phox or NOX2) once assembled on the phagolysosome 
membrane, pumps electrons to reduce oxygen to superoxide anion (and derived species). 
Efficient production of ROS needs proper association of NADPH oxidase subunits. 
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Several studies suggest that phagocyte NADPH oxidase has a major contribution in the 
initiation and progression of many physiological and pathophysiological events, including 
thyroid hormone production in the thyroid gland, ischemia-reperfusion injury in multiple 
organs, septic shock, obesity, cancer, neuronal degeneration, and cardiovascular diseases 
(Caillou et al., 2001; Andreadou et al., 2009; Kleikers et al., 2012; Fu et al., 2014).  
The important role of NADPH oxidase in host defence against invading microorganisms is 
demonstrated by an inherited human genetic disorder known as Chronic granulomatous 
disease (CGD), which is characterized by an absence of ROS production due to a 
deficiency in one of the components of the NADPH oxidase resulting in life-threatening 
microbial infections (Kannengiesser et al., 2008). Recurrent, often life-threatening, 
microbial infections usually start in the early stages of life. Different forms of CGD 
include gp91phox-deficient form (approximately 75%), p47phox deficient form 
(approximately 25%), p67phox deficient form (< 5%) and p22phox deficient form (< 5%) 
(Roos et al., 1996; Meischl & Ross, 1998; Kannengiesser et al., 2008; El –Benna et al., 
2009). The importance of p47phox in host defence was also demonstrated in p47phox 
knockout mice. These mice developed lethal infections and granulomatous inflammation 
similar to those encountered in human CGD patients (Jackson et al., 1995). 
1.6.2. Other sources of ROS in macrophages 
 
Both generation and degradation of ROS is tightly regulated. In macrophages there are 
several vital sources of ROS, as well as multilevel antioxidant defences. Macrophage 
mechanisms of ROS generation and antioxidant defence are discussed below. 
 
The physiological generation of ROS can occur as a by-product of several biological 
reactions. The ROS is mainly produced as a by-product within mitochondria or by the 
enzymes, namely, cyclooxygenase, lipooxygenase, xanthine oxidase, cytochrome p-450 
and other cellular elements (Bedard & Krause 2007).  
 
Mitochondria are thought to generate superoxide as a result of leakage from the electron 
transport chain (ETC). The ETC consists of a series of protein carriers found in the inner 
membrane of mitochondria. Electrons pass from a donor such as NADH and succinate 
along the electron transport chain to oxygen which is reduced to water. Most of the oxygen 
in respiring organisms is used this way, but a small percentage (1 to 2 %) is converted to 
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superoxide by one electron reduction. The dismutation of superoxide results in the 
formation of hydrogen peroxide. The formed hydrogen peroxide is broken down into water 
and oxygen by peroxidases. However, under normal conditions with functional 
mitochondrial antioxidant defence, ROS accumulating to have a physiological or 
pathophysiological effect is still unclear. The presence of a physiological inhibitor of the 
electron transport chain might explain this. Under in vivo conditions NO have been shown 
to inhibit complex IV of ETC and may modulate mitochondrial ROS production. Calcium 
uptake by mitochondria has been shown to increase mitochondrial metabolism and activate 
ETC and might thereby, increase stimulation of the superoxide molecule. (Poderoso et al., 
1996; Moncada and Erusalimsky, 2002).  
 
Cyclooxygenase (COX) and lipooxygenase are the enzymes involved in metabolism of 
unsaturated fatty acids such as arachidonic acid and are known to contribute to free radical 
production (Rice Evans & Bruckdorfer, 1992; Ricciotti & FitzGerald, 2011). The COX 
enzyme catalyzes the conversion of arachidonic acid to prostaglandins and thromboxane. 
Lipooxygenase catalyse the oxygenation of arachidonic acid to hydroxyeicosatetraenoic 
acid and hydroperoxyeicosatetraenoic acid. The ROS is produced as a by product during 
the fatty acid metabolism and also results from several studies suggest that COX 
metabolites are capable of stimulating NADPH oxidase and thereby ROS generation 
(Hong et al., 2008; Wang et al., 2010). These products are further known to be involved in 
the stimulation of NADPH oxidase (Hong et al., 2008) and thereby ROS production. 
 
Xanthine oxidase is a form of xanthine oxidoreductase, which is known as a source of ROS 
in macrophages. The enzyme catalyses the oxidation of purines such as hypoxanthine and 
xanthine and can further catalyse the oxidation of xanthine to uric acid (Berry & Hare 
2004; Nakai et al., 2006). During this process xanthine oxidase reduces oxygen to 
superoxide and thereby contributes to ROS production (Kelley et al., 2010). 
 
Cytochrome p450 serves as a source of free radicals.  The monooxygenase activity of this 
enzyme activates oxygen which is inserted into a substrate. A reactive intermediate might 
be formed during this process. However, this enzyme also exhibits an oxidase activity by 
molecular oxygen not being incorporated into the substrate but rather the oxygen may be 
released from oxy-complex of cytochrome p450 complex as superoxide anions (Zangar et 
al., 2004). 
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Most of the sources of ROS indicate the ROS production as by-product. The NADPH 
oxidase is an example of an enzyme system that generates ROS not as a by-product, but 
rather as a functional molecule of an enzyme system. The activated NADPH oxidase 
generates superoxide by reduction of molecular oxygen using NADPH as an electron 
donor (Babior et al., 2002). The non-phagocytic NADPH oxidase such as endothelial 
NAD(P)H oxidase also exists. But these unlike phagocyte oxidase are constitutively 
expressed and do not generate high level of superoxide. The endothelial NADPH oxidase 
however utilises both NADH and NADPH as a substrate unlike phagocyte oxidase which 
preferentially uses NADPH (Lasseguen and Clempus, 2003).  
 
1.6.3. Inducible nitric oxide synthase 
 
Nitric oxide is a small and short lived signalling molecule involved in various 
physiological and pathophysiological conditions in the human body (Korhonen et al., 
2005). The NO is synthesized by a family of enzymes called the nitric oxide synthases 
(NOS), which convert the amino acid L-arginine into L-citrulline and NO (figure 1.2) 
(Korhonen, et al., 2005; He et al., 2006). The NOS belong to a family of three isoenzymes: 
neuronal [nNOS also known as NOS-1], inducible [iNOS also known as NOS-2] and 
endothelial eNOS [also known as NOS-3]. These isoforms differ in their tissue 
distribution, calcium sensitivity and upstream activators (see table 1.4).  
The NO produced by the host phagocytic cells plays a major role in innate immunity, 
largely due to the ability of NO to inhibit or kill a broad range of microorganisms by its 
reactivity towards diverse cellular constituents such as [Fe–S] clusters and haem (Fang 
2004). The half-life of NO in the biological system is very short, ranging from 1 to 30 
seconds (Knowles and Moncada 1992; Feldman et al., 1993; Eich et al., 1996). It is rapidly 
oxidised to nitrite or nitrate (MacMicking et al., 1997). The NO, when combined with ROS 
can also form other radicals of even greater cytotoxicity such as peroxynitrite. Therefore, 
NO is regarded as one of the effective host immune responses against invading 
microorganisms (Fang 2004).     
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Figure 1.2 Synthesis of nitric oxide from L-arginine and oxygen by iNOS. The above 
figure shows the phases involved in the nitric oxide synthase reaction pathway. Electrons are 
donated from NADPH to the reductase domain and then progress through FAD and FMN to the 
oxygenase domain. Electron flow through the reductase domain requires the presence of bound 
Calmodulin. There the electrons interact with the haem and BH4 at the active site in order to 
catalyse the reaction of oxygen with L-arginine resulting in the formation of L-citrulline and NO. 
[Nicotinamide adenine dinucleotide phosphate (NADPH), Flavin adenine dinucleotide (FAD), 
Flavin mononucleotide (FMN), Tetrahydrobiopeterin (BH4).  
 
 
Table 1.4: Comparison of nitric oxide synthase isoforms. Adapted from Knowles and 
Moncada, 1994; Alderton et al., 2001 & Nahrevanian 2009 [N-methyl-D-aspartate (NMDA)] 
 
 
NOS 
isoforms 
Molecular 
weight 
Tissue distribution Activators Expression & 
Calcium sensitivity  
nNOS 
[NOS-1] 
161kDa Neurons Steroid 
hormones, 
cytokines, 
NMDA 
Constitutively 
expressed 
 Calcium dependent 
 
iNOS 
[NOS-2] 
131KDa Macrophages, 
endothelial cells, 
Smooth muscle cells 
Cytokines 
Endotoxins 
Inducible, 
Calcium 
independent 
eNOS 
[NOS-3] 
133kDa Endothelial cells, 
cardiac myocytes, 
epithelial cells, 
reproductive organs 
Shear stress, 
histamine, 
bradykinin, 
thrombin,  
estradiol 
Constitutively 
expressed 
Calcium dependent 
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1.7. Macrophage phagocytosis 
Phagocytosis is a primordial adaptation. In primitive organisms it is primarily used for the 
acquisition of nutrients and in higher organisms it is an important process which is a 
critical former line of defence against invading pathogens (Aderem and Underhill 1999).  
Phagocytosis of pathogens by macrophages initiates the innate immune response, which in 
turn orchestrates the adaptive response. Professional phagocytes have a vast and 
sophisticated arsenal of microbicidal features. Phagocytosis can be broken down into a 
series of defined steps (Flannagan et al. 2009; Rieger et al. 2010).  
 Recognition of the particle 
 Adherence and  internalisation into the phagosome  
 Phagosomal maturation and degradation of ingested particle.  
1.7.1. Pathogen recognition 
 
Macrophages are able to sense and migrate up the concentration gradients of 
chemoattractants in search of primary sites of infection and inflammation through a 
process known as chemotaxis (El-Benna et al, 2009). During inflammatory conditions, 
macrophage migrate towards the infection site attracted by chemoattractants such as the 
complement fraction C5a, the N-formyl-methionyl-leucyl-phenylalanine (fMLF) peptide, 
interleukin 8 (IL-8) and leukotriene B4 (LTB4) released by mitochondria or bacteria (El-
Benna et al, 2009; Nathan and Cunningham -bussell 2013). 
 
A primary challenge to the innate immune system is the discrimination of numerous 
potential pathogens from self by using a restricted number of germ-line encoded 
phagocytic receptors (Medzhitov & Janeway, 2002; Aderem 2003; Taylor et al., 2005). 
Macrophages can differentiate between the self and non-self-molecules by scanning the 
chemical structure of the microbes. Pathogens usually possess some common conserved 
moieties called pathogen associated molecular patterns (PAMP’s) which are recognised by 
pathogen pattern recognising receptors (PRR) present over the macrophage surface.  
On the basis of function, PRR are divided into signalling PRR and endocytic PRR. 
Signalling PRR include membrane bound Toll like receptors (TLR), cytoplasmic 
nucleotide binding oligomerisation domain receptors (NOD) and G-protein coupled 
21 
 
receptors known as formyl peptide receptors.  Endocytic PRR recognise carbohydrate 
moieties and comprise mannose receptors, glucan receptors and scavenger receptors and 
are involved in microbial attachment, engulfment and destruction by macrophages (Taylor 
et al., 2005; Akira et al., 2006;Takeuchi & Akira, 2010).  
Induction of phagocytosis requires receptor-mediated recognition of particles. Ten TLRs 
have been identified in humans and 12 in mice. Different TLRs recognize the different 
molecular patterns of microorganisms and self-components. For example, TLR-2 
recognises peptidoglycan, TLR-3 recognises double stranded RNA, TLR-5 recognises 
flagellin and TLR-9 recognises unmethylated bacterial DNA. It is this receptor-ligand 
binding which orchestrate an immune response (Takeuchi and Akira, 2010). A diverse 
range of PRRs results in a rapid and efficient immune response to remove the 
microorganism from the host (Callol et al., 2013), however, species can evolve, changing 
targeted molecules on the cell surface to avoid detection and ingestion (Turvey and Broide, 
2010; Cambier et al., 2014; Kugelberg, 2014).  
Under normal conditions, the microbiota is the largest source of microbial stimulation in 
the gut. The recognition of microbial products may serve to prime the innate immune 
system, stimulation which is provided by the commensal bacteria (Clarke et al., 2010). 
Under these homeostatic conditions, there is a low expression of TLR2 and TLR4 and they 
are therefore unresponsive to TLR stimuli (Melmed et al., 2003; Abreu et al., 2001). 
However, under inflammatory conditions, TLR expression is increased, which contributes 
to both inflammation as well as immune tolerance (Abreu et al., 2002; Kivit et al., 2014). 
Ligation of suitable bacterial components with phagocyte receptors triggers the flushing of 
phagosome equipped with antimicrobial compounds. 
1.7.2. Pathogen Ingestion 
Once recognised by the macrophage’s PRRs then particle bound ligand is ingested via the 
process of phagocytosis (Aderem and Underhill, 1999; Booth et al. 2001). The cytoplasmic 
domain of the receptors recruits Rho GTPases, although the exact enzyme is dependent on 
the type of receptor, for example; complement receptors recruit Rho whilst Fc receptors 
recruit Rac and CDC42 (Castellano et al., 2000; Heasman & Ridley, 2008).  
Mammalian Rho GTPases comprise a family of 20 intracellular signalling molecules, well 
known for their important roles in regulating the actin cytoskeleton. Most Rho GTPases 
22 
 
switch between active GTP-bound and inactive GDP-bound conformations. The cycling of 
Rho GTPases between these two states is regulated by three sets of proteins; guanine 
nucleotide exchange factors (GEFs), GTPase activating proteins (GAPs) and guanine 
nucleotide dissociation inhibitors (GDIs).  The GDP bound form Rac1 and CDC42 are 
most likely to regulate actin polymerization, whereas Rac2 is activated in an F-actin 
depleted region at the base of the phagocytic cup (Castellano et al, 2000; Heasman & 
Ridley, 2008).  
In response to a chemotactic gradient, cells polarize and form a leading edge pointing 
toward the chemoattractant source and a posterior structure called the uropod. Actin 
polymerization within the leading edge drives up-gradient protrusion, whereas myosin 
activity in the uropod detaches at the rear of the cell. The proper coordination of these 
polarized events is essential for directional migration and depends on the asymmetrical 
distribution of specific molecular determinants. A hallmark of phagocyte polarization is the 
asymmetrical accumulation of the phospholipid phosphatidylinositol (3, 4, 5)-triphosphate 
[PIP3] in the leading edge. The formation of PIP3 is catalysed by Phosphatidylinositol 
kinases (PI3 kinase) (Chimini & Chavrier, 2000; Kuiper et al., 2011). The actin 
polymerisation underneath the receptor-ligand complex leads to the rearrangement of the 
cytoskeleton as two pseudopodia are driven around the target (Bokoch, 2005).  
A phagocytic synapse (junction) like structure is formed by the lipid rafts produced by 
localisation of heat shock proteins (hsp70 and hsp 90), CD14 and TLR-4 (Triantafilou et 
al., 2002; Pfeiffer et al., 2001). Lipid rafts are the membrane surface domains consisting 
mainly of cholesterol and glycosphingolipids and  are involved in cell signalling cascades, 
cell adhesion, migration and  macrophage phagocytosis  (Simons and Toomre, 2000; 
Gomez-Mouton et al., 2001; Nagao et al., 2011). These phagocytic synapses accumulate 
and cause the initial zippering of the membrane around the bacteria (May and Machesky, 
2001; Silverstein, 1995).  
The local reorganisation of F-actin that occurs at a phagosome is due, at least in part, to the 
recruitment and/or activation of actin-nucleating molecules like the seven subunit Arp2/3 
complex (Greenberg, 1995; Aderem and Underhill, 1999; May and Machesky, 2001). It 
has been described that phosphatidylinositol (3, 4, 5) triphosphate (PIP3) along with 
Arp2/3 complex is involved in the scanning of surfaces for the particle to be taken up 
(Gerisch et al., 2009). Nucleation of the actin cytoskeleton, restructuring of filament 
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network and formation of the phagocytic cup occurs once Arp2/3 complex and integrin β2 
are recruited under the lipid raft resulting in the formation of membrane phagosome. These 
activities would promote or stabilise the zipper-type interaction between the phagocytic 
receptors and the particle-bound ligands inducing a progressive engulfment of the particle 
and eventually the internalisation of the particle.  
Once most of the target is surrounded by the phagocyte plasma membrane, PI3 kinase 
activity leads to the final engulfment which results in the internalisation of the pathogenic 
material in a membrane closed phagosome (Araki et al., 1996; Weber et al., 2006).  
Calcium is considered to be an important secondary messenger in the transduction of 
signals during bacterial ingestion. Cytosolic calcium levels have been found to increase as 
a result of the binding of an immune cell surface receptors which leads to the rapid 
activation of a number of molecules involved in the promotion of cellular functions, 
including, activation of a number of signalling pathways (Gronski et al., 2009).  
Following the completion of the engulfing stage the actin is depolymerised and 
disassociates from the phagosome whilst the PRR, which is of no use to the macrophage 
internally, is recycled to the cell surface where it can once again bind its respective ligand. 
Such complex cytoskeletal remodelling during ingestion is accompanied by membrane 
remodelling locally, contributing to the pseudopod extension towards the cell and sealing 
into the phagosome (Greenberg & Grinstein, 2002). 
1.7.3. Pathogen digestion 
Pathogen digestion starts in mature phagosome. The phagosome maturation commences 
immediately after bacterial internalisation and sealing of the phagosome.  Maturation of 
phagosomes occurs via a series of fusion events with organelles of the endocytic pathway 
(Niedergang & Chavrier, 2004; Stuart & Ezekowitz, 2005). Ultimately, this leads to the 
insertion of lysosomal membrane proteins (LIMPII, Lamps) in the phagosomal membrane 
and to the delivery of lysosomal lytic enzymes into the lumen of the phagosome (Henry et 
al., 2004). The fusion and fission events are regulated by Rab and SNARE proteins. The 
Rab proteins (Rab 5, 7, 11) are key constituents or regulators of phagosome fusion 
machineries and help in the recognition of membranes that should fuse specifically (Pei et 
al., 2012). The SNARE proteins act as downstream regulators and are involved in pulling 
the membranes together for fusion up to a few nanometres (Duclos et al., 2000; Duclos, 
2003).  
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Accumulation of PI3P on the phagosomal membrane is vital and occurs soon after 
phagosome closure and is also essential for phagosome maturation (Desjardins et al., 1997; 
McBride et al., 1999; Duclos et al., 2000; Vieira et al., 2002). At the core of these multi-
layered changes, a degradative, highly acidic internal environment impeding microbial 
growth and metabolism is created (Flannagan et al., 2009). Several downstream regulators 
orchestrate phagosome maturation in a sequential manner. Syntaxin 7 and Syntaxin 13 
(belonging to the SNARE proteins family) present on late and recycling endosomes are 
involved in phagosome maturation. The SNARE complex along with Rab5 facilitates the 
fusion of phagosome and lysosome resulting in the formation of phagolysosome (Duclos et 
al., 2000; Duclos, 2003). In addition, phagosome acidification and calcium fluxes 
modulates phagosomes maturation (Collins et al., 2002; Harrison et al., 2003; Ungermann 
& Langosch, 2005; Yates et al., 2005; Verhaert et al.,2005; Haas, 2007). 
Concomitantly with phagosomes maturation two important processes are brought into play. 
The first course of action is known as respiratory burst, comprising the rapid and striking 
activation of oxidative metabolism and the production of superoxide (Halliwell and 
Gutteridge, 2006; Niedergang and Chavrier, 2004) and concomitant toxic species. The 
second process, called degranulation, corresponds to the release of the contents of 
cytoplasmic granules into the endosomal vacuole.  
 
The permutation of these processes results in the killing and digestion of the engulfed 
bacteria and the development of an inflammatory response. The secondary recruitment of 
circulating neutrophils and macrophages is triggered by a number of additional 
chemotactic factors released from the site of inflammation. It has been shown that 
unstimulated human phagocytes consume relatively little O2 (less than 1 n mol O2. min
-1. 
107 cells at 37°C). Within a few seconds after contact with specific stimuli, the rate of O2 
consumption abruptly increases by a factor of 50 – 100 (Morel et al., 1991). The collective 
outcome of free radical production leads to impaired bacterial metabolism and irreparable 
DNA damage leading to bacterial killing (Flannagan et al. 2009; Dupre-Crochet et al., 
2013). 
 
Phagosomes are also equipped with a mixture of endopeptidases, exopeptidases and 
hydrolases that degrade various microbial components. Lactoferrin creates a bacteriostatic 
condition within phagosomes by creating a nutrient deprived environment. The low pH in 
the phagosomes results in bacterial degradation. Defensins and cathelicidins cause 
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membrane permeabilisation. Lysozyme causes hydrolysis of carbohydrates while 
phospholipase A2 causes hydrolysis of lipids. Several proteases including cathepsin D, 
cathepsin G and aminopeptidases are involved in bacterial protein hydrolysis (Underhill & 
Ozinsky, 2002; Flannagan et al., 2009).  
 
1.8. Free radicals or Reactive species 
 
A free radical can be defined as ‘any species capable of independent existence (hence the 
term free) that contain one or more unpaired electrons (Halliwell and Gutteridge, 2006). 
Reactive oxygen species (ROS) is a collective term that may be either oxygen or non-
radical oxygen derivatives. Hence, all oxygen radicals are ROS but not all ROS are oxygen 
radicals (Halliwell and Gutteridge 2006). Similarly, reactive nitrogen species are nitrogen 
derived radical or non-radical species. There is some degree of overlap or confusion in 
literature about the classification of free radicals. For example peroxynitrite (ONOO-) and 
nitric oxide (NO or also referred as NO.) may be classified either way. A list of free 
radicals commonly mentioned in literature is listed in table 1.5. A role of free radicals on 
phagocytosis by macrophages is listed in table 1.6.  
 
For several years ROS was considered as an inevitable but unwanted by-product of an 
aerobic existence. The ROS is now well recognised and are known to act as second 
messengers that regulate intracellular signal transduction pathways under a variety of 
physiological and pathophysiological conditions (Moraes et al., 2006; Dupre-Crochet et 
al., 2013). This occurs predominantly via oxidation of thiols (-SH) on protein cysteine 
residues, resulting in reversible protein posttranslational modifications such as 
glutathionylation, disulfide bond formation and sulfenic acid formation (Hattori et al., 
2010). 
 
The NADPH oxidase mediated ROS production also acts as a physiological regulator of 
pseudopod formation and was found highly enriched near the leading edge of migrating 
neutrophils (Hattori et al., 2010). In addition, the NADPH oxidase is also essential for 
chemoattractant-elicited depolarization of membrane potential and can regulate Ca2+, K+ 
homeostasis in neutrophils (Rada 2005; Hattori et al., 2010).  
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Table 1.5: Reactive oxygen and nitrogen species. Table 1.5 shows a list of reactive oxygen 
and nitrogen species produced in our body differentiated as radical and non-radical species. 
 
 
 
 
 
 
 
 
Upon activation by various stimuli, the macrophage NADPH oxidase transfers electrons 
from the cytosolic NADPH to molecular oxygen releasing superoxide into the phagosomal 
lumen (see equation 1 below). Inside the phagosome, oxygen free radicals are then 
converted rapidly to hydrogen peroxide (H2O2). The H2O2 can also be converted by 
myeloperoxidase into hypochlorous acid and chloramines. These compounds appear in 
parallel in the phagosome at quite different concentrations (DeCoursey and Ligeti, 2005; 
Klebanoff, 2005). The ROS scavenging enzymes namely, superoxide dismutase (SOD) and 
catalase also plays a vital role in ROS production by macrophages. The SOD converts 
superoxide to hydrogen peroxide (see equation 2) while catalase catalyses the conversion 
of H2O2 to water and oxygen (see equation 3) (Slauch, 2011).  
 
 
 
 
 
 
 
 
 
                               Reactive oxygen and nitrogen species 
Radicals                                                            Non-radicals 
Superoxide [O2.-] Hydrogen peroxide [H2O2] 
Hydroxyl [OH.]     Peroxynitrite [ONOO-] 
Nitric oxide [NO or NO.] Organic peroxides[ROOH] 
Alkoxyl [RO.] Hypochlorous acid [HOCl] 
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1.8.1. Role of ROS during bacterial ingestion 
The ROS are identified as essential players for modulating chemotaxis and are known to 
regulate the process of chemotaxis by directly modulating actin glutathionylation and 
polymerization (Sakai et al., 2012). Studies by Sakai et al. (2012) found that the 
pharmacological inhibition of oxidative burst resulted in complete inhibition of actin 
glutathionylation, suggesting that NADPH-oxidase mediated ROS plays a key role in 
eliciting actin glutathionylation.  
Evidence that ROS influence phagocytosis is provided by the observation that the 
amplification of ingestion during phagocytosis is deficient in neutrophils from patients 
with chronic granulomatous disease (Gresham et al 1988; Fialkow et al., 2007). The 
neutrophils with inhibited ROS production formed more frequent multiple pseudopodia 
and showed reduced chemotaxis efficiency as they migrated up a chemoattractant 
concentration gradient (Kuiper et al., 2011; Sakai et al., 2012). 
Reactive oxygen intermediates such as H2O2 also enhance the Fcγ receptor (FcγR) 
signalling and amplify phagocytic capacity. The FcγR mediate the internalisation of 
opsonized particles by mononuclear phagocytes. Cross-linking of FcγR leads to the 
activation of protein tyrosine kinases and phosphorylation of immunoreceptor tyrosine-
based activation motifs (ITAMs) within FcγR subunits, both obligatory early signals for 
phagocytosis (Pricop et al., 1999). In an inflammatory environment hydrogen peroxide is 
produced by activated macrophages at an estimated rate of 2–6 x 10-14 mol.hour-1 cell-1 and 
may reach a concentration of 10–100 μM in the vicinity of these cells (Nathan and Root 
1977; Keisari et al., 1983; Droge 2002).  
Studies by Kuiper et al. (2011) hypothesised that local ROS production in phagocytes such 
as neutrophils could regulate Phosphatidylinositol (3, 4, 5)-triphosphate (PIP3) levels 
through redox regulation of Phosphatase and tensin homolog-a phosphatase (PTEN). The 
PTEN negatively regulates PIP3 by dephosphorylating phosphoinositide substrates. They 
further identified PTEN to be a major target of chemoattractant induced ROS formation 
and demonstrate that ROS production down regulates PTEN activity (Shelton et al., 2005; 
Clavreul et al 2006; Hattori et al 2010). Decreased PTEN activity is found to increase 
PIP3, which could be reversed by ROS scavengers or genetic ablation of NADPH oxidase 
(Kuiper et al., 2011).  
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1.8.2. Role of ROS in bacterial digestion 
 
The first role of ROS discovered in phagocytes was their microbicidal activity which can 
be attributed to a sequence of chemical reactions happening both inside and outside the 
phagosomes (Dupre-Crochet et al., 2013). Bacterial digestion or killing occurs due to 
production of ROS within the macrophage phagosome. The hydroxyl radical is perhaps the 
most reactive of ROS and as it rapidly combines with target molecule in its immediate 
vicinity, can initiate a free radical chain reaction leading to the peroxidation of lipids and 
proteins. Superoxide is less reactive than hydroxyl radicals and thus may diffuse some 
distance in the cell before it encounters an appropriate reaction partner. Hydrogen peroxide 
is even less reactive and therefore longer lived. Additionally, H2O2 is membrane permeable 
and thereby can easily reach the extracellular space from phagocytic cells and diffuse other 
cells and thus exhibits a paracrine role (Fialkow et al., 2007). The importance of ROS 
mediated bacterial killing by phagocytes is evidenced in CGD where the individual suffers 
from life threatening microbial infections (Meischl and Ross 1998; Kannengiesser et al., 
2008, El-Benna et al., 2009; Dupre-Crochet et al., 2013). 
Upon phagocytosis of bacteria, ROS is produced by NADPH oxidase in the small volume 
of phagosome. The ROS is not only produced on the phagosomal membrane, but is also 
observed on non-phagosomal intracellular organelles.  Winterbourn et al., (2006) estimated 
the concentration of superoxide by modelling the steady state concentration of superoxide 
in phagosomes. The steady state concentration of superoxide and hydrogen peroxide were 
found to be 25 μM and 2 μM respectively (Winterbourn et al., 2006).  
The fusion of azurophilic granules containing myeloperoxidase enzyme with the 
phagosomes results in the formation of HOCl from Cl and H2O2 (Klebanoff, 2005).  
Winterbourn et al. (2006) estimated that HOCl is produced at a rate of 134 mM min-1 and 
the concentration of phagosomal myeloperoxidase was ~1 mM. Nevertheless, the 
consequence of myeloperoxidase deficiency is not as drastic as expected as several major 
ROS producing myeloperoxidase independent killing mechanisms exist (Park et al., 2005; 
Dupre- Crochet et al., 2013).  
The ROS not only kills the bacteria but also influences the overall environment of the 
phagocyte. Extracellular ROS production and the diffusion of ROS like H2O2 across the 
membrane enable ROS signalling in the extracellular space and in neighbouring cells. The 
ROS are often considered as a stimulator for inflammation and a mediator of inflammatory 
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tissue damage, however evidence for the anti-inflammatory role of ROS is also 
accumulating (Lambeth et al., 2008; Sareila et al., 2011). 
1.8.3. Role of RNS in macrophage phagocytosis 
 
The NO is a critical component of mammalian host defence that is produced 
in macrophages and other cells comprising the innate immune system. The discovery that, 
iNOS from activated macrophages produce copious amount of nitric oxide and their 
subsequent derivatives provided a new perspective of bacterial killing (Fang 2004).  
 
The NO is toxic at high concentration, as it can inactivate critical enzymes essential for 
microbial physiological processes such as mitochondrial aconitase and NADH: ubiquinone 
oxidoreductase by interacting with iron sulphur centres to form iron sulphur nitrosyl 
derivatives, and inhibit both DNA and protein synthesis (Haddad et al., 1994; Stamler et 
al., 2001; Schapiro et al., 2003). In previous studies it is indicated that NO is an important, 
but possibly not essential, contributor in the control of the acute phase of parasitic 
infections (Qiu et al., 2009).  
 
Macrophages have the opportunity to produce superoxide and NO in nearly equimolar 
amounts and thus can be proliferic generators of their joint and particularly destructive 
product peroxynitrite (Haddad et al., 1994; Fang, 1997). In the intraphagosomal 
environment, NO can combine with ROS and undergo either spontaneous or catalytic 
conversion to a range of RNS, including nitrogen dioxide, peroxynitrite, dinitrogen 
trioxide, dinitrosyl iron complexes, nitrosothiols and nitroxyl radicals (Dupre-crochet et al 
2013). 
 
Studies have shown that peroxynitrite was toxic to invading bacteria from the detection of 
3-nitrotyrosine residues in the proteins of infected human cells or tissues (Beckman et al., 
1992; Ischiropoulos et al., 1992; Evans et al., 1996). It is known that activated alveolar 
macrophages release both NO and superoxide which reacts at a near diffusion limited rate 
6.7 x 109 M-1s-1 to form peroxynitrite (Haddad et al 1994; Xia & Zweier, 1997; Nathan & 
Shiloh, 2000; Lundberg et al., 2004; Nioche et al., 2004).  
 
Under mildly acidic conditions peroxynitrous acid (ONOOH) may form as the result of 
interaction between nitrite and hydrogen peroxide (H2O2) which can kill bacteria such as E. 
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coli (Kono et al., 1994). Another possible method of NO toxicity relies upon the formation 
of S-nitrosothiols (RSNO) (De groote et al., 1995; Vallance and Charles 1998). However, 
many RSNO have bacteriostatic effects on bacteria such as E. coli and Salmonella that are 
resistant to NO (Vallance and Charles 1998). Bacteria such as Staphylococci, which are 
deficient in low molecular weight thiols such as glutathione, are sensitive to S-nitrosothiols 
as they are unable to protect themselves. On the other hand bacteria such as E. coli with 
high thiol concentrations are normally resistant to NO itself but are sensitive to 
peroxynitrite and S-nitrosothiols (Vallance and Charles 1998). 
 
The nitric oxide synthase activity of iNOS requires the enzyme to be in dimeric form. 
Work by Sun et al. (2010) found that the oxidative stress acts as a brake on the NO 
generation by conversion of the active iNOS dimer in to inactive monomer (NOS 
uncoupling). They also proposed that decrease in iNOS activity was also due to oxidation 
of tetrahydrobiopterin (BH4) an important co-factor for NOS. 
 
The L-arginine is the main substrate for NO production from iNOS. Study by Xia and 
Zweier, (1997) found that depleting the cytosolic L-arginine triggered production of both 
superoxide and NO generation from iNOS, which combined to form peroxynitrite. They 
observed that, this iNOS mediated increase in the peroxynitrite formation resulted in the 
increased antibacterial activity by RAW 264.7 macrophages. Thus iNOS mediated 
superoxide and peroxynitrite generation could be particularly important in the cytotoxic 
action of macrophages.  
 
Studies by Murray and Nathan attempted to determine the in vivo macrophage microbicidal 
mechanism and tried to identify the relative contribution of ROS and RNS in macrophage 
mediated intracellular host defence. In early stage (2 weeks) of liver infection with 
Leishmania donovani, an intracellular parasite, they found that both gp91phox-/- and iNOS 
knockout mice displayed increased susceptibility to infection. They concluded that ROS 
and RNS probably act together during the first two weeks or the early stage of intracellular 
infection to regulate mononuclear inflammatory cells and the initial extent of microbial 
replication. However, they also found that RNS alone is sufficient for the eventual control 
of visceral infection (Murray & Nathan, 1999). 
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Study Microbe/ 
Stimulus 
Macrophage 
source 
Treatment Experiment 
condition 
Effect on phagocytosis Inference 
 
Van der Goes 
et al., (1998) 
Myelin Rat peritoneal 
macrophages 
100 mM 
Apocynin 
In vitro Decreased uptake of myelin ROS regulates myelin 
phagocytosis 
   
   100 μM DPI In vitro Decreased uptake of myelin 
   Allopurinol In vitro No effect on myelin uptake 
Gantt et al., 
(2001) 
Leishmania 
chagasi 
Human 
monocyte 
derived 
macrophages 
(MDM) and 
Murine bone 
marrow 
derived 
macrophages 
(BMM) 
 
0.4 mM 
Tempol 
 
 
 
 
 
 
In vitro No effect on bacterial uptake. 
However, significantly 
increased level of infection in 
Human MDM. Murine BMM 
also had increased levels of 
infection but non-significant. 
 
Both superoxide and NO 
contribute to intracellular 
killing of L. chagasi in 
human and murine 
macrophages. 
1 mM        
L-NMMA 
In vitro Significantly higher parasite 
burden compared with 
untreated control BMM and 
MDM 
Philippe et al., 
(2003) 
Aspergillus 
fumigatus 
conidia 
Murine 
macrophages 
DPI 
PAO 
In vitro No effect on uptake. 
Significantly reduced in vitro 
killing 
 
A. fumigatus killing is 
mediated by reactive 
oxygen intermediates. 
     
Table 1.6: Role of free radicals on phagocytosis by macrophages. [Bone-marrow derived macrophages (BMM); NG –monomethyl - L-
Arginine (L-NMMA); Diphenylene iodonium chloride (DPI); Monocyte derived macrophages (MDM); Phenylarsideoxide (PAO)] 
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  Segal et al., 
(2003) 
Burkholderia 
Cepacia 
 
Chromobacterium 
violaceum 
 
Murine 
macrophages 
 In vivo Despite the lower inoculum 
in p47 phox-/- mice, the 
bacterial burden was higher 
than those in iNOS-/- and 
wild-type mice. 
Phagocyte NADPH 
oxidase but not iNOS is 
essential for  early control 
of infection 
Brennan et al.,  
(2004) 
Coxiella 
burnetti 
Murine 
macrophages 
J774.16 
 
Catalase 
 
L-NMMA 
 
In vitro J774.16 significantly 
inhibited bacterial replication. 
Catalase and L-NMMA 
reversed the effect 
Both iNOS and NADPH 
oxidase contribute to the 
control of virulent phase-1  
C. burnetti infection 
C57BL/6 
 
C57BL/6 
(p47 phox-/-) 
 
C57BL/6 
(iNOS-/-) 
 In vivo 
 
 
 
 
 
iNOS-/-  were less effective at 
controlling C.burnetti than 
wild type and that p47 phox-/-  
mice were even less effective 
than iNOS-/- 
Qiu et al., 
(2009) 
Acinetobacter 
baumannii 
Murine 
macrophages 
C57BL/6 
 
B6.129S-
Cybb tm1Din/J 
gp91 phox-/- 
 
B6.129P2-
NOS2tm1 Lau/J 
iNOS-/- 
 In vivo gp91phox-/- but not NOS2-/- 
mice are highly susceptible to 
A. Baumanni infection. 
NADPH phagocyte 
oxidase appears to have a 
crucial role in host defence 
against A. Baumanni 
infection. 
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1.9. Research gaps, novelty, aims and objectives  
 
Though probiotics have been shown to have multiple effects on macrophages, the exact 
mechanism is still contested. One approach this study employed was to investigate the 
effect of probiotic conditioned media from a single probiotic strain Lactobacillus 
rhamnosus GG on macrophages and understand the bacterial-macrophage interactions.  
Current literature on the role of probiotics into the phagocytic process by the phagocytic 
cells such as macrophages is mostly looked at the total number of phagosomes after a 
certain time period.  Studies have described the effect of probiotics as either an increase or 
decrease in phagocytosis. None of the studies looked at the effect of cell free LGG-CM on 
phagocytosis as two phases of phagocytosis namely ingestion and digestion. The purpose 
of this study was to differentiate the effect of LGG-CM on bacterial ingestion and 
digestion as two separate entities.  
There is also a gap in understanding of the role of LGG-CM mediated NO and ROS 
production and regulation by murine macrophages. Most of the studies investigating free 
radicals production from macrophages have investigated the ROS production as an end 
point study and have investigated ROS production at one or two time points. This study 
has identified this gap and investigated the effect of LGG-CM as a continuous study and 
has examined the pattern and kinetics of free radical production by macrophages. 
So far, to the best of our knowledge, there are no studies that report or demonstrate 
whether probiotics exert their effect through the release of soluble factors with the inherent 
ability to induce ROS generation or indeed activate a signalling cascade that might regulate 
NO production in a parallel system. The hypothesis of this study was that the LGG-CM 
modulates macrophage phagocytic activity. 
This research aims to: 
 Investigate the effect of cell-free LGG-CM on bacterial macrophage interactions with 
respect to bacterial phagocytosis. 
 Understand the physiological mechanisms of the observed functional attribute with 
respect to free radical production in presence of LGG-CM. 
. 
 
 
34 
 
 
To achieve the above aims, the following objectives are met by this research: 
1. Understanding the role of probiotics as immunomodulatory agents from existing 
literature. 
2. Preparation of an effective LGG-CM and determining the methods to investigate the 
influence of LGG-CM on murine macrophages using various microbiological and 
immunological techniques. 
3. Identifying the effect of LGG-CM on macrophage and bacterial viability. 
4. Understanding the effect of LGG-CM on NO production by macrophages. 
5. Identifying the effect of LGG-CM on bacterial phagocytosis process by macrophages  
6. Understanding the role of LGG-CM on signalling mechanisms modulation of observed 
functional attribute (phagocytosis). 
7. Discussion and comparison of current findings with respect to existing literature and 
recommendations for future work. 
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2.0. CHAPTER 2 
 
A list of chemicals used in the experiments is listed in appendix A. 
2.1. Culturing and sub-culturing of murine macrophage cell line J774 
 
The murine macrophage cells J774 were gratefully received as a gift from Professor Anwar 
R Baydoun, University of Hertfordshire. 
 
The J774 cells were cultured in T-75 tissue culture flasks which were labelled with cell 
type, date and passage number. The J774 cells were grown in Dulbecco’s modified Eagle 
medium (DMEM) supplemented with 10 % Fetal Bovine Serum (FBS) and 1 % 
penicillin/streptomycin in a humidified tissue culture incubator at 370C and 5 % CO2. The 
cells were sub-cultured every 2 to 3 days after examining the confluency under Olympus 
CKX41 inverted culture microscope at 400 x magnification.  
 
2.1.1. Storage of macrophages 
 
Sub-culturing of cells was performed to prevent the T-75 flask surface adhered 
macrophages to exceed the flask capacity. This process was performed depending upon 
cell growth, typically every 2 to 3 days.  
 
The J774 cells were grown and made up a stock for future experiments and stored at -800C 
in liquid nitrogen. Approximately 5 x 106 cells ml-1 were stored in a cryovials containing 1 
ml of freezing mixture (10 % Dimethyl sulfoxide and 90 % FBS). These vials were frozen 
at -800C in a Haier ULT freezer DW-86L490.  After 24 hours the vials were transferred to 
storage in a liquid nitrogen container (CN509X7, Thermo Scientific Thermolyne) until 
required. 
 
When needed, frozen cells were carefully removed from liquid nitrogen containers and 
rapidly defrosted in a 370C water bath taking care not to submerge the vial. The contents 
were then slowly pipetted out in to T-25 flasks containing 4 ml of prewarmed media 
(370C). The cells were then incubated at 370C in a humidified 5 % CO2 atmosphere and 
allowed to attach. After a few hours, the flasks were removed from the incubator. The old 
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media containing any dead cells and traces of DMSO was removed and replenished with 
fresh macrophage culture media and incubated further to grow. 
2.1.2. Enumeration of macrophages 
 
Macrophages were counted by the trypan blue dye exclusion method. A confluent 
monolayer of J774 cells were scraped and then aspirated with a Pasteur pipette. Then, 100 
µl of the sample was mixed with 100 µl of 0.4 % trypan blue and added to two chambers 
of the haemocytometer (Neubauer type) and covered by a cover slip.  The cell suspension 
was allowed to settle for at least 15 seconds. The haemocytometer was placed onto a 
microscope stage and cells in the middle, large square of each chamber (with an area of 1 
mm2 and a depth of 0.1 mm) were counted. The averaged cell number was multiplied by 2 
as it was diluted in trypan blue. The following equation was used to enumerate the total 
number of macrophages per ml. 
≈ Number of cells per ml = [Mean cell count x Dilution Factor] x Conversion factor 
                                         = [Mean cell count x 2] x 104 
2.2. Culturing and storage of Lactobacillus rhamnosus GG (LGG) 
A pure culture of LGG was extracted from a Culturelle® probiotic tablet. The tablet was 
split open under sterile conditions and inoculated into 100 ml de Man, Rogosa and Sharpe 
(MRS) broth (52 g MRS L-1 distilled water) and incubated in an orbital incubator at 370C 
at 150 rpm. As it was not possible to start each time with a Culturelle® tablet, some cells 
were stored at -800C. To accomplish this, after confirmation of attainment of the 
exponential phase the culture was centrifuged for 10 minutes at 5000 rpm. The supernatant 
was discarded and bacterial cells were suspended in cryovials containing 15 % glycerol 
and 85 % MRS broth and stored at -200C. 
2.2.1. Monitoring the bacterial growth and change in pH of LGG culture 
medium 
 
The LGG were cultured in MRS broth at 370C according to ATCC guidelines. Frozen 
stocks (-200C) of LGG were inoculated in prewarmed MRS broth grown at 370C and 150 
rpm for 16 hours. From this, a 1 ml sample of overnight LGG culture was transferred to a 
fresh and sterile MRS medium. An aliquot was collected every hour for optical density 
(600 nm) measurements and pH readings. The readings were taken every hour up to 12 
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hours. Due to laboratory time constraints the next readings were after 24 hours. The 
bacterial growth curve was constructed by plotting the absorbance against time. 
 
2.2.2. Preparation of LGG conditioned cell culture medium (LGG-CM) 
 
Cell-free LGG-CM was prepared using a slightly modified method from studies by 
Christensen et al. (2002) and Yan et al. (2007). The frozen stocks (-200C) of LGG were 
inoculated in MRS broth grown at 370C and oscillated at 150 rpm for 18 hours. From this 
culture, 1 ml of overnight LGG culture was transferred to a fresh and sterile MRS medium 
and incubated at 370C and 150 rpm for 18 hours. 
 
The LGG culture in MRS broth was then centrifuged for 5 minutes at 10,000 rpm and the 
supernatant discarded. The bacterial pellet was washed twice with Phosphate buffered 
saline (PBS) and the pellet was suspended in 40 ml DMEM and incubated for a further 20 
to 24 hours (late exponential or early stationary phase). The LGG culture in DMEM was 
then centrifuged for 5 minutes at 10,000 rpm. To obtain a cell-free conditioned medium; 
the supernatant extracted after centrifugation was filtered through 0.45 µm Minisart® 
syringe filters followed by 0.22 µm Millipore syringe filters. The supernatant was then 
aliquot into small Eppendorf tubes and stored at -200C for future use.  
2.2.3. Enumeration of Lactobacillus rhamnosus GG 
 
To enumerate the LGG count inoculated to prepare cell-free LGG-CM, a 100 μl aliquot of 
LGG culture was serially diluted and plated onto MRS agar plates and incubated at 370C 
for 24 hours. The bacterial colonies (white, convex, smooth, opaque and round colonies of 
LGG) were enumerated by colony counting technique. 
2.3. Culturing, storage and enumeration of E. coli HfrC 
To culture the E.coli cells nutrient broth was prepared by adding 13 g of nutrient broth in 1 
litre of water. A 50 ml aliquot of media was added to each flask and autoclaved. Nutrient 
agar media was prepared by dissolving 28 g of nutrient agar in 1 litre of water and 
autoclaved. The agar was poured into sterile petridishes under sterile conditions and left to 
solidify overnight. The plates were then inverted to prevent any condensation and left to 
dry for at least 3 days prior to use. The E. coli frozen at -200C were thawed down and 1 ml 
of E.coli suspension from frozen stock was used to inoculate 50 ml of nutrient broth at 
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370C and 150 rpm. The media was incubated for 9 hours. Then 100 µl of fresh E.coli 
culture was inoculated into 50 ml nutrient broth and incubated overnight at 370C and 150 
rpm. The bacterial cell number were enumerated by serial dilution and plating techniques. 
The optical density of bacterial suspension can be adjusted from growth curve and for 
E.coli OD600=1, corresponds approximately to10
9 CFU ml-1.  
2.4. Experiments investigating antimicrobial properties of LGG-CM 
 
To determine whether the LGG-CM demonstrated antibacterial properties within the 
specified time frame of incubation of E. coli HfrC, the E. coli was grown overnight in 
nutrient broth at 370C and 150 rpm. A 1 ml sample of bacterial culture was centrifuged and 
the pellet was washed with DMEM carefully and suspended in 1ml of DMEM/FBS devoid 
of penicillin/streptomycin. A 22 μl of this suspension was dispensed in 1 ml of varying 
concentrations of acid neutralised LGG-CM (5 %, 10 % and 75 % and 100 % LGG-CM, 
pH 7.4 ± 0.2) for 1 hour, 6 hours and 24 hours respectively. After the respective time 
periods, the cells were serially diluted and plated onto nutrient agar plates. The viable 
bacterial colonies were enumerated by colony counting technique after incubating the 
plates for 20 hours at 370C and were expressed as log10 CFU ml
-1. 
 
2.5. Effect of LGG-CM on macrophage viability 
2.5.1. Background to MTT cell proliferation assay 
 
The MTT [3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide, a tetrazole)] 
assay is a colorimetric assay, which is based on the cleavage of yellow tetrazolium salt 
MTT to purple formazan crystals by metabolically active cells (Mosmann, 1983; Vistica et 
al., 1991). This assay is mainly used to investigate the effect of any treatment on cell 
viability and proliferation. 
The absorbance of the purple coloured formazan solution was measured at two different 
wavelengths 562 nm (test wavelength) and 620 nm (reference wavelength). Subtracting the 
readings of reference wavelength from test wavelength eliminates any background noise 
such as debris or scratches. The reduction of MTT takes place only when mitochondrial 
reductase enzymes are active, and therefore conversion can be directly related to the 
number of viable cells. By comparing the amount of purple formazan produced by cells in 
presence of treatments to the amount of formazan produced by untreated control cells, the 
effect of the treatments on cell viability and proliferation can be figured out. The MTT 
40 
 
solubilised in phosphate buffered saline (PBS) are yellowish in colour. Mitochondrial 
dehydrogenases of viable macrophages cleave the tetrazolium ring into purple MTT 
formazan crystals which are insoluble in aqueous solutions. The crystals can be dissolved 
in solvent like acidified isopropanol (originally described by Mosmann, 1983) or the 
method by Tada et al. (1986), where 10 % SDS in 0.01 M HCl was used as solvent. An 
increase in cell number results in an increase in the amount of MTT formazan formed and 
an increase in absorbance. 
 
2.5.2. Macrophage number optimisation for MTT assay 
 
Stock solutions of MTT were prepared by dissolving one vial of MTT (5 mg) in 1 ml 
sterile PBS. The solution was mixed and vortexed until completely dissolved. The MTT 
solutions were quickly aliquot and stored in dark at -200C.  
 
Macrophages were scraped and cell number was adjusted to 5x105 cells ml-1. Cells were 
diluted and seeded at various cell densities from 1000 to 500000 cells ml-1 in a 96 well 
plate and were allowed to attach. After cell attachment, 10 µl of MTT (stock solution 5 mg 
ml-1 in PBS) was added to 100 µl of the medium in the 96 well plates. The microplate was 
incubated for 4 hours at 370C and 5 % CO2 in a humidified incubator. The wells in the 
microplate were then viewed through an inverted microscope for the formation of 
intracellular purple punctate formazan precipitate. Then 100 µl of solubilisation solution 
(10 % SDS in 0.01 M HCl) was added making sure not to remove any crystals from the 
well. The plates were left in a humidified cell culture incubator overnight. The plates were 
visualised after confirming the complete solubilisation of formazan crystals. The optical 
density reading was read at 562 nm and 620 nm in a microwell plate reader (Asys Hitech 
expert plus, SLS). The reference wavelength values were subtracted from the respective 
test wavelength values. The percent viability was then calculated by using the formula:    
                                                          ] 
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Figure 2.1: Cell optimisation for macrophage viability studies. The figure represents the 
cell number and respective optical density reading in the macrophage cell optimisation experiment 
by MTT assay. Results are expressed as the mean absorbance of 3 experiments performed in 
triplicate. Experiments were performed to determine optimal cell concentration for MTT assay. The 
optical density readings were taken at 562 nm and 620 nm respectively. Final absorbance was 
calculated by subtracting optical density readings from 562 nm with reference wavelength 620 nm. 
 
2.5.3. Cell proliferation assay in presence of LGG-CM 
 
Macrophages were cultured in T-75 flasks and sub-cultured when confluent. For MTT 
assay, the macrophages were scraped and enumerated by trypan blue assay as described in 
section 2.1.2. Macrophage optimisation for MTT assay was performed as described in 
section 2.5.2.  
 
For investigating the effect of cell-free LGG-CM on macrophage viability and 
proliferation, macrophages were seeded at a cell density of 1x105 cells ml-1 at least 4 hours 
before the addition of treatments.  Cell free LGG-CM was prepared at the dilutions of 10 
% LGG, 75 % LGG and 100 % LGG, both in the presence and absence of 20 μg ml-1 LPS. 
Macrophage viability was also assessed in the presence of E. coli in the above treatments. 
Macrophages were incubated with various treatments for various time periods. After the 
respective time periods MTT reagent was added and incubated for 4 hours. The formation 
of purple formazan crystals were observed under 400 x magnification in an inverted 
culture microscope. This was followed by the addition of 100 μl of solubilisation solution 
to dissolve the formazan crystals. The percent cell viability was calculated as in section 
2.5.2 after measuring the absorbance at 562 nm and 620 nm in a microplate reader.  
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
0 1000 10000 100000 200000 300000 400000 500000 
O
D
 [5
62
-6
20
nm
] 
macrophages/ml 
42 
 
2.6. Measurement of total nitrite using Griess assay 
The NO is synthesised in the biological system by the enzymes nitric oxide synthases. The 
NO is short lived and gets easily converted to nitrite, a stable end product by reacting with 
oxygen.  
The total nitrite concentration in the cell culture medium is often used as an indication for 
total NO production (Green et al., 1982; Sun et al., 2003). Griess assay is therefore used to 
measure total nitrite in the cell culture medium. The principle is based on the diazotisation 
reaction where nitrite reacts with Griess reagents (1:1 ratio of 1 % sulfanilamide in 10 % 
orthophosphoric acid [reagent 1] and 0.2 % napthylethylenediamine [reagent 2] to form an 
azo dye (figure 2.2).  
 
 
 
Figure 2.2: Chemistry of Griess reaction. Nitrite reacts with Griess reagents to form an azo 
product that absorbs strongly at 540 nm [Image adapted from Sun et al., 2003] 
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2.6.1. Preparation of nitrite standard curve 
A stock solution of 0.1 M sodium nitrite (NaNO2) was prepared by dissolving 34.5 mg of 
sodium nitrite in 5 ml of DMEM. A 1 mM working solution of sodium nitrite was then 
prepared by adding 40 μl of 1 M sodium nitrite to 3960 μl DMEM. Various dilutions of the 
working solutions were prepared as in table 2.1.  
 
Table 2.1: Protocol for preparing a standard curve using sodium nitrite. Various 
concentrations of sodium nitrite solutions were then prepared by diluting working solutions of 
sodium nitrite as shown in table 2.1. 
 
 
 
 
 
 
 
 
 
 
 
 
A serial dilution of sodium nitrite solution (1, 2, 3, 4, 5 and 10 nmoles per 100 μl) in the 
cell culture medium was prepared to use as standards. Then, 100 μl of standards ranging 
from 0 to 10 nmoles per 100 μl were added to sterile 96 well plates.  The Griess reagent 
(1:1 mixture of Reagent 1 and Reagent 2) was prepared and 100 μl added into each well. 
The plate was incubated for 15 minutes at room temperature and the absorbance was 
measured at 540 nm in a micro-plate reader (Asys Hitech microplate reader). The 
instrument was switched on 20 minutes before use and the calibrations were performed for 
the desired wavelength. Digiread software was used to control the instrument and collect 
the raw data and transfer to Microsoft excel. A standard curve of sodium nitrite was 
constructed by plotting the absorbance of serial dilutions of sodium nitrite against nitrite 
concentrations. 
Volume of 1 mM 
NaNO2 (µl) 
Volume of DMEM 
(µl) 
      Final [NaNO2]  
(nanomoles / 100 µl) 
0 1000 0 
10 990 1 
20 980 2 
30 970 3 
40 960 4 
50 950 5 
100 900 10 
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y = 0.1123x + 0.0331 
R² = 0.9967 
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2.6.2. Calculations to measure nitrite produced from macrophages using a 
standard curve 
 
A standard curve of sodium nitrite was constructed by plotting the concentration of sodium 
nitrite on the x-axis and related absorbance value on the y-axis. A linear trendline equation 
and R2 value (co-efficient of determination) was then plotted on the graph.  
A linear trendline equation         was used to calculate the unknown concentrations 
of nitrite produced from various treatments. The x-coordinate corresponds to the unknown 
concentration to be determined, m is the slope or the gradient of the trendline and C is the 
y-intercept. To determine the unknown concentration (x-value) from the optical density 
reading corresponding to the standard curve, the following steps were followed. (An 
example of slope and y-intercept values are taken from figure 2.3, where m=0.1123 and 
C=0.0331). 
       
          
 Substituting the values from the standard curve, 
                                                                            
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: A standard curve of nitrite generated by Griess assay. The graph represents  
an example for a standard curve of nitrite. A linear trend line equation used to estimate the nitrite 
concentration of the unknown sample is depicted in the graph with its corresponding R2 value. 
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2.6.3. Effect of LGG-CM on nitrite production from macrophages 
 
To determine the effect of LGG-CM on nitrite production, macrophages were enumerated 
and plated in 24 well plates and incubated in a humidified cell culture incubator at 370C 
and 5 % CO2. The macrophages were then treated with serial dilutions of LGG-CM both in 
the presence and absence of LPS for 24 hours. After the incubation period, the nitrite 
accumulated in the spent culture medium from each well was measured by Griess assay.  
 
2.7. Experiments monitoring macrophage phagocytosis of bacteria by 
gentamicin protection assay. 
 
The principle of gentamicin protection assay (GPA) is based on the inability of 
aminoglycoside antibiotic gentamicin to penetrate into eukaryotic cells. The GPA was used 
to study macrophage phagocytosis of E. coli in the presence of LGG-CM, LPS and LGG-
CM+LPS combinations. Experiments were designed to investigate the effect of various 
concentrations of LGG-CM both in the presence and absence of LPS on bacterial ingestion 
and digestion.  
 
2.7.1. Preparation of Bacterial culture 
  
The E.coli HfrC cells were cultured in nutrient broth as described in section 2.3. On the 
day of the experiment, E.coli grown overnight from fresh bacterial inoculums was used in 
the experiment. A 22 μl ml-1 of 1:1 diluted (bacterial culture: sterile nutrient broth media 
resulting in approximately 2.5× 107 CFU ml-1 E.coli) bacterial culture was centrifuged for 2 
minutes at 10,000 rpm. The media was discarded and the pellet was washed twice with 
antibiotic free DMEM by alternate rounds of centrifugation at room temperature. The 
bacterial pellet was suspended in DMEM and was added to universals containing DMEM 
on its own (control), 20 µg ml-1 LPS; various dilutions of LGG-CM (10 %, 75 % and 100 
% LGG-CM) and respective LGG-CM+LPS combination.  
 
2.7.2. Preparation of macrophages 
 
Macrophages were cultured in T-75 flasks as discussed in section 2.1. The cells were 
scraped and enumerated as in section 2.1.2. Following enumeration of macrophages from 
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the trypan blue dye exclusion technique, macrophages were plated in 24 well plates at a 
concentration of 5 x105 macrophages per well.  
 
2.7.3. Experiments monitoring effect of LGG-CM on bacterial ingestion by 
gentamicin protection assay 
 
On the day of the experiment, the media to be used for the experiment was left in the 370C 
water bath to warm up. The bacterial inoculums and macrophages were prepared as 
explained in section 2.7.1 and 2.7.2 respectively. The bacteria suspended in the control and 
treatments were then added to macrophages at a multiplicity of infection (MOI) of 50:1 in 
24 well plate and the plates were gently shaken to initiate the bacterial contact with 
macrophages. A 100 μl of bacterial inoculums were serially diluted and plated to ensure 
the MOI reached approximately 50:1.  
 
For monitoring bacterial ingestion, macrophages and bacteria were coincubated for a 
period of 30 minutes and 60 minutes in a humidified cell culture incubator at 370C and 5 % 
CO2. After the respective incubation periods cells were washed with prewarmed PBS. 
Cells were then treated with 200 μg ml-1 gentamicin sulphate for 10 to 12 minutes to kill all 
extracellular bacteria. The cells were then lysed with 1x lysis buffer and immediately 
scraped using a cell scraper. The contents were quickly transferred to an Eppendorf tube. 
The bacteria were then enumerated by plating the lysed suspension onto the surface of agar 
plates by the spread plate method using plastic disposable spreaders. The plates were 
incubated at 370C for 18 to 22 hours and bacterial number was enumerated by colony 
counting assay. Figure 2.4 demonstrates the pictorial representation of steps involved in 
experiments monitoring bacterial ingestion by macrophages. 
 
2.7.4. Experiments monitoring effect of LGG-CM on bacterial digestion by 
gentamicin protection assay 
 
Macrophages were seeded in 24-well-plates (5 x 105 cells per well) and infected with E. 
coli at an MOI of 50:1 and incubated for 60 minutes at 37°C and 5 % CO2.  
 
After the bacterial ingestion time, medium was carefully removed, cells washed once with 
prewarmed PBS and medium containing 200 µg ml-1 gentamicin sulphate was added to kill 
all extracellular bacteria. Macrophages were then incubated in the respective treatments 
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containing 20 µg ml-1 gentamicin. The treatments included DMEM on its own (control), 20 
μg ml-1 LPS; various dilutions of LGG-CM (10 %, 75 % and 100 % LGG) and respective 
LGG-CM+LPS combinations.  
 
After specific time periods, cells were washed once with PBS and intracellular bacteria 
released by adding 1x lysis buffer. Undigested bacteria were subsequently recovered from 
lysed macrophages at an interval of 40 minutes for up to 280 minutes. Samples were 
diluted in saline and plated on nutrient agar plates for determination of the recovered 
colony forming units (CFU). Figure 2.5 demonstrates the pictorial representation of steps 
involved in experiments monitoring bacterial digestion by macrophages. 
 
2.7.5. Analysing the bacterial digestion curve 
 
In the studies monitoring bacterial digestion the first measurement of bacterial number 
recovered from macrophages was 15 minutes after gentamicin addition, after which the 
bacteria were recovered every 40 minutes up to 280 minutes. The recovered bacteria were 
expressed as CFU ml-1. The bacterial killing curve from all the treatments appeared to 
follow the exponential pattern. The following steps were followed to calculate the slope 
from exponential equation:   a = a0 e 
–kt. 
 
1. The bacteria recovered at each time point (a) expressed as CFU ml-1 was divided by 
bacteria recovered at the first time point (a0) for all the treatments. 
2. Then, natural log of a/a0 values were determined (ln a/a0). 
3. The ln a/a0 values were plotted against time. 
4. By converting an exponential graph into a linear one (y= mx + c), the slope or the 
rate of digestion could be directly calculated from the m value in the linear 
equation. 
5. The slopes derived from each experiment were averaged and plotted against their 
respective treatment. 
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Figure 2.4: Schematic representation of experiments to monitor bacterial ingestion. 
Variable ingestion periods are represented as T1 and T2 in the figure. The red circle with a line 
through indicates bacterial killing by gentamicin.  
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2.8. Acridine- orange crystal violet staining technique for monitoring 
macrophage phagocytosis of E. coli 
 
The Acridine orange staining technique was used to image phagocytosis and digestion of 
E. coli coincubated with macrophages in the presence of LGG-CM. This technique has 
been widely used in previous studies investigating bacterial macrophage interactions 
(Zanetti et al., 1987; Pruzanski and Saito, 1988; Takao et al., 1996). The captured images 
were pseudo-coloured using the Image Hopper programme so that live bacteria appear 
green and dead bacteria appear bright red or yellow fluorescence. Images were captured at 
an excitation and emission wavelength of 485 nm and 528 nm respectively with a 60x 
objective. A bright field image was grabbed along with the fluorescence images.  
2.8.1. Imaging of effect of LGG-CM on bacterial ingestion  
 
Macrophages were grown in Mattek glass bottom culture dishes (P35G-0-14-C) for imaging 
phagocytosis. Briefly, 1ml of overnight grown E. coli culture was centrifuged for a minute 
at 10,000 rpm and the cells were washed with prewarmed PBS. Then the bacteria were 
labelled with 0.01 % acridine orange for 45 seconds. Excess dye was removed by washing 
the cells 3 times with PBS. The bacteria were observed under a microscope to confirm the 
dye uptake. For monitoring bacterial ingestion, E.coli was then added to the macrophages 
which were adhered to the bottom of Mattek dishes and incubated for 15, 30 and 60 
minutes. After the respective time intervals, just before imaging, 0.05 % crystal violet 
dissolved in PBS was added to the petridishes to quench extracellular fluorescence. Crystal 
violet does not penetrate intact macrophage membrane and thereby don’t quench 
fluorescence of intracellular bacteria (Takao et al., 1996). 
2.8.2. Imaging of effect of LGG-CM on bacterial digestion  
 
Macrophages and bacteria were prepared for imaging as described in 2.8.1. The acridine 
orange labelled E.coli was then added to the macrophages adhered to the Mattek dishes 
and incubated for 60 minutes. After coincubation period cells were washed once with 
prewarmed PBS and extracellular bacteria was killed by gentamicin treatment. For 
monitoring bacterial digestion, images were grabbed at 15, 60, 120, 180, 240 and 300 
minutes after a coincubation period of 60 minutes.  At respective time intervals, just before 
imaging, 0.05 % crystal violet dissolved in PBS was added to the petridishes to quench any 
extracellular fluorescence.  Images were grabbed using Open lab software and analysed 
using Image Hopper 2 (Samsara research, UK).  
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2.9. Experiments investigating LGG-CM mediated free radicals 
production on macrophage phagocytosis using pharmacological 
inhibitors and scavengers 
 
Free radicals inhibitors (ROS and NO inhibitors) and scavengers were used to investigate 
the role of LGG-CM induced changes in ROS and NO production on macrophage 
phagocytosis. Inhibitors used were L-NMMA (inhibitor of NO synthase), apocynin 
(NADPH oxidase inhibitor); allopurinol (xanthine oxidase inhibitors) and ROS scavengers 
namely, polyethylene glycol conjugated SOD and catalase as mentioned in Carter et al., 
(2004). 
2.9.1. Experiments investigating LGG-CM mediated free radicals production 
on bacterial ingestion 
Macrophages were enumerated and plated at 5x105 cells ml-1. Cells were preincubated for 
an hour with 100 μM apocynin and 100 μM allopurinol and ROS scavengers namely; 
polyethylene glycol conjugated 75 units ml-1 SOD and 100 units ml-1 catalase. After the 
preincubation period, bacteria in the respective treatments were added at 50:1 MOI and 
incubated for 60 minutes to allow macrophage ingestion of bacteria. The cells were washed 
with PBS after 60 minutes and gentamicin was added to kill the extracellular bacteria. The 
bacteria recovered from the various treatments were then enumerated by plating the liquid 
suspension by serially diluting and plating onto the surface of nutrient agar plates by the 
spread plate method using plastic disposable spreaders. The agar plates were incubated at 
370C.  The bacterial colonies were then enumerated by colony counting technique which 
provided a direct indication of the role and nature of free radicals involved in LGG-CM 
mediated bacterial ingestion. The experiment protocol for investigating LGG-CM mediated 
free radicals production on bacterial ingestion using specific inhibitors/scavengers is 
depicted in fig 2.6. 
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2.9.2. Experiments investigating LGG-CM mediated free radicals production 
on bacterial digestion 
In order to investigate the potential role of free radicals involved in bacterial digestion in 
the presence of LGG-CM, macrophages were plated at a cell density of 5x105 cells ml-1. 
Cells were preincubated for an hour with 100 μM L-NMMA, 100 μM apocynin, 100 μM 
allopurinol and ROS scavengers namely; polyethylene glycol conjugated 75 units ml-1 
SOD and 100 units ml-1 catalase. After the preincubation period, the macrophages and 
bacteria were coincubated in the respective treatment in the presence of scavengers or 
inhibitors for 60 minutes at 50:1 MOI to allow macrophage ingestion of bacteria. The cells 
were washed once with prewarmed PBS after 60 minutes of macrophage –bacterial 
coincubation and gentamicin was added to kill the extracellular bacteria. Various 
treatments were then added (various concentrations of LGG-CM, LPS, LGG-CM+LPS 
combination plus inhibitors/scavengers) and incubated for 280 minutes in the presence of 
20 μg ml-1 gentamicin sulphate. The bacteria recovered from the various treatments at end 
of 280 minutes were then enumerated by plating the liquid suspension by serially diluting 
and plating onto the surface of nutrient agar plates by the spread plate method using plastic 
disposable spreaders. The plates were incubated at 370C.  Enumeration of the recovered 
colonies by colony counting technique gave a direct indication of the role and nature of 
free radicals involved in LGG-CM mediated bacterial digestion. The experiment protocol 
for investigating LGG-CM mediated free radicals production on bacterial digestion using 
specific inhibitors or scavengers is depicted in figure 2.7. 
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Figure 2.6: Diagrammatic representation of experiments monitoring bacterial 
ingestion in the presence of free radicals inhibitors and scavengers.   
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Figure 2.7: Diagrammatic representation of experiments monitoring bacterial 
digestion in the presence of free radicals inhibitors and scavengers. T1 and T2 
represent 60 minutes and 280 minutes time points, at which the bacteria were recovered.  
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2.10. Fluorescence probes  
2.10.1. ROS detection probe 
The ROS production was monitored using a ROS specific dye, namely H2DCFDA-AM (2’, 
7’-Dichlorodihydrofluorescein diacetate diacetoxymethyl ester). It is a membrane 
permeant molecule that passes through the cell membrane. After cell penetration, 
H2DCFDA-AM is hydrolysed by cellular esterase to 2’, 7’-dichlorodihydrofluorescein 
diacetate (H2DCFDA) that is non-fluorescent, but switched to fluorescent 
dichlorofluorescein (DCF) when oxidised by intracellular ROS (Rastogi et al., 2010).  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8: Formation of fluorescent compound DCF by Reactive oxygen species 
[Modified image from Held & Newick, 2008]. 
 
2.10.2. Nitric oxide detection probe 
The NO production was monitored using cell permeable nitric oxide specific dye- 
Diaminofluorescein-FM diacetate (DAFFM-DA). It is an analog of diaminofluorescein and 
is more permeable and can be easily hydrolysed to DAF-FM via cellular esterases. 
 
 
 
Figure 2.9: Formation of fluorescent derivative of DAF-FM from DAFFM-DA 
[Modified image from Molecular probes, 2001] 
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2.11. Imaging of free radical production using fluorescence 
microscope 
 
Fluorescence imaging of free radicals production from macrophages treated with LGG-CM 
were performed using Nikon Eclipse TE-2000U fluorescence microscope. The microscope 
was switched on at least an hour before the start of experiment. Glass sterile cover slips 
(one per treatment) were placed in small Nunclon petri dishes. 
 
Macrophages were scraped, enumerated and 1 ml of macrophage culture was added to 
small petridishes containing glass coverslips and incubated overnight in a humidified tissue 
culture incubator at 370C and 5 % carbon dioxide. On the day of the experiment, the media 
was replaced by 5 µM H2DCFDA for ROS measurement or 5 µM DAFFM-DA for NO 
measurement for labelling the macrophages. The cells were then left in the cell culture 
incubator for 45 minutes. The medium was then removed; the cells washed three times 
with phosphate buffered saline and fresh prewarmed phenol red free DMEM was added.  
 
The cover slip was then removed and attached to the bottom of the imaging chamber 
(macrophage affixed side facing up) before the medium was added onto the chamber. The 
chamber was then placed under an inverted microscope where a bright field filter was used 
to focus the cells prior to the fluorescence imaging. A single channel heater controller 
(model TC-324B) was used to control the temperature at 370C.  
 
Both manual (Open lab) and time-lapse software was utilised for grabbing images. The 
fluorescence images of free radical production were grabbed from macrophages cultured 
on cover slips in the presence of untreated, 20 μg ml-1 LPS treated and 10 % LGG and 75 
% LGG treated macrophages at various time periods. The time lapse measure plot 1 
programme was used to measure ROS and NO using fluorescence filters which have an 
excitation and emission wavelength of 485 nm and 528 nm. The images were saved as tiff 
files and analysed using Image Hopper 2.  
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2.11.1. Experiment setup to measure the changes in free radical production 
using fluorescence microplate reader 
For measuring the changes in free radical production using fluorescence microplate reader, 
macrophages were either labelled with 5 µM H2DCFDA for ROS measurement or 5 µM 
DAFFM-DA for NO measurement.  
The optimal cell loading concentration, time of incubation, temperature and dye retention 
time were determined by several pilot experiments. After macrophage attachment, the 
media was removed and cells were treated with respective fluorescent dyes for 45 minutes 
at 370C and 5 % CO2. After 45 minutes, the loading media was removed and the cells were 
washed with PBS to remove any extracellular dye. The cells were returned with 
prewarmed phenol red free DMEM and incubated at 370C and 5 % CO2  for 15 minutes 
more to allow a short recovery time for cellular esterases to hydrolyse the acetate groups 
and render the dye responsive to oxidation.  
Various concentrations of LGG-CM were then added to wells (n=4). The baseline 
fluorescence intensity of the loaded samples was measured from untreated cells and the 
value was subtracted automatically from the programme from the sample fluorescent 
values. Protocol parameters were created and customised prior to the start of the 
experiment to avoid any possible error. Protocol parameters were stored in a protocol file 
with .PRT extension. The parameters and customisation process involved detection method 
as fluorescence, reading type as kinetic where readings were taken every 2 minutes, filter 
sets were defined at a wavelength selection of 485 nm excitation and 528 nm emission. 
The plate type was selected as a 96 well plate and the well details were defined. Well 
details mainly included labelling the wells as blank or as specific treatments. Wells were 
monitored throughout the experiment by the KC4 software programme, so that any 
fluctuations would be shown at the end. The plate layout for each experiment was designed 
so that it was possible to collect both the data obtained from treatments and treatment-
blank. The audit trail logged in by KC4 software gave detailed information of events that 
happened at any time of the experiment. The programme was set to preheating mode so 
that optimal temperature of 370C was attained before the start of experiment. In the plate 
description parameter, details of experiment date and number of replicates was entered. A 
similar setup was used for measuring NO using DAFFM-DA. 
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2.11.2. Measurement of rate of ROS production by macrophages in the 
presence of LGG-CM during bacterial ingestion using fluorescence 
microplate reader 
The macrophages were scraped from the flask and enumerated by trypan blue dye 
exclusion method as described in section 2.1.2. A 100 µl sample of cell suspension was 
then plated at a cell density of 5x105 cells ml-1 in black clear bottom cell culture treated 96 
well plates (n=4). 
 After cell attachment, cells were treated with 5 μM H2DCFDA. The cells were incubated 
in dark at 370C for 45 minutes. After incubation period cells were washed with PBS to 
remove any excess dye. The cells were returned with prewarmed phenol red free DMEM 
and incubated at 370C and 5% CO2  for 15 minutes more to allow a short recovery time for 
cellular esterase to hydrolyse the acetate groups and render the dye responsive to oxidation.  
Then, 100 μl of treatments (various concentrations of LGG-CM, LPS, and LGG-CM + 
LPS combination both in the presence and absence of live E. coli HfrC) were added to the 
wells in quadruplicate and the fluorescence readings were started immediately in a 
fluorescence microplate reader with a pre-set temperature at 370C. The oxidation of the 
fluorescence dye by oxygen free radicals was detected by monitoring the increase in 
fluorescence by fluorescence microplate reader. The readings were taken every 2 minutes 
at a wavelength selection of 485 nm excitation and 528 nm emissions for 60 minutes. The 
experiment protocol for ROS measurement is depicted in Figure 2.10.  
2.11.3. Measurement of rate of NO production by macrophages in presence 
of LGG-CM during bacterial ingestion. 
 
For measuring NO production from macrophages treated with LGG-CM during ingestion 
period, experiments were performed in a similar manner to those described in section 
2.11.2 for ROS measurement, the only difference being the macrophages were labelled 
with NO specific dye DAFFM-DA. 
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2.11.4. Measurement of rate of ROS production by macrophages in the 
presence of LGG-CM during bacterial digestion. 
 
To further investigate the effects of LGG-CM on free radicals production by macrophages 
during bacterial digestion, a fluorescence microplate reader was used to monitor changes in 
free radicals production. Briefly, 100 μl of macrophage culture was plated at a density of 
5x105 cells ml-1 in black clear bottom cell culture treated 96 well plates.  
 
After loading the macrophages with H2DCFDA cells were washed with PBS. Then 
macrophages were coincubated with E.coli for 60 minutes. After 60 minutes, the 
macrophages were treated with 200 μg ml-1 gentamicin. Then, 100 μl of treatments 
(various concentrations of LGG-CM, LPS, LGG-CM +LPS combination both in presence 
and absence of live E. Coli HfrC) were added to the wells in quadruplicate and the 
fluorescence readings were started immediately in a fluorescence microplate reader preset 
to 370C and the fluorescence readings were taken for up to 280 minutes at 2 minute 
intervals. 
 
The fluorescence data was plotted in an excel spread sheet. The rate of free radical 
production from the macrophages in the presence of various treatments was then calculated 
by Cumulative Sum (see section 2.11.6). The experiment protocol for free radical 
measurement during digestion period is depicted in figure 2.11. 
 
2.11.5. Measurement of rate of NO production by macrophages in the 
presence of LGG-CM during bacterial digestion 
 
For measuring NO production during digestion period, experiments were performed as 
described in section 2.11.4, the only difference being the macrophages were labelled with 
NO specific dye- DAFFM-DA. 
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2.11.6. CuSum analysis of free radical production by macrophages 
 
For analysing the data sets from studies monitoring changes in free radical production 
using fluorescence microplate reader, raw experimental values for free radical production 
(test values) were plotted against time. The average of fluorescence measurements from 
control macrophages was used as the ‘target value’. There was heterogeneity of pattern of 
free radical production in measured test (experimental) values between LGG-CM treated 
and untreated macrophages but the details were unclear.  
 
CuSum was used in the analysis of fluorescence measurements to compare the rate of free 
radical production from macrophages from various treatments. The CuSum methodology is 
a simple technique that has frequently been applied to elucidate trends in time domain data 
(Stanton et al., 1992). It works by comparing each data point to a reference or target value 
(k) and then cumulatively summing the differences (Biau et al., 2007; Tam, 2009).  If the 
underlying mean of the data points is constant the method produces a straight line whose 
slope is determined by the difference between the mean value and the chosen reference 
value. Small random variations are smoothed so the technique can reveal differences and 
changes in the mean value (Biau et al., 2007). When analysing the data sets, raw 
experimental values (test values) were plotted out against time. The average of the 
fluorescence measurements from the control macrophages was used as k, the ‘target value’. 
This was then used to calculate the CuSum values.  
 
The first CuSum Co value is calculated using equation 1. 
                                                                                       ...........1 
Where Fo is the first fluorescence reading in the time series and k is the ‘target’ or 
reference value. The next and subsequent CuSum values are calculated using equation 2 
and 3 
                                            
                                             
and so on, where Cn is the n
th CuSum value and Fn is the n
th fluorescence reading in the 
time series. 
During an increase in free radical production from macrophages, the experimental values 
are mostly positive and so the CuSum values steadily increase and vice versa. As long as 
the free radical production is largely negative when compared to target value the CuSum 
value tends to remain close to zero.  
63 
 
2.12. Quantification of the expression of NADPH oxidase subunits by 
western blotting  
The effect of LGG-CM on the expression of gp91 phox and p47 phox in J774 macrophages 
was investigated using SDS-PAGE and western blotting. This was performed to investigate 
the time dependent changes in NADPH oxidase activity. Macrophages were first treated 
with various dilutions of LGG-CM, 20 µg ml-1 LPS, LGG-CM+LPS combination for 2 
hours, 6 hours and 24 hours.  After the specific incubation time the treatments were 
removed, cells washed with ice cold PBS and lysed. The BCA (Bicinchoninic acid) assay 
was performed to identify the concentration of protein present in each lysed sample. The 
samples were stored in -200C until the proteins were separated by SDS-PAGE (Sodium 
dodecyl sulphate polyacrylamide gel electrophoresis) (see detailed methodology for each 
step in section 2.13). The proteins were separated in a 0.75 mm discontinuous vertical slab 
minigel in an applied electric field. The separated proteins were blotted on to a PVDF 
membrane by a semidry transfer technique and the proteins of interest gp91 phox and p47 
phox were identified using specific antibodies after blocking the membranes with 5 % non-
fat dried milk (see detailed methodology for each step in section 2.14 and 2.15).  Specific 
primary and secondary antibodies used to detect NADPH oxidase subunits gp91 phox and 
p47 phox are listed in table 2.4 (see details in section 2.16). The proteins are then detected 
by enhanced chemiluminiscence (see details in section 2.17).  
2.13. Lysis of cells and extraction of samples for western blot 
 
On the day of the experiment stock solution of lysis buffer (10 x) was diluted to 1 x lysis 
buffer and 5 µL of 200 mM sodium orthovanadate and 2 µl of protease cocktail inhibitor 
was added. The cells in the 24 well plate were then washed with ice cold PBS. Excess PBS 
was carefully aspirated without disturbing the cells. To extract the cell lysate, 100 µl of 
lysis buffer preheated at 950C was added to each well and the plate was left on the ice tray. 
The cells were scraped and transferred to individual pre-labelled eppendorf tubes placed in 
ice. The samples were then sonicated 5 times for 30 seconds, resting for 30 seconds 
between each run. The samples were then centrifuged at 10000 rpm for 3 minutes. The 
supernatant was carefully transferred to another set of pre-labelled eppendorf tubes and 
heated at 950C for 10 minutes. The BCA assay was performed to identify the concentration 
of protein present in each sample and the samples were stored at -200C.  
64 
 
2.13.1. Measurement of the total protein in cell lysate using BCA protein 
assay 
 
The Bicinchoninic acid (BCA) protein assay is the colorimetric detection technique for 
quantitative estimation of the protein. The principle of the BCA assay is based on the 
reduction of cupric (Cu2+) to cuprous (Cu1+) ion by protein in an alkaline medium and 
formation of the purple coloured water soluble complex measurable by spectrophotometer. 
The BCA assay is a highly sensitive and selective assay for cuprous cation (Cu1+) (Smith et 
al., 1985). 
The BCA assay is 100 times more sensitive with respect to detection limit when compared 
to Biuret reagent (Smith et al., 1985; Wiechelman et al., 1988; Olsen and Markwell, 2007). 
In BCA assay BSA (Bovine Serum albumin) was used for preparing a protein standard 
curve.  
 
 
Protein + Cu2+                         Cu+.................................................................... Step 1 
    
Cu+     +     2BCA 
  
                                                               BCA-Cu+ complex............................. Step 2         
 
Figure 2.12: Reaction of BCA assay. This assay occurs in a two-step reaction. The first step 
is the biuret reaction, which involves the reduction of cupric ion to cuprous ion, in an alkaline 
environment, which results in a faint blue colour. In the second step of the colour development 
reaction, Bicinchoninic acid (BCA) reacts with the reduced cuprous cation that was formed in step 
one. The intense purple-coloured reaction product results from the chelation of two molecules of 
BCA with one cuprous ion. The BCA/copper complex is water-soluble and exhibits a strong linear 
absorbance at 562 nm with increasing protein concentrations.  
 
 
 
 
 
 
 
 
 
 
 
 
OH-  
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Table 2.2: Protocol for preparing a standard curve using BSA. A stock solution (10 mg 
ml-1) was prepared by dissolving 0.05 g of BSA in 5 ml of lysis buffer (1 x). A serial dilution of 
BSA solution was prepared using a 10 mg ml-1 BSA solution. In order to construct standard curve, 
absorbance was plotted as a function of total protein concentration. The protocol for preparing 
standard curve of BSA is shown in the table below.  
 
 
 
 
 
 
 
 
 
 
 
2.13.2. Preparation of standard curve for protein. 
 
A 10 µl of each concentration of BSA standard ranging from 0 to 30 μg per 10 µl was 
added in triplicate to the 96-well plate. An aliquot of 10 μl macrophage lysate from each 
treatment was also added in triplicate to the other empty wells in the same 96-well plate. 
Then BCA reagent was prepared by mixing BCA reagent A with BCA reagent B (50:1 
ratio). After a homogenous colour formation of BCA reagent mixture, a 100 μl of BCA 
reagent was added into all the wells and incubated for 60 min at room temperature. The 
absorbance was measured at 562 nm using the Asys Hitech expert plus microplate reader. 
The absorbance of blank was subtracted from the BSA standard and the average 
absorbance of the standards was plotted against the respective protein concentration. The 
amount of total protein in the unknown macrophage lysate from untreated, LPS treated and 
LGG-CM ± LPS treated macrophages was then determined from the standard curve 
(Figure 2.13) using the values from the slope and y–intercept from the linear trendline 
equation y = mx+c. The unknown concentration of protein lysate from macrophages 
incubated with various treatments was calculated from the above linear trendline equation 
as described in section 2.6.2. 
Volume of            
10 mg/ml BSA  
( µl) 
Volume of 1X 
lysis buffer (µl) 
Final [BSA]  
(µg/10µl) 
0 100 0 
10 990 1 
20 980 2 
30 970 3 
50 950 5 
100 900 10 
150 850 15 
200 800 20 
250 750 25 
300 700 30 
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Figure 2.13: A representative standard curve of protein (BSA). The standard curve of 
protein can be used to convert optical densities of the unknown solutions to their respective protein 
concentration using a linear trendline equation. 
 
2.14. Principle and background of SDS-PAGE and Western blotting  
SDS-PAGE is based on the principle that a charged molecule will migrate in an electric 
field towards an electrode with an opposite sign. In SDS-PAGE proteins are separated 
based on their size or molecular weight, under the influence of an applied electric field. 
The SDS is a detergent used to remove the complex secondary, tertiary or quaternary 
protein structure. The linear polypeptide chains are then separated according to their 
molecular weight, which migrate in the gel. This migration rate again depends on the pore 
size of the gel and also the buffer system. The amount of SDS bound to the protein is 
proportional to the molecular weight of the protein and is independent of the protein 
sequence, so the proteins will migrate through the gel according to their size.  
Western blot or the protein immunoblot is an analytical technique used to detect specific 
proteins from a cell lysate. The term blotting refers to the transfer of separated proteins 
from the gel to a second matrix which is generally PVDF (Polyvinylidine fluoride) or 
nitrocellulose membrane. Next the membrane is blocked to prevent any non-specific 
binding of antibodies to the membrane using fat free milk or BSA. The transferred protein 
is complexed with a primary antibody and suitable enzyme labelled (horseradish 
peroxidase or alkaline phosphatase) secondary antibody. An appropriate chemiluminiscent 
substrate is then added to the enzyme and together they produce light as a by-product. The 
y = 0.0173x + 0.0225 
R² = 0.9886 
0.0 
0.1 
0.2 
0.3 
0.4 
0.5 
0.6 
0 5 10 15 20 25 30 35 
O
D
 5
62
  n
m
 
protein (μg) 
67 
 
output will be proportional to the amount of secondary antibody bound to the protein of 
interest. When an x-ray film is exposed to the secondary antibody treated membrane, bands 
are formed on the x-ray film. Measuring the band size or intensity defines the 
concentration of the expressed protein of interest. 
2.14.1. Preparation of gels 
Discontinuous gels were constructed with two different acrylamide gels, one on top of 
other. Firstly, an 8 % resolving gel was prepared (see table 2.3). Gel at this concentration 
of acrylamide /polyacrylamide mixture was used for separating proteins generally in the 
range of molecular weight ranging from 40 to 200 kDa. For the gel to mould between the 
glass plates the glass plates were carefully cleaned, dried and the small glass plate was 
placed on the large plate with a spacer and inserted into the casting frame. The pressure 
clamps were locked and checked for any leakage before pouring the resolving mixture. 
Approximately 3.7 ml of resolving gel mixture was poured in between the plates and 
immediately covered with a layer of ultrapure water to prevent any bubbles or air traps. 
The gels were allowed to polymerise for 45 minutes.  
Table 2.3: Composition of resolving and stacking gel 
 
 
 
 
 
 
 
 
After solidification of the resolving gel, the stacking gel was prepared as shown in table 
2.3. The water layer over the top of resolving gel was carefully removed and the stacking 
gel was carefully added on the top of the resolving gel. A 10 well comb was immediately 
Ingredients 8 % Resolving gel 5 % Stacking gel 
Gel volume 10 ml (2 gels) 5 ml (2 gels) 
Ultra-pure water 4.68 ml 2.84 ml 
30 % Acrylamide 2.67 ml 0.833 ml 
1.5 M Tris pH8.8 2.50 ml - 
0.5 M Tris pH 6.8 - 1.25 ml 
10 % SDS 0.1 ml 0.050 ml 
10 % APS 0.075 ml 0.025 ml 
TEMED 0.015 ml 0.005 ml 
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placed over the stacking gel making sure not to entrap any air bubbles. The stacking gel 
was then allowed to polymerise for 30 minutes before the samples were loaded.  
After polymerization of the stacking gel, the plates were carefully removed and the wells 
washed with 1x tank Buffer (0.025 M Tris-HCl, 0.192 M Glycine, 0.1 % SDS). The whole 
gel cassette was placed in a mini-protean 3 electrophoresis tank and the tank buffer was 
poured into the tank. The gels were then left in the tank to equilibrate for 5 minutes.  
2.14.2. Separation of proteins using SDS-PAGE 
The protein samples were removed from the -200C freezer and mixed with 2 x loading 
buffer and heated for 5 minutes at 950C. The comb from the gel cassette was removed and 
the samples (15 µg) were loaded into the wells. A rainbow molecular weight marker (5 µl) 
was loaded in the first well in the first gel, and the 9th well in the second gel to mark the 
orientation and to identify the molecular weight of the proteins. The electrophoresis was 
run at 90 volts until the proteins moved out of the stacking gel and the voltage was 
increased to 200 volts for the rest of the time period. The electric supply was stopped when 
the tracker dye moved to the end of the gel. 
2.15. Transfer of separated proteins from the gel to the PVDF 
membrane 
The proteins from the gel were transferred to the PVDF membrane by the semi-dry transfer 
technique (V20-SDB Semi-Dry Western Blotting). The gels were removed from the glass 
plates in electrophoresis unit and the stacking gel was removed with a gel cutter. The gels 
were then rinsed in the transfer buffer. A PVDF (Polyvinyldifluoride) membrane was used 
for the protein transfer. The PVDF membranes were soaked in methanol for 20 seconds 
and placed in the transfer buffer for equilibration. The filter papers were cut according to 
the size of the gels and were also soaked in the transfer buffer. For transferring, 3 filter 
papers were placed on the blot unit, followed by the PVDF membrane and gel and the 
sandwich completed by placing 3 more pre-soaked buffer saturated filter papers on top. 
Any air bubbles were carefully removed using a glass pipette. The proteins were 
transferred for 2 hours at an applied current of 0.8 mA cm-2 and the voltage limited to less 
than 13 volts. 
The PVDF membrane was blocked by placing the membrane in the blocking buffer (10 ml 
of 10 x washing buffer, 100 μl Tween-20, 5 % non-fat dried milk, 90 ml ultrapure water). 
The membrane was rocked on a shaker for 15 minutes at a moderate speed and placed 
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overnight at 40C to prevent the non-specific binding of antibodies. The membrane was 
again placed on a shaker for 15 minutes before being probed with a primary antibody. 
2.16. Probing the membrane with antibodies 
After blocking the PVDF membrane, the membrane was incubated with a primary 
antibody. The primary antibody is normally obtained by immunising an animal with the 
protein of interest, and collecting the antibodies the animal produces against that protein. 
The primary antibodies used for gp91phox , p47phox, β-actin are listed in table 2.4. 
 
The PVDF membrane (after blocking) was sealed in a hybridisation bag filled with a 
primary antibody diluted in the blocking buffer. The membrane was then placed on a  
rotary shaker for 2 hours. After the incubation period, the membrane was washed three 
times with wash buffer (10 mM Tri-HCl pH 7.5, 100 mM NaCl, 0.1 % Tween-20) whilst 
shaking. The wash buffer was replaced, fresh, every 10 minutes and the membrane washed 
with gentle shaking. These washing steps removed any unbound, excessive primary 
antibody from the membrane. The membrane was again incubated with a secondary 
antibody and incubated for an hour (see table 2.4). This antibody binds to the primary 
antibody already bound to the protein of interest and is conjugated with horseradish 
peroxidase. After incubation with the secondary antibody, the membrane was again 
washed with wash buffer 3 times as described above. 
 
Table 2.4: Antibodies used for identifying protein of interest.  The table below lists the 
primary antibodies used for detecting various components of NADPH oxidase and a corresponding 
secondary antibody used for detection. 
 
 
 
Protein of interest Molecular 
weight (KDa) 
Antibody information 
(SantaCruz Biotechnology) 
Dilution 
gp91phox 65 SC130543 
 
1:500 
p47phox 47 SC17845 
 
1:250 
β-actin 43 SC47778 
 
1:500 
Goat-antimouse IgG-HRP - SC-2005  
 
 
1:3000 
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2.17. Detection of protein by enhanced chemiluminescence (ECL) and 
quantification of western blots by scanning densitometry 
 
The membrane was removed from the washing buffer and placed on clean cling film. 
Enhanced chemiluminescence detection solution was prepared (detection reagents 1 and 2 
mixed at 1:1 ratio) as described by the manufacturer and applied to the membrane for 1 
min at room temperature. Excess solution was drained and the PVDF membrane was 
carefully wrapped with cling film avoiding any trapped air bubbles. The membrane was 
then fixed to a cassette and was exposed to an autoradiography film for 1 to 3 minutes in 
the dark room. The film was immediately developed using Carestream® Kodak® 
autoradiography GBX developer and fixed with Carestream® Kodak® autoradiography 
GBX fixer.  
The bands that developed on the autoradiography film were quantified using Image J, an 
image processing and analysing programme, where the film harbouring western blot  bands 
were converted into values that are subsequently presented as graphs with accompanying 
statistics. Each band was scanned and its intensity noted by the Image J programme. The 
values obtained for the macrophages incubated with each treatment were compared to 
those of their respective controls.  
2.18. Statistical analysis 
 
Unless otherwise stated, the results are expressed as the mean ± S.E.M as indicated in 
individual experiments. Statistical differences between the means were determined by one-
way analysis of variance (ANOVA) followed by Dunnett multiple comparison post-hoc 
tests. A p-value of less than 0.05 was considered to be statistically significant. The 
analyses were performed using prism version 3.00 for windows (Graph pad software, San 
Diego, USA).  
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                                                  CHAPTER 3 
 
Effect of LGG-CM on cell-viability and 
nitric oxide production by 
macrophages 
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3.0. CHAPTER 3 
3.1. Introduction 
Activated macrophage produce NO and ROS (e.g. superoxide and hydrogen peroxide), 
which aid the destruction of ingested microbes. The previous work in the lab had 
demonstrated that J774 macrophages produce NO in the presence of VSL#3 (formulation 
containing 8 different probiotic strains) conditioned medium. This study also demonstrated 
that LGG-CM produced a low but slightly enhanced basal level of inducible nitric oxide 
synthase (iNOS) enzyme expression in J774 murine macrophages. However, when LGG-
CM was applied in combination with LPS, iNOS expression from macrophages was 
apparently reduced (Sarker et al., 2011). 
 
Our initial experiments were focussed on investigating the effect of LGG-CM on NO 
production by J774 murine macrophages. The mouse macrophage cell line J774 has been 
shown to respond to LPS by producing NO through the activation of iNOS gene (Hattori et 
al., 1996). The NO production is required to maintain normal physiology of the 
macrophages. However its production could be affected by the immunomodulatory 
substances that either increase or decrease the production of these molecules (Abbas et al., 
2007). The NO can induce a cytoprotective or cytotoxic effect depending on its 
concentration level (Wiley, J.W. 2007). The LGG by itself or cell free conditioned medium 
has been shown to induce NO production via the iNOS pathway and the mechanism has 
shown to be similar to that of LPS mediated NO production by the macrophages 
(Korhonen et al., 2002). 
 
The NO has a very short half-life and is normally oxidised to nitrite or nitrate end product. 
Studies have shown the expression of iNOS being induced in murine macrophages in the 
presence of 20 μg ml-1 LPS (Stuehr & Marletta, 1985), however, others suggested the 
additional requirement for IFN-γ (Lorsbach & Russell, 1992; Nathan, 1992; Lorsbach et 
al., 1993; Weisz et al., 1996; Kidd, 2003; Cunha et al., 1993; Fang, 1997) for successful 
nitrite detection from murine macrophages.  
 
It has been generally accepted that the live probiotic bacteria are responsible for any health 
beneficial activities. However, currently the concept of probiotic derived factors induced 
health benefits is also extensively suggested (see section 1.5.2). It has been shown that the 
factors influencing the efficiency of the probiotic conditioned medium mainly depend on 
the growth conditions of probiotic bacteria; both physical and nutritional factors and 
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bacterial cell density for example. Variation in probiotics effects can also be attributed to 
the initial cell density used to prepare the probiotic conditioned medium. Most of the 
studies, including this study, have employed probiotic bacteria at a cell density of 109 CFU 
ml-1 (Donnet Hughes et al., 1999, Lee et al., 2012). 
 
Several in vitro evidences suggest that certain probiotic strains can inhibit the growth and 
adhesion of a range of enteropathogens (Bernet-Carnard et al., 1997; Coconnier et al., 
1993; Coconnier et al., 1997; Hudault et al., 1997; Gopal et al., 2001; Demerdash and 
Mostafa, 2008; Ridwan et al., 2008; Lu et al., 2009). The effectiveness of probiotics to 
treat Helicobacter pylori gastroenteritis and urovaginal infections have also been 
demonstrated in well-designed in vitro and in vivo experimental studies (Reid et al., 2003; 
Servin, 2004). In relation to the infection in the intestinal tract, several studies have 
reported that probiotics are effective in decreasing the severity and duration of rotavirus 
infections in children as well as preventing acute and traveller’s diarrhoea in adults 
(Ouwehand et al., 2002; Reid et al., 2003; Reid et al., 2011). For most of the competitive 
exclusion studies, and in conditions as mentioned above such as acute, rotavirus and 
traveller’s diarrhoea, live probiotics are used as they compete for nutrition and space in the 
gut microenvironment. 
 
Studies have demonstrated that the LGG produce antimicrobial substances with activity 
against potential pathogens (Silva et al, 1987; Ridwan et al., 2008; Lu et al., 2009). The 
mechanism of the antibacterial activity of the Lactobacillus strains appears to be 
multifactorial (Servin, 2004). Their antibacterial effectiveness depends on factors such as 
the secretion of antibacterial proteins and the secretion of metabolites like lactic acid and 
acetic acid (Richard et al., 2006). The Lactobacillus strains have also been shown to inhibit 
the growth of bacterial pathogens and sometimes even kill them (Vandenbergh 1993; 
Keersmaecker et al., 2006; Suskovic et al., 2010).  However, health benefits that can be 
attributed to one probiotic strain cannot be extrapolated to other probiotic strains, or 
mixtures of strains as there is wide diversity in probiotic bacteria demonstrating 
antibacterial activity (Roselli et al., 2006; López et al. 2010; Snel et al. 2010; Van Hemert 
et al. 2010; Vissers et al., 2010, Vissers et al., 2011). 
 
This study primarily aimed at the successful preparation of LGG-CM and confirming the 
presence of the secretion of active components in LGG-CM by detecting nitrite production 
from macrophages treated with LGG-CM. This study also aimed to test if cell free LGG-
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CM demonstrate antibacterial activity on E. coli HfrC. At first, a growth curve of 
Lactobacillus rhamnosus GG was generated to identify the growth pattern of LGG over a 
period of time. This was followed by preparing the cell free LGG-CM and determining the 
effect of LGG-CM on bacterial viability. Next experiments were focussed on determining 
the effect of LGG-CM on macrophage viability and NO production by macrophages. 
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3.2. Results 
3.2.1. LGG growth curve 
 
Figure 3.1 represents the growth pattern of LGG. Optical density readings were taken 
every hour up to 12 hours and continued again at 24, 25, 26, 29 and 31 hours. The graph 
represents the sigmoidal pattern of LGG growth. When viable LGG was inoculated into the 
fresh MRS medium, it took some time to adjust to the new growth environment. This 
phase is termed as ‘lag phase’, in which cells increase in size, but the bacteria were not 
able to replicate and, therefore, a lag in increase in optical density reading was observed. 
For the first few hours, the bacterial growth was slow, as expected in the lag phase. The lag 
phase lasted for about 5 hours. Once the LGG entered the exponential phase (log phase) of 
growth, the metabolic activity of LGG increased and bacterial number started replicating 
and the nutrients in the growth medium were used at the maximal rate. The growth of LGG 
increased exponentially during this period. It was observed that at the 12th hour bacteria 
were still in the log phase where bacterial numbers were increasing at an exponential rate. 
Experiments could not be continued from 12 hours to 24 hours due to laboratory time 
constraints. At 24 hours bacteria had already attained the stationary phase, which was 
indicated by no further increase in optical density reading (Figure 3.1). This was an 
equilibrium phase where the bacterial growth rate was almost stable as indicated with 
fairly constant optical density readings. 
 
3.2.2. The pH Changes in the culture medium during LGG growth  
 
The LGG grows in the liquid culture medium using available nutrients such as 
carbohydrates and aminoacids. The breakdown of these compounds to organic acids such 
as lactic acid results in a decrease in pH of the culture medium. As the bacterial number 
increases the available nutrients are used at a faster rate resulting in a reduction in pH. 
Figure 3.2 shows change in pH in the LGG culture medium during LGG growth. The pH 
readings were taken every hour up to 12 hours and then continued again at 24, 25, 26, 29 
and 31 hours. In the control MRS medium, the pH had remained constant during all the 
measurements. In the LGG culture medium, the pH remained fairly constant (≈ pH 6.0) 
during lag phase. However, the pH in the LGG culture medium started to drop after 4 
hours of incubation and continued to fall until the end of the log phase. The pH started to 
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reduce into acidic range during the log phase. At the stationary phase, the pH of the LGG 
culture medium was found to be static around 4. The drop in pH indicated the growth of 
inoculated LGG in the MRS culture medium. After 30 hours of incubation, the pH reading 
of the LGG culture medium was approximately 3.8.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Growth phases of Lactobacillus rhamnosus GG. Experiments were 
performed in triplicate and repeated 3 times. Graph represents mean optical density readings of 3 
separate experiments. Error bars indicate ± SE of the mean. Error bars where not seen are obscured 
by the data points. Sterile MRS medium was used as blank. Optical density readings were taken at 
an interval of 60 minutes for up to 12 hours at a wavelength of 600 nm using a spectrophotometer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Change in pH against time of culture medium during LGG growth. 
Experiments were performed in triplicate and repeated 3 times. Graph represents the mean of 3 
separate experiments. Error bars indicate ± SE of the mean. The pH readings were taken at an 
interval of 60 minutes for up to 12 hours and then again continued at 24, 25 , 26, 29 and 31 hours. 
Error bars where not seen are obscured by the data points. 
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3.2.3. Effect of cell-free LGG conditioned media on E. coli viability 
 
The experiment to determine the antibacterial role of LGG-CM was performed as 
described in section 2.4 in chapter 2.  The antibacterial activity of LGG was examined at 1 
hour, 6 hours and 24 hours time points. Figure 3.3 shows the recovered bacterial colonies 
numbers from the control and the LGG-CM treatments. There was no significant 
difference in E. coli recovery between bacteria cultured in the control medium and in the 
various dilutions of the LGG-CM even after 24 hours of incubation time.  
 
The bacterial recovery from the control medium at 1 hour incubation period was 7.51 ± 
0.05 log10 CFU ml
-1. However, there was a small drop of bacterial recovery to 7.13 ± 0.12 
log10 CFU ml
-1 at 24 hours. There was no change in bacterial number from the highest 
concentration of LGG-CM tested (100 % LGG) ranging from 7.51 ± 0.06 log10 CFU ml
-1 
at 1 hour to 7.58 ± 0.09 log10 CFU ml
-1 at 24 hours incubation. The LGG-CM (pH 7.4 ± 
0.2) therefore tested for antibacterial activity against E. coli HfrC appeared to be non-toxic 
to bacteria.  
 
There was no significant difference in bacterial number in control medium between 1 hour 
and 6 hours. However, the bacterial number was significantly lower from control medium 
at 24 hours when compared to the bacterial recovery at 1 hour and 6 hours (p<0.05). We 
also observed a significantly low bacterial number from 5 % LGG-CM between 6 hours 
and 24 hours incubation period (p<0.01). 
There was no significant difference in bacterial number at 1 hour, 6 hours and 24 hours 
time point of incubation when bacteria were incubated in 10 % LGG-CM, 75 % LGG-CM 
and 100 % LGG-CM (p>0.05). 
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Figure 3.3: Bacterial recovery after incubation with LGG-CM. E. coli HfrC was incubated 
in various dilutions of LGG-CM for 1 hour (A), 6 hours (B) and 24 hours (C). Recovered bacteria 
were serially diluted, plated and enumerated by colony counting technique. Experiments were 
performed at least in duplicate and repeated at least 3 to 5 times. Statistical analysis was performed 
by One-way ANOVA and there was no significant difference between bacterial recoveries from 
control to various dilutions of LGG-CM at all the three time points (P˃0.05). 
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3.2.4. Effect of LGG-CM on macrophage viability 
 
To investigate the effect of LGG-CM on J774 macrophage viability, MTT experiments 
were performed as described in section 2.5.3. Experiments were performed to investigate 
the effect of LGG-CM (pH 7.4 ± 0.2) on macrophage viability at 1 hour, 6 hours and 24 
hours to match other experimental protocols used in this study. The percent cell viability 
was calculated as described in section 2.5.2. The percent macrophage viability from LPS, 
10 % LGG-CM, 75 % LGG-CM and 100 % LGG-CM and E. coli treated macrophages at 1 
hour was found to be 126 % ± 5 %, 124 % ± 19 %, 105 % ± 30 %, 98 % ± 14 %, 105 % ± 
2 % respectively (fig 3.4A). There was no significant difference in macrophage viability 
when macrophages were incubated with LGG-CM and LGG-CM ± LPS during the first 60 
minutes of incubation (Fig 3.4B). 
 
Experiments to investigate the effect of LGG-CM (pH 7.4 ± 0.2) on bacterial digestion 
were performed, approximately, for up to 6 hours. Thus, the effect of LGG-CM on 
macrophage viability was assessed after 6 hours of treatment incubation (Fig C & D). The 
percent macrophage viability from LPS, 10 % LGG-CM, 75 % LGG and 100 % LGG-CM 
and E. coli treated macrophages at 6 hours was 92 % ± 1 %, 108 % ± 5 %, 83 % ± 5 %, 99 
% ± 15 %, 105 %  ± 9 % respectively (Fig 3.4C). There was no significant difference in 
macrophage viability when macrophages were incubated with LGG-CM and LGG-CM ± 
LPS during the first 6 hours of incubation (Fig 3.4D). 
 
Initial experiments of the effect of LGG-CM (pH 7.4 ± 0.2) and LPS on nitrite production 
by macrophages were measured by Griess assay at 24 hours incubation period. However, 
these experiments included treatments alone and were performed in the absence of live 
bacteria. To determine the effect of these treatments on macrophage viability, MTT assay 
was performed after incubating the macrophages with LGG-CM and LPS for 24 hours (Fig 
E & F). The percent macrophage viability from LPS, 10 % LGG-CM, 75 % LGG-CM and 
100 % LGG-CM treated macrophages at 24 hours was 74 % ± 1 %, 102 % ± 10 %, 97  % ± 
12 %, 94 % ± 7 % respectively (Fig 3.4E). The LPS in presence of LGG-CM did not have 
any effect on macrophage viability (Fig 3.4F).  
There was significant difference in percent macrophage viability between macrophages  
treated with the LPS on its own at 6 hours and 24 hours when compared to macrophage 
viability at 1 hour incubation period (p<0.01). The 10 % LGG-CM, 75 % LGG-CM and 
100 % LGG-CM treated macrophages had no effect on macrophage viability at 1 hour, 6 
hours and 24 hours (p>0.05). 
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Figure 3.4: Effect of LGG-CM on macrophage viability. Macrophage viability was 
assessed in the presence of LGG-CM at 1 hour, 6 hours and 24 hours. The experiments were 
performed both in the presence and absence of LPS and E. coli. Experiments investigating 
macrophage viability at 1 hour were performed in triplicate and repeated 2 times (Figure A & B). 
Experiments investigating macrophage viability at 6 hours were performed in triplicate and 
repeated 3 times. (Figure C & D). Experiments investigating the macrophage viability at 24 hours 
were also performed in triplicate and repeated 3 times (Figure E & F). Error bars represents ± 
standard error of the mean. Statistical significance was determined by one-way ANOVA. There 
was no significant difference in macrophage viability between the treatments with respect to the 
control at any time point.  
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3.2.5. Effect of LPS on NO production in J774 macrophages 
 
Confluent macrophages were treated for 24 hours with various dilutions of LPS (1 μg ml-1, 
10 μg ml-1, 20 μg ml-1, 50 μg ml-1 and 100 μg ml-1). Macrophages produced variable 
amount of nitrite and there was no significant difference between nitrite produced from 
macrophages incubated with various concentrations of LPS.  
The amount of nitrite produced from macrophages treated with 1 μg ml-1, 10 μg ml-1, 20 μg 
ml-1, 50 μg ml-1 and 100 μg ml-1 for 24 hours was 25 ± 4 μM, 32 ± 4 μM, 31± 4 μM, 32 ± 2 
μM, 28 ± 2 μM respectively. 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 3.5: Nitric oxide production from macrophages treated with LPS. Various 
concentrations of LPS were used to treat confluent monolayers of J774 macrophage for 24 hours 
and NO production was measured by Griess assay. Data was from seven experiments (mean ± 
S.E.M) performed in triplicate. Statistical analysis was performed using One-way ANOVA. There 
was no significant difference in nitrite production between any of the LPS concentrations tested (p 
˂ 0.05). 
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3.2.6. Effect of LGG-CM on nitric oxide production in J774 macrophages 
 
Confluent macrophages were treated for 24 hours with LGG-CM (pH 7.4 ± 0.2).  Various 
dilutions of the LGG-CM (100 %, 75 %, 50 %, 25 % and 10 %) dose dependently 
increased a low level of NO production in J774 cells.  The dose-response curve log mean 
effective dose (log EC50) was -0.5417 ± 0.001. This lower EC50 value indicated the 
presence of active components even at the lower concentration of LGG-CM. The half 
maximal effective concentration (EC50) for LGG-CM which induces a response halfway 
between the baseline and maximum NO production after 24 hours exposure period to 
macrophages is around 28.8 % LGG-CM. The maximal estimated nitrite production from 
undiluted LGG-CM at 24 hours was 2.5 ± 0.3 μM. Results indicate that 10 % LGG-CM 
treated macrophages significantly differed in nitrite production with respect to 
macrophages treated with a higher concentration of LGG-CM. There was no statistically 
significant difference in the nitrite production between macrophages treated with 25 % 
LGG-CM and higher concentrations of LGG-CM (P ˃ 0.05). Figure 3.6 shows that the 
amount of nitrite produced from macrophages treated with 100 %, 75 %, 50 % and 25 % 
and 10 % LGG-CM at 24 hours was 2.5 ± 0.3 μM, 2.6 ± 0.5 μM, 2.5 ± 1.2 μM, 0.9 ± 0.3 
μM, 0.2 ± 0.3 μM respectively. These results demonstrated the concentration dependent 
variation in the effect of LGG-CM on macrophage nitrite production. 
 
 
 
 
    
 
 
 
 
Figure 3.6: Basal NO production response to macrophages treated with LGG-CM.  
Various dilutions of LGG-CM were used to treat confluent monolayers of J774 macrophage for 24 
hours and NO production was measured by Griess assay. Data was from seven experiments (mean 
± SEM) performed in triplicate. The lower log EC50 value indicates the presence of strong active 
components in the LGG-CM which is effective even at a lower concentration. Statistical analysis 
was performed using one-way ANOVA followed by the Dunnett multiple comparison test. An 
asterisk indicates significant difference between nitrite production from macrophages treated with 
10 % LGG-CM and macrophages treated with higher concentrations of LGG-CM (dilutions of 50 
%, 75 % and 100 % LGG-CM).  
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3.2.7. Effect of LGG-CM on LPS induced NO production in J774 
macrophages  
 
The experiments were carried out to examine the effect of LGG-CM on LPS induced NO 
production in J774 macrophages. The macrophages were treated with a combination of 
various dilutions of LGG-CM (75 %, 50 %, 25 % and 10 %) and LPS (1 μg ml-1). After a 
24 hour incubation period, the nitrite accumulated in the spent culture medium from each 
well was measured by Griess assay as described in section 2.6.3. Different dilutions of 
LGG-CM inhibited the nitrite produced by LPS (1 µg ml-1) in a concentration dependent 
manner.  
 
Figure 3.7 shows that macrophages exposed to LGG-CM for 24 hours produced NO in a 
concentration dependent manner. The data from figure 3.5 and 3.6 is also plotted in figure 
3.7 for comparison of NO production from LPS and LGG-CM. We observed that in the 
presence of the LGG-CM+LPS combination, the macrophages demonstrated a 
concentration dependent reduction of nitrite accumulation in the medium compared to LPS 
on its own. The concentration of LPS used for macrophage stimulation being constant, and 
increasing the concentration of LGG-CM in LGG-CM + LPS combination treatment, 
resulted in a decrease in the production of the nitrite end product (Fig. 3.7).  
 
From the dose response curve, the amount of nitrite production from 20 µg ml-1 LPS was 
not significantly different from 1 µg ml-1 LPS. The amount of nitrite produced from 1 µg 
ml-1 LPS and 20 µg ml-1 LPS treated macrophages was 25 ± 4 µM and 31 ± 4 µM 
respectively (Figure 3.5). Therefore, in the LGG-CM+LPS combination treatment of 
macrophages 1 µg ml-1 LPS was used.  
 
The amount of nitrite produced from the macrophages treated with 75 %, 50 %, 25 % and 
10 % LGG-CM in the presence of LPS at 24 hours was 15 ± 3 μM, 17± 3 μM, 19 ± 3 μM, 
23 ± 3 μM respectively. The LGG-CM at a higher concentration, therefore reduce the 
effect of LPS induced NO production from macrophages. This demonstrates the beneficial 
role of LGG-CM during inflammatory conditions as it prevents unnecessary host damage. 
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Figure 3.7: The effect of various concentrations of LGG-CM and LGG-CM + LPS 
combination on basal NO production from J774 macrophages. Macrophages were 
treated with different dilutions of LGG-CM both in the presence and absence of 1 μg ml-1 LPS. 
Figure 3.7 illustrates the nitrite production from macrophages stimulated with 20 µg ml-1 LPS on its 
own, various dilutions of LGG-CM on its own and in the presence of LPS (1 µg ml-1). 
Accumulated nitrite was measured by Griess assay after 24 hours. Results are the mean of 7 
separate experiments performed in triplicate. Error bars indicate ± standard error of the mean. 
Statistical analysis was performed using one-way ANOVA followed by Dunnett multiple 
comparison test. An asterisk indicates a significant difference between macrophages treated with 
various dilutions of LGG-CM + LPS combinations and LPS on its own (* P˂0.05; ** P˂0.01). A 
significant difference was observed in nitrite production between LPS and LGG-CM + LPS treated 
macrophages (dilutions of 75 %, 50 % and 25 % LGG-CM + LPS treatments).       
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3.3. Discussion: 
3.3.1. Effect of LGG-CM on nitrite production by macrophages 
 
Current knowledge on the inflammatory role of NO is poorly understood. In low or 
physiological concentration it may play a protective role by preventing host cellular 
damage by reducing inflammation (Alican & Kubes, 1996; Brown, 2003; Lundberg et al., 
2004) increasing blood flow and also by stimulating mitochondrial biogenesis (Brown, 
2003).  
 
However, overproduction of NO during inflammation has been shown to cause 
cytotoxicity, especially if the inflammation becomes chronic (Brown, 2003). Increased 
iNOS expression and NO production are involved in inflammatory conditions such as IBD, 
asthma and rheumatoid arthritis (Alican & Kubes, 1996; ter Steege et al., 1997). Similar 
observations were also obtained from in vitro studies, where it was shown that up-
regulation of NO biosynthesis is responsible for the increased epithelial cell lines 
permeability (Unno et al., 1995). 
 
In this study, the production of NO by J774 macrophages following activation with LPS 
and LGG-CM was reflected by the accumulation of the nitrite end product in the culture 
medium. We found that the LGG-CM treated macrophages produced a low level and 
concentration dependant NO production at 24 hours. The LPS on its own treated 
macrophages produced 25 ± 4 µM NO.  However, when LGG-CM was applied with LPS, 
the LGG-CM has dose dependently reduced the LPS induced NO production from J774 
murine macrophages at 24 hours. These results were consistent from work by Lee et al. 
(2008), who demonstrated that supernatant prepared from several Lactobacillus and 
Bifidobacterium species demonstrated a decrease in LPS induced NO production in RAW 
264.7 macrophages (Lee et al., 2008).  
 
In our experiments monitoring nitrite production in the first 5 hours of macrophage 
incubation (5x105 cells ml-1) with LGG-CM and LPS, it was not possible to detect nitrite 
accumulation. These results are consistent with previous studies by Weinberg et al., (1995) 
who demonstrated that the time course analysis of iNOS m-RNA expression showed a 
detectable expression of the iNOS protein only after 8 hours of stimulatory period in 
human blood monocytes and peritoneal macrophages (Weinberg et al., 1995). 
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3.3.2. LGG Growth curve and cell free-conditioned DMEM 
The growth curves of LGG were established before the start of the experiment in order to 
correlate the optical density of the culture with the bacterial growth phase and pH. It was 
determined that the bacterial concentration of LGG, at the end of the log phase/ beginning 
of the stationary phase was approximately 2 x 109 CFU ml-1. Studies by Pena and 
Versalovic have shown that the conditioned media prepared at these phases has most 
potent immunomodulatory activity (Pena and Versalovic, 2003). 
Experiments were performed to investigate the effect of LGG-CM on the viability of E. 
coli HfrC (see section 3.2.3) and macrophages (see section 3.2.4). It was vital to confirm 
that LGG-CM is non-toxic to both the macrophage and the bacterial populations for the 
project. Otherwise, any reduction or increase in bacterial populations could imply that the 
bacteria being killed by LGG-CM or LGG-CM in itself, being toxic to macrophages. In the 
present study, antibacterial activity of LGG-CM was investigated by incubating the 
bacteria in various dilutions of LGG-CM and enumerating the bacterial number by serial 
dilution and plating. Macrophage viability in the presence of LGG-CM was assessed by 
MTT cell-proliferation assay. The LGG-CM was found to be non-toxic to both bacteria 
and J774 murine macrophages. 
 
3.3.3. Effect of cell-free LGG-CM on bacterial viability 
 
The E. coli viability assays in the presence of LGG-CM were performed with slight 
modifications as described previously (Coconnier et al., 1997; Keersmaecker et al., 2006).  
Briefly, colony count assays were performed by incubating bacteria with the different 
dilutions of cell free LGG conditioned DMEM (pH 7.4 ± 0.2) and the control media at 
370C. At predetermined intervals, aliquots were removed, serially diluted and plated on 
nutrient agar plates to determine colony counts.  
 
The antimicrobial activity of LGG-CM was examined at different time points (Figure 
3.3). The E. coli viability remained unaffected at 1 hour and even after 6 hours of contact 
with LGG-CM (Fig 3.3A & 3.3B). The difference in results were statistically insignificant 
to demonstrate the antibacterial activity of LGG-CM, against bacterial strain E. coli HfrC 
(p˃0.05) and no significant changes were observed after 24 hours treatments with the 
conditioned medium  (Figure 3.3C). 
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Under in vivo conditions, several factors determine the efficiency of probiotics to 
demonstrate antibacterial activity including cell viability, cell concentration and the nature 
of the probiotic used (heat killed and live bacteria). In the in vitro experiments 
investigating the antibacterial activity of LGG-CM, factors such as the presence of organic 
acids and proteins demonstrating antibacterial activity determine the potency of cell-free 
LGG conditioned DMEM as an antibacterial agent (Servin, 2004). 
 
Whole live LGG (Silva et al., 1987 & Ridwan et al., 2008) and the peptides secreted in the 
LGG culture media (Lu et al., 2009) have demonstrated antibacterial activity against a 
wide range of microbes. The effect of whole live LGG was suggested due to lactic acid 
produced by the bacteria.  Lactic acid not only lowers the pH of the culture medium but 
also functions as a permeabilizer of the outer membrane of Gram negative bacteria (Servin 
2004). 
 
Bacteriocins are demonstrated as antibacterial and are secreted from a number of lactic 
acid bacteria (Messens et al., 2002; Neysens, et al., 2003, Servin 2004). The production of 
bacteriocins were growth associated, dependent on temperature, pH value, a complex 
nitrogen source and environmental conditions (Messens et al., 2002; Neysens, et al., 2003; 
Servin 2004). The maximum production of antimicrobial bacteriocins was found in the pH 
range of 4.0 and 6.0 (Messens et al., 2002). 
 
Lu et al. (2009) demonstrated a dose-dependent antibacterial effect of LGG supernatant on 
E. coli growth.  They identified novel proteins from probiotic supernatant namely, 
NPSRQERR and PDENK (molecular weight less than 1000 K Da) responsible for 
antibacterial activity. The LGG concentration used in their studies to prepare the LGG 
supernatant was in a range between 108 to 109 CFU ml-1. They extracted and concentrated 
the active proteins in their experiments. Contrastingly, from literature, some studies have 
shown that, the active ingredient demonstrating antibacterial activity produced from LGG 
was a non-proteinaceous substance (Silva et al., 1987; Keersmaecker et al., 2006).  
 
Studies by Sigrid et al., (2006) observed that LGG produces a pH dependent, heat-stable, 
non-proteinaceous, low molecular weight antimicrobial compound. They observed that 
when the probiotic supernatant was tested at a pH of 6.6, the antimicrobial activity was no 
longer present as it was reflected by the faster generation of Salmonella when compared to 
the Salmonella growth observed at pH 5. Our study supports the work of Keersmaecker et 
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al. (2006) where the antibacterial activity was not found from bacteria grown in LGG-CM 
at near neutral pH (7.4 ± 0.2). 
 
To rule out the possibility that the antimicrobial activity of the LGG supernatant was only 
due to the low pH, they grew the bacteria in sterile MRS at pH 5. In this case, a shorter 
generation time (doubling time) and lag phase of Salmonella growth was observed as 
compared to LGG supernatant at pH 5.0. They attributed this property to the presence of 
undissociated organic acids in the LGG supernatant. The pH influences the ratio of 
dissociated to undissociated acid, as explained by the Henderson–Hasselbach equation. 
Although both forms can inhibit bacterial growth, the undissociated form of organic acids 
was reported to be further inhibitory per mole, than its corresponding dissociated form 
(Presser et al., 1997). This study found five compounds in the culture medium having 
antibacterial activity, which included an unidentified compound, acetic acid, pyroglutamic 
acid, formic acid and lactic acid. The first three compounds were identified by them even 
in sterile MRS medium. The formic acid concentration was not enough to bring 
antibacterial activity. They concluded that the observed antibacterial property was from 
lactic acid which is consistent with findings by Silva et al., 1987. 
 
The role of pH in demonstrating the antibacterial activity of probiotics can also be 
explained by the findings of Ridwan et al. (2008) who demonstrated that the probiotic 
supernatant at pH 7 from multispecies probiotic ecologic 641 did not demonstrate any 
antibacterial activity. However, live bacteria demonstrated the bactericidal activity and 
therefore attributed the antibacterial property to organic acids produced. 
 
However, not all the lactic acid producing probiotic bacteria demonstrate antibacterial 
activity (Asahara et al., 2001). Asahara et al found that Lactobacillus strains such as L. 
fermentum ATCC 14931T, L. jensenii ATCC 25258T, L. plantarum ATCC 14917T and L. 
reuteri JCM 1112T had no significant effect on antimicrobial activity against Escherichia 
coli in a murine urinary tract infection (UTI) model.  
 
Another study by Roselli et al. (2006) found that E. coli K88 viability was unaffected by 
the presence of LGG or LGG supernatant, when 108 CFU ml-1 E. coli were grown in 
DMEM with or without LGG (109 and 1010 CFU ml-1) or their equivalent spent culture 
supernatant fractions for 2 hours. 
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In our study investigating the effect of cell-free LGG-CM on macrophage bacterial 
interactions, it was important to investigate the antibacterial activity of LGG-CM at the 
same conditions as the gentamicin protection assay was performed. During gentamicin 
protection assay, the pH of cell free LGG-CM was adjusted to 7.4 ± 0.2 and the pH were 
adjusted in this range as this would be favourable for maintaining macrophage viability. 
However, most of the studies investigating for antibacterial activity have investigated at a 
far low pH.  
 
We can therefore assume that, as the pH was not in the acidic range, the antibacterial 
activity of LGG-CM on E. coli was not observed. As determining the components or 
factors exhibiting antibacterial activity of cell-free LGG-CM was not the foremost interest 
or objective of this project, experiments were not oriented in a direction to change the pH 
of the conditioned medium or concentrate the LGG-CM and further investigate the effect 
of LGG-CM on bacterial viability.  
 
3.3.4. Effect of LGG-CM on macrophage viability  
 
From figure 3.4, LGG-CM did not demonstrate any effect on macrophage viability. The 
Gentamicin protection assay was performed for an approximate period of 6 hours. The 
LGG-CM and other treatments were non-toxic to macrophages during the first 6 hours of 
incubation. There was no evidence for any antiproliferative effects of LGG-CM on the 
macrophages within this time frame.  
 
Experiments investigating for nitrite production by Griess assay were performed at a 24 
hour incubation period in the presence of various dilutions of LGG-CM both in the 
presence and absence of 1 µg ml-1 LPS. These experiments were performed in the absence 
of E. coli. The results from Figure 3.4 indicate that LGG-CM and other treatments do not 
demonstrate any toxic effects to macrophages even after 24 hour incubation period. There 
was no significant difference between the control and cells treated with LGG-CM and thus 
LGG-CM used at the concentration of 10 % LGG, 75 % LGG and 100 % LGG and their 
LPS combination are non-toxic and did not cause any significant cellular toxicity in this 
study.  
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3.4. Chapter Summary 
 
The LGG-CM investigated at several dilutions (10 % LGG, 75 % LGG and 100 % LGG) 
were found to be non- toxic to both J774 macrophage cell line and E. coli HfrC. The LGG-
CM produced a dual effect on NO production in J774 cells. The LGG-CM on its own 
produced a basal low level of NO production from the macrophages at 24 hours. The LPS 
by itself produced a high concentration of NO from the macrophages. However, when 
LGG-CM was co-applied with LPS, it produced a concentration dependent decrease in NO 
production from the macrophages when compared to LPS on its own treated macrophages. 
The basal low level of NO production to LGG-CM may contribute to regulate 
physiological processes in J774 macrophages to maintain a healthy environment.  
However, the property of LGG-CM to reduce the LPS induced excessive NO production is 
probably beneficial in inflammatory conditions, such as Ulcerative colitis and Crohn’s 
disease, by cutting off excess NO production to the inflammatory mediator or bacterial 
infection and could reduce collateral tissue damage to the host.  
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4.0. CHAPTER 4  
4.1. Introduction 
Macrophages function within the innate immune system by recognizing, internalizing, and 
destroying the invading microorganisms inside their phagosomes. Once formed, the 
intracellular phagosome undergoes maturation where a phagosome vacuole goes through a 
series of fission and fusion events, modifying both membrane and luminal contents (Huynh 
et al., 2007). The main changes include the modification of a phagosomes vacuole into an 
acidic environment and the production of hydrolytic enzymes and toxic free radical 
compounds (Fang, 2004; Cross and Segal, 2004; Yates et al., 2005). Additionally, 
phagosome maturation plays an important role in mounting a successful adaptive immune 
response by destroying microorganisms and presenting antigens to T-lymphocytes. 
 
There is considerable interest in the role of probiotic bacteria in the modulation of immune 
functions (Round et al., 2010). Probiotics have long been known to contribute to the 
modulation of immune activity and play a vital role in maintaining overall intestinal health 
(Yan and Polk, 2012). Probiotic bacteria have also been suggested to activate the host 
innate immune function by influencing phagocytic activity of their immune cells including 
polymorphonuclear cells (Donnet-Hughes et al., 1999; Arunachalam et al., 2000; Sheih et 
al., 2001; Gill et al., 2001; Berman et al., 2006; Kotzamandis et al., 2010: Galdeano et al., 
2011; Marranzino et al., 2012). Daily ingestion of probiotic supplements has been 
previously shown to enhance the innate immune function by significantly increasing the 
number of phagocytic monocytes and neutrophils and salivary immunoglobulin A levels in 
healthy non-elderly adults (Berman et al., 2006).  
 
Current literature, on the role of probiotics into the phagocytic process by the phagocytic 
cells has mostly looked at the total number of phagosomes after a certain time period.  
Increased phagocytic ability might refer to either increased bacterial ingestion or increased 
bacterial killing. Very few works in the past have attempted to differentiate between 
ingestion and digestion phases of the phagocytic ability of macrophages, where, the 
phagocytosis assays focus on enumerating the recovery of ingested bacteria and killing 
assays determine the bacterial digestion by phagocytic cells (Hampton et al., 1994; 
Hampton and Winterbourn, 1999; Winterbourn, 2008).  
 
The main aim of this chapter was to investigate the effect of LGG-CM on bacterial 
ingestion and digestion by macrophages. The cell free LGG-CM was used in this study 
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instead of whole live LGG. A challenge associated with stimulating macrophages with 
whole live LGG to measure phagocytosis is that the macrophages are equally as likely to 
ingest the live probiotic bacteria as they are the pathogen. As a result, the number of E. coli 
surviving inside the macrophages may well be lower, or the triggered immune response 
might be different, due to the co-ingestion of LGG. Thus, cell-free LGG-CM was 
employed as in previous studies from literature (Yan and Polk 2002, Vincenti, 2010).  
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4.2. Results 
4.2.1. Effect of LGG-CM on E. coli ingestion by J774 macrophages  
 
In these experiments macrophages and bacteria were co-incubated for 30 and 60 minutes at 
370C in the presence of 20 µg ml-1 LPS, various dilutions of LGG-CM and also in 
combination of LGG-CM+LPS.  There was no significant difference between the number 
of E. coli recovered after 30 minutes or at 60 minutes of ingestion period in control as well 
as from various treatments. 
 
However, our results demonstrate that macrophage ingested significantly less bacteria in 
the presence of LGG-CM or LGG-CM+LPS combination treatments when compared to 
control at either 30 minutes or 60 minutes time points (Fig.4.1). The addition of LPS along 
with LGG-CM had no significant difference in bacterial ingestion compared to LGG-CM 
on its own. 
 
Bacterial ingestion studies in presence of low and high LGG-CM were performed as 2 
different sets of experiments (4.1A and 4.1 B as one set and 4.1C and 4.1D as another set). 
Bacterial recovery from low or high concentrations of LGG-CM treated macrophages were 
therefore compared to the bacterial recovery from the respective control macrophages.  
 
From Figure 4.1A and 4.1B, the bacteria recovered (average log10 CFU ml
-1) from control 
macrophage, LPS, 10 % LGG and 10 % LGG-CM treated macrophages at 30 minutes 
(figure 4.1 A) and at 60 minutes (Fig. 4.1B) was 4.9±0.03, 4.81±0.03, 4.65±0.07, 
4.69±0.04 and 4.92±0.04, 4.81±0.03, 4.66±0.07, 4.52±0.07 respectively.  
 
From Figure 4.1C and 4.1D, the recovered bacteria (average log10 CFU ml
-1) from the 
untreated macrophages, LPS, 75 % LGG, 75 % LGG+LPS, 100 % LGG, 100% LGG-
CM+LPS at 30 minutes  and 60 minutes was 5.45±0.03, 5.23±0.02, 5.11±0.04, 5.09±0.02, 
5.04±0.03, 4.87±0.12 and 5.49±0.04, 5.23±0.01, 5.1±0.03, 5.08±0.02, 5.05±0.02, 
4.83±0.15 respectively.  
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Figure 4.1: Bacterial ingestion in presence of LGG-CM and LPS. Results demonstrate E. 
coli recovered from macrophages expressed as log10 CFU ml
-1 from various treatments. Figure A 
and B represents the bacterial recovery from control, LPS and 10 % LGG ± LPS at 30 and 60 
minutes respectively. Figure C and D represents the bacterial recovery from control, LPS, 75 % 
LGG ± LPS and 100% LGG± LPS at 30 and 60 minutes respectively. Experiments were performed 
in duplicate and repeated 3 times. Statistical analysis was carried out using One way ANOVA 
followed by Dunnett’s multiple comparison tests using Graphpad prism 3. Error bars represents ± 
standard error of the mean. Asterisks indicate significant difference to control (* p< 0.05; 
**p<0.01). 
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4.2.2. Monitoring the effect of cell free LGG-CM on bacterial ingestion by 
macrophages using acridine orange crystal violet staining. 
 
To further investigate the above findings (Figure 4.1) produced by gentamicin protection 
assay that macrophages ingest  less bacteria in the presence of  LGG-CM, fluorescently 
labelled E.coli ingestion was monitored by using a fluorescence microscope (figure 4.2). 
 
The fluorescently labelled E.coli was added to the confluent macrophages and incubated 
for 15, 30 and 60 minutes. After the respective time intervals, just before imaging 0.05 % 
crystal violet dissolved in PBS was added to the petridishes to quench extracellular 
fluorescence (see Chapter 2, Section 2.8.1).  
 
In the pseudocoloured images viable ingested bacteria appeared green and any bacteria 
killed appeared red. It was possible to view that macrophages treated with LGG-CM had 
lower fluorescence intensity indicating the lower number of bacteria residing in the 
macrophages. We detected a negligible number of dead bacteria during this bacterial 
ingestion period (Figure 4.2).  
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Control 15 min   
LPS  15 min   
10% LGG 15 min   
75% LGG 15 min   
LPS  30 min   
10% LGG 30min   
75% LGG 30min   
LPS  60 min   
10% LGG 60min   
75% LGG 60min   
Control 30 min   Control 60 min   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2: Monitoring bacterial ingestion in the presence of LGG-CM and LPS by 
acridine orange and crystal violet staining using a fluorescence microscope. 
Macrophages were coincubated with acridine orange labelled E. coli in control (row 1), 20 μg ml-1 
LPS (row 2), 10 % LGG (row 3) and 75 % LGG (row 4).  Images are representative of one of the 
three experiments performed. Vertical panels illustrate pseudo coloured fluorescence images 
grabbed at variable ingestion periods of 15, 30 and 60 minutes (columns A, B & C).  
                 A                                 B                                     C 
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4.2.3. Bacterial digestion curves  
 
To investigate the effect of LGG-CM on E.coli digestion by macrophages, bacterial 
recovery was monitored for set periods of time after a constant ingestion period of 60 
minutes. At 60 minutes, gentamicin (200 µg ml-1) was added to kill the remaining 
extracellular E. coli and intracellular E. coli was recovered within 15 minutes. The bacteria 
were recovered every 40 minutes up to 280 minutes. 
 
The bacteria recovered at each time point (a) expressed as CFU ml-1 was divided by the 
bacteria recovered at the first time point (a0) for all the treatments (see Figure 4.3). The 
results showed that in the control and as well as in all the treatments, there was a time 
dependant decline in the number of viable E. coli recovered from the macrophages over the 
period of  280 minutes. 
 
In the presence of higher concentration of LGG-CM, there were reduced bacterial recovery 
compared to the control or 10 % LGG-CM treated macrophages. This reduction in 
bacterial number was pronounced during the first 100 minutes of the bacterial digestion 
period (see Figure 4.3). It is evident in Figure 4.3 that the bacterial killing by the 
macrophages was slower in 10 % LGG-CM treated macrophages. At the end of the 
digestion period (280 minutes), macrophages treated with LPS, 10 % LGG, 10 % 
LGG±LPS and also untreated macrophages had a greater number of undigested bacteria 
compared to macrophages treated with a high concentration of LGG-CM.  
 
The time dependent bacterial recovery from control, LPS, 10 % LGG-CM, 10 % LGG-
CM+LPS treated macrophages appears to be similar (see Figure 4.3 A, B, C & D). 
However, the bacterial recovery from the higher concentration of LGG-CM shows a sharp 
decline of bacterial number within the first 100 minutes of digestion period both in the 
presence and absence of LPS (see Figure 4.3 E, F, G & H). 
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Figure 4.3.Recovered bacteria from macrophages during bacterial digestion period. 
The graphs represent the normalised data expressed as CFU ml-1. Experiments were performed in 
duplicate and repeated at least three times. Error bars indicate ± standard error of the mean. Where 
the error bars are not seen they are obscured by the data.  
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4.2.4. Bacterial digestion rate by macrophages to LGG-CM treatment 
 
The methodology for calculating the digestion rate from the recovered bacterial colonies is 
discussed in Chapter 2 Section 2.7.5. It was found that, the macrophages treated with high 
concentration of LGG-CM demonstrated a significantly increased rate of bacterial 
digestion compared to the control. However, a lower concentration of LGG-CM (10 % 
LGG-CM) did not show a significant difference in bacterial digestion rate when compared 
to the control.  
The digestion rate (min-1) of control, 20 μg ml-1 LPS, 10 % LGG-CM and 10 % LGG-
CM+LPS treated macrophages was 0.004 ± 0.0004, 0.007 ± 0.001, 0.003±0.0005 and 
0.005 ±0.0005.  
The digestion rate of macrophages from 75 % LGG-CM, 75 % LGG-CM+LPS, and 100 % 
LGG-CM, 100 % LGG-CM + LPS treated macrophages was 0.022 ±0.0028, 0.025 ± 
0.0029, 0.017 ±0.0047, and 0.018 ±0.0070 min-1. 
In figure 4.4, the digestion rate was non-significant between LPS and 10 % LGG ± LPS 
treated macrophages in comparison to the control macrophages. However, the higher 
concentration of LGG-CM (75 % LGG ± LPS and 100% LGG ± LPS) treated 
macrophages demonstrated a significantly enhanced bacterial digestion rate when 
compared to the macrophages treated with LPS. Similarly, the digestion rate of 
macrophages from 10 % LGG ± LPS treated macrophages were significantly different 
from the higher concentration of LGG-CM treated macrophages. 
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Figure 4.4: Macrophage digestion rate. The graph represents the bacterial digestion rate 
expressed as min-1. Experiments were performed at least in duplicate and repeated at least three 
times. Error bars indicate ± standard error of the mean. Statistical analysis was carried out using 
Graph pad Prism 3. The Dunnett multiple comparison post-hoc test was performed after observing 
a significant difference from One way ANOVA. A ** (p˂ 0.01) indicates a significant difference in 
the bacterial digestion rate when compared to the control. 
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4.2.5. Monitoring the effect of cell free LGG-CM on bacterial digestion by 
macrophages by acridine orange staining. 
 
It was found from experiments monitoring bacterial ingestion by acridine orange staining 
that LGG-CM treated macrophages ingested less bacteria (figure 4.2). To further monitor 
and image the fate of ingested bacteria in the presence of LGG-CM, bacterial cells were 
fluorescently labelled with acridine orange and bacterial digestion was monitored using a 
fluorescence microscope. Experiments were performed as described in Section 2.8.2 in 
Chapter 2. 
 
In the pseudocoloured images viable ingested bacteria appeared green and any bacteria 
killed appeared red. In Figure 4.5, it was possible to view that, the macrophages treated 
with 75 % LGG-CM demonstrated a rapid bacterial killing which was evident by increased 
number of dead cells (appearing red) within the macrophages (see column ‘C’ in Fig. 4.5). 
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4.3. Discussion 
4.3.1. Reduction in bacterial ingestion by macrophages treated with LGG-CM 
 
In this study, a cell-free extract of LGG-CM was used to ensure that only the effect 
belonging to products which are constitutively released from the LGG were investigated. 
Since macrophages were exposed to a model bacterium (E. coli), the use of LGG cells, 
rather than the cell free extract, would have complicated the interpretation of the number of 
bacteria ingested by the macrophages.  
 
Microbes possess certain patterns on their cell membrane known as microbe associated 
molecular patterns (MAMP) which are recognised by certain pattern recognising receptors 
(PRR) present on immune cells such as macrophages. Toll like receptors (TLR) are a type 
of pattern recognition receptor that are broadly shared by microbes. Gram negative bacteria 
are generally recognised by TLR-4 and Gram positive bacteria are sensed by TLR-2 either 
as a dimer with TLR-1 or TLR-6 (Takeuchi and Akira, 2010).  
 
Macrophages differentially regulate the phagocytosis of Gram positive and Gram negative 
bacteria. A study by Paul-Clark et al., (2006) investigated the phagolysosome activity of 
murine macrophages as a response to Staphylococcus aureus (Gram positive bacteria) and 
E. coli (Gram negative bacteria). They observed that Gram negative bacteria significantly 
increased the NO production mediated by TLR-4 at 24 hours. However, S. aureus 
produced a delayed (48-72 hours) NO production mediated by collaborative interactions 
between TLR-2, TLR-1 and TLR-6. The live LGG has previously been shown to enhance 
TLR-2 expression in human macrophages. This interaction is known to be essential for 
NFkβ activation (Miettinen et al., 2008), which regulates the induction of the iNOS gene 
(Aktan, 2004).  
 
This study has analysed the interactions of murine macrophage J774 with E. coli HfrC in 
the presence of various concentrations of cell free LGG-CM. Gentamicin protection assay 
was used as a quantitative method to enumerate the viable bacterial recovery after the 
bacterial ingestion period and also during different digestion periods by the macrophages. 
The internalised bacteria were released by lysing the macrophages and enumerated them 
after serial dilution and plating. The viable bacteria recovered after 15 minutes of ingestion 
was very low for the controls as well as for the treatments. However, after a 30 minute 
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ingestion period, the recovered intracellular bacterial number was found to be a premium 
level and there was no further ingestion of E. coli at 60 minutes of incubation (Figure 4.1).  
The results above were further supported by imaging the bacterial ingestion using the 
Acridine-orange crystal violet staining technique. In the images, it could be observed that 
nearly all intracellular bacteria appeared viable at 30 minutes and 60 minutes and the E. 
coli were unevenly distributed in the macrophages (Figure 4.2). Clumped bacteria in the 
phagosomes or bacterial spots in the cytosol was found to be difficult to enumerate since 
the images were captured at 600X magnification and this resolution was found to be 
insufficient for manual quantification. Thus acridine orange and crystal violet staining was 
used only as a semi-quantitative approach. 
 
At both 30 minutes and 60 minutes, the macrophages treated with LGG-CM ingested 
significantly less bacteria. A similar effect was also observed by Vincenti (2010), who 
investigated phagocytosis of E. coli HfrC by a J774 murine macrophage cell line in the 
presence of cell-free LGG-CM. His study found that LGG-CM treated macrophages 
recovered significantly less bacteria compared to untreated cells at both 30 and 60 minutes. 
He suggested that this reduced recovery of bacteria from macrophages as a response to 
LGG-CM was due to the enhanced bacterial digestion within 60 minutes of incubation. 
 
Our findings indicated that macrophages as a response to LGG-CM ingested significantly 
less bacteria. Given, that the significant killing in this period (within 60 minutes) is not 
apparent, as shown by fluorescence images by acridine orange-crystal violet staining in 
Figure 4.2, it could be interpreted that probiotics interfere or suppress the ingestion of E. 
coli by macrophages. 
   
Campbell et al. (2001) had described that 30 minutes is the minimum time required before 
any significant killing of the bacteria occur. Bacterial killing usually occur in the later 
stages of phagosomes maturation, when the phagosomes reach the final maturation stage to 
become phagolysosome. At this stage phagolysosome gain a range of weapons for 
bacterial destruction such as antimicrobial peptides and free radicals (Flannagan et al., 
2009). The process of bacterial killing in the phagolysosome requires from several minutes 
to few hours depending upon the bacterial strain (Nusse, 2011).  
 
It is important to consider the effect a bacterial population, or the phagocyte concentration, 
can have on bacterial recovery results. The bacteria’s ability to survive in a macrophage 
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intracellular environment also determines the final recovery and multiplicity of infection, 
as some pathogenic bacteria might induce macrophage cell death (Hamrick et al., 2000). 
Without the ability of E. coli HfrC to survive within a macrophage intracellular 
environment, and extracellular bacteria being killed by gentamicin, there is a negligible 
chance of E. coli being multiplied or increased during a short interval period of bacterial 
ingestion in the control group. The first assumption of LGG-CM being an antibacterial 
agent was negated by a non-significant difference in the bacterial recovery between 
bacteria grown in the presence and absence of LGG-CM (Figure 3.3).  
 
The killing of bacteria in steadily maturing phagosomes could have an impact on viable 
cell recovery. Thus, in our experiments, while investigating bacterial ingestion for an extra 
time point at 60 minutes was also investigated. The E. coli recovered from the control and 
LGG-CM treated macrophages at 60 minutes was nearly identical to the number of E. coli 
recovered at 30 min suggesting no bacterial killing occurs within this time frame (Figure 
4.1). 
 
It is well recognised that LPS stimulates the macrophages to induce an iNOS expression 
through the NFκβ pathway which is further responsible for NO production (Raetz et al., 
1991; Alderton et al., 2005; Reddy & Reddanna, 2009). Thus, 20 μg ml-1 LPS were used as 
a positive control and from previous studies and at the concentration utilised LPS was 
supposed to illicit an immediate effect (Vincenti., 2010; Hatcher and Lambrecht, 1993). In 
our studies macrophage treatment with 20 μg ml-1 LPS resulted in the reduced ingestion of 
bacteria but the reduction was not significantly different compared to the control 
macrophages.  
 
There are studies which have shown that LPS is ingested by phagocytes as a phagocytic 
target and that they induce the signal mediated by the TLR-4 receptor. When bacteria 
containing a LPS moiety in their outer cell wall are incubated along with LPS on its own 
with the macrophages, LPS might potentially act as an alternative target for the 
macrophages as they share the common recognising receptor TLR-4 (Hornef et al., 2003; 
Dunzendorfer et al., 2004).  
 
Studies by Sivagnanam et al. (2010) used a quantitative real time PCR to investigate the 
regulation of 13 mRNA sequences involved in various inflammatory responses in rat 
microglial cells as a response to E. coli and LPS treatments. Their results showed that E. 
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coli and LPS stimulated different cytokines production separately. However, when E. coli 
and LPS was applied in combination, 12 of the13 genes monitored were expressed at the 
same level as compared to E. coli alone as a sole immunomostimulator. As LPS alone did 
not demonstrate the immunomodulatory effect when in LPS and E. coli combination, 
Sivagnanam et al. (2010) concluded that the ingestion of E. coli dominates over LPS, 
during macrophage co-stimulation. It is, therefore, possible that in our studies, the lower 
recovery from LPS treated macrophages might be due to shared TLR-4 receptor occupancy 
by both LPS and live E. coli.  
 
In our study we observed a significant reduction in bacterial ingestion in the presence of 
LGG-CM irrespective of the concentration tested. However, studies from Kim et al., 
(2006a), demonstrated significantly enhanced phagocytosis of fluorescent microparticles 
by peritoneal macrophages from mice orally administered with heat killed whole probiotic 
Lactococcus lactis ssp lactis when compared to groups administered with the PBS, cell 
wall or cytoplasmic fraction. The microparticles incorporated into the cells were measured 
by flow cytometry.  However it has to be noted that, in our phagocytosis studies 
macrophages were challenged with live E. coli cells in the presence of cell free LGG-CM 
which might have a different effect on the macrophage ingestion process.  
 
Earlier researches have not focussed much on the effect of LGG-CM on bacterial ingestion 
and digestion as two separate physical entities. The term phagocytosis assay is slightly 
misapprehended as this might be either the combined uptake and killing assays or only one 
of them. This study has, therefore, investigated the effect of LGG-CM on bacterial 
ingestion and digestion as two separate experimental set ups using murine macrophage 
J774 and a model bacterium E. coli. In our study we have explored phagocytosis further as 
ingestion and digestion phases. Our study protocol supports the work by Zhou and Kobzik. 
(2007) who had investigated the effect of concentrated ambient particles on uptake and 
digestion of Streptococcus pneumonia by J774 macrophage as two separate studies. The 
comparison of literature reporting various parameters of gentamicin protection assay has 
been shown in Table 4.1. 
 
Princivalli et al. (2009) tested live LGG and LGG supernatant for their ability to prevent 
group A streptococci (GAS) infections. They found that both live LGG and LGG 
supernatant significantly prevented GAS infecting the human respiratory cell line both in 
competition and displacement assays. The mechanism described for the reduced bacteria in 
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respiratory cells was mediated through the cell surface proteins expressed on live LGG, 
and also present in LGG supernatant which competes for the same Fn-receptor necessary 
for GAS binding in respiratory cells. 
 
It is unlikely that organic acids released by LGG (Keersmaecker et al., 2006) might play a 
role in the modulation of bacterial ingestion by macrophage as the pH of the LGG-CM 
used in the study was set to neutral (pH 7). The LGG is known to express cell surface 
proteins which are present both on the live bacterial surface and also secreted actively in 
the supernatant (Princivalli et al., 2009). The first possible mechanism of observed 
reduction in bacterial ingestion in presence of LGG-CM might be due to these secreted 
bacterial proteins being present in the cell free conditioned medium which might be 
actively blocking the receptors either through stearic hindrance or through specific 
receptor–target interactions (Bernet Camard et al., 1997; Coconnier et al., 1997; Princivalli 
et al., 2009). 
 
The second possible mechanism might be due to the regulation of immune responses and 
downstream signalling pathways, such as free radicals production, which are known to 
regulate the process of chemotaxis by directly modulating actin glutathionylation and 
polymerization (Sakai et al., 2012). 
 
4.3.2. LGG-CM increases digestion rate of macrophages 
 
Experiments investigating the bacterial digestion by gentamicin protection assay were 
performed for up to 280 minutes post ingestion (see Figure 4.3). The duration of 
monitoring bacterial digestion is in agreement with previous literature (Levitz et al., 1986; 
Michaliszyn et al., 1995; Marr et al., 2001; Philippe et al., 2003). It is well documented 
that macrophages undergo apoptosis approximately 8 to 16 hours after bacterial ingestion. 
This is clearly after the intracellular destruction of most of the ingested bacteria 
approximately 4 hours post ingestion period (Baran et al., 1996; Hamrick et al., 2000; 
Hacker et al., 2002; Kirschnek et al., 2005). So, in our studies approximately 4 hours time 
period of monitoring bacterial digestion was sufficient to determine the rate of bacterial 
digestion. 
 
Bacterial digestion in macrophages, as a response to various treatments and in control 
cells, was also investigated by acridine orange crystal violet staining technique (see section 
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2.8.2 in Chapter 2). Acridine orange staining has previously been used in study by Takao et 
al., (1996) to monitor bacterial phagocytosis. The E.coli was labelled with acridine orange 
and fluorescence measurements were made every hour for up to 300 minutes.  
 
The J774 macrophages were quite efficient at taking up the bacteria that were visible as 
fluorescent spots inside the cells. On pseudo-colouring the grey scale images, viable 
bacteria appeared green and any bacteria killed appeared red. After approximately one 
hour of bacterial ingestion, the bacteria were largely localised in cellular compartments 
around the nucleus. It was possible to see that the macrophages treated with 75 % LGG-
CM demonstrated a rapid rate of bacterial killing which was evident by the increased 
number of dead cells (appearing red) from the macrophages treated with a higher 
concentration of LGG-CM (see Figure 4.5).  
 
Experiments investigating the effect of LGG-CM on bacterial digestion were performed at 
a multiplicity of infection of 50:1. To avoid under evaluation of the killing rate as 
determined independently from the rate of phagocytosis, the number of extracellular 
bacteria present during the killing assay must be sufficiently low; otherwise the 
macrophages will continue to phagocytise bacteria during the assay. At these bacteria to 
macrophage ratio, the plating of extracellular media did not reveal a presence of 
extracellular bacteria. From these findings it may be concluded that, the results of the 
bacterial digestion studies which measure the decrease in the number of viable bacteria 
during the incubation of the macrophages containing ingested bacteria, represent 
intracellular bacterial killing.  
 
The rate of decrease in the total number of bacteria within the macrophages is a measure of 
the rate of intracellular killing.  In figure 4.4 the bacterial recovery data during different 
digestion period were normalised and digestion rate was calculated (see chapter 2, Section 
2.7.5). As the comparison for bacterial digestion rate between treatments was performed by 
calculating the rate by dividing recovered bacterial number at various time points by the 
initial recovered bacterial number (a/a0), the increased bacterial digestion rate observed 
from the LGG-CM treated macrophages was due to rapid bacterial killing.  
The LPS and 10% LGG-CM treated macrophages ingested less bacteria compared to 
control, however they did not have any effect on the bacterial digestion rate by the 
macrophages. The rate of bacterial killing in the untreated cells were significantly low 
(p<0.01) compared to macrophages treated with 75% or 100% LGG-CM. The bacterial 
110 
 
digestion rate from 10 % LGG-CM was significantly low when compared to 75 % LGG-
CM or 100 % LGG-CM treated macrophages. The rate of bacterial digestion from the 
macrophages treated with 75 % LGG-CM and 100 % LGG-CM was 0.022 ± 0.003 and 
0.017 ± 0.005 respectively. This observed rate was significantly different from the rate of 
bacterial digestion from control macrophages, which was 0.004 ± 0.0004. The rate of 
bacterial digestion from both LPS (0.007 ± 0.001) and 10 % LGG-CM (0.003 ± 0.001) 
treated macrophages were non-significant from the control (Figure 4.4). The possible 
mechanisms that a higher concentration of LGG-CM induced an increased bacterial 
digestion rate are investigated in Chapter 5. 
 
In this study, the rate of intracellular killing is calculated by fitting an exponential curve to 
the bacterial digestion data (see Section 2.7.5). The trendline plotted from the recovered 
bacteria versus time showed an exponential trend in bacterial killing. Similar exponential 
decrease in bacterial number was also found by Van Dissel et al., (1985). They found that 
opsonised Salmonella enteric serovar Typhimurium underwent an exponential decrease 
after being taken up by murine macrophages over a 90 minute period of their assay. In 
contrast Hamrick et al., (2000) showed that the digestion of E. coli by murine macrophage 
follows a parabolic shape, started with an initial exponential pattern in bacterial killing 
followed by a slight upward slope, as time progressed indicating the bacterial number 
increasing slightly. They concluded that the parabolic curve might be due to inefficiency in 
extracellular bacterial killing by low concentration of gentamicin (5 μg ml-1). 
 
It’s quite irrational to compare the rates from previous studies as the variation is expected 
due to the difference in assay conditions and the use of different macrophages and bacterial 
strains. The comparison of the bacterial digestion rate from previous studies has been made 
irrespective of the variability in experimental conditions and is listed in Table 4.2. In 
summary, and to the best of our knowledge, this is the first study investigating the effect of 
LGG-CM on bacterial digestion rate and these findings can be used as a comparison on the 
effect of various probiotics on bacterial digestion rate in future. 
4.4. Chapter Summary 
 
Macrophages treated with LGG-CM ingest significantly less bacteria during both 30 
minutes and 60 minutes of macrophage-bacterial coincubation irrespective of the 
concentration tested. However, an increased bacterial digestion rate was observed only 
from macrophages treated with a higher concentration of LGG-CM. 
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Study reference Macrophage 
origin 
Bacterial strain Initial 
inoculums 
CFU ml-1 
MOI Incubation 
period 
[minutes] 
Recovery 
CFU ml-1 
Bacteria 
Per 
macrophage 
This study Murine E. coli HfrC 2.5x107 50:1 30 2.8x105 0.56 
 
This study Murine E. coli HfrC 2.5x107 50:1 60 3.0x105 0.62 
Buchmeier and Heffron, (1989) Murine Salmonella typhimurium * Undefined 10-20:1 0,60,240, 
1440 
Undefined Undefined 
Boyce and Adler 
(2000) 
 
Murine 
 
Pasteurella multocida  M1404 1.0x107 Undefined 30 1.8x103 
 
Undefined 
Pasteurella multocida  PBA875 1.0x107 Undefined 30 7.1x103 
 
Undefined 
Pasteurella multocida  PBA1514 1.0x107 Undefined 30 1. 2x103 
 
Undefined 
Hatcher and Lambrecht, (1993) Murine Salmonella typhimurium * 1x106 20:1 120 Undefined Undefined 
Wells et al. (1990) 
 
Murine 
 
Proteus mirabilis M13 8 X 107 100:1 3 (in vivo) Undefined 0.03 
Proteus mirabilis H1 8 X 107 100:1 3 (in vivo) Undefined 0.02 
Escherichia coli M14 8 X 107 100:1 3 (in vivo) Undefined 0.48 
Escherichia coli A-D M5 8 X 107 100:1 3 (in vivo) Undefined 0.45 
Escherichia coli H40 8 X 107 100:1 3 (in vivo) Undefined 0.28 
Nagl et al. (2002) 
 
Human 
 
Staphylococcus aureus ATCC25923 ≈6 X 105 10:1 30 Undefined 21.90 
Escherichia coli ATCC 11129 ≈2X105 10:1 30 Undefined 19.00 
Table 4.1: Comparison of literature reporting various parameters of GPA.  [*: Strains which are pathogenic and exhibit characters like invasiveness and are 
capable of surviving in macrophages.] Colony forming units (CFU); Multiplicity of infection (MOI); Not defined (ND) 
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Poermadjaja and Frost, (2000) 
 
Poultry 
 
Pasteurella multocida  VP161 107 100:1 30 5 X 105 1.00 
Pasteurella multocida  VP138 107 100:1 30 6 X 105 1.2 
Pasteurella multocida  VP17 * 107 100:1 30 9 X 105 1.8 
Pasteurella multocida  VP21 * 107 100:1 30 8 X 105 1.6 
Pasteurella multocida  VP161 107 100:1 60 6 X 105 1.2 
Pasteurella multocida  VP138 107 100:1 60 Undefined Undefined 
Pasteurella multocida  VP17 107 100:1 60 Undefined Undefined 
Pasteurella multocida  VP21 107 100:1 60 Undefined Undefined 
De Koning - Ward et al.  (1998) 
 
Murine 
 
Yersinia enterocolitica  JP273v 2 X 107 10:1 30 6 X 103 0.003 
Yersinia enterocolitica 8081c * 2 X 107 10:1 30 2.6 X 105 0.13 
Escherichia coli HB101 2 X 107 10:1 30 2.0 X 104 0.010 
Escherichia coli HB101(pVM101)* 2 X 107 10:1 30 3.3 X 105 0.17 
Fernandez Prada, (1997) Murine Shigella flexneri  M90T-W, M90T-A3, SC403, 
2457-T, M4243A, M90T-55, BS103 
ND 3-30:1 30 Undefined Undefined 
Tabrizi and Robins –Browne, 
(1993) 
 
Murine Escherichia coli HB101 
 
5x106 5:1 30 Undefined Undefined 
Yersinia enterocolitica 8081c * ND 5:1 30 Undefined Undefined 
Laroux et al. (2005) Murine Escherichia coli          ( F18) 1x107 10:1 120 ≈4.5x104 Undefined 
113 
 
 
Larsen & Boesen, (2001) Fish Vibrio anguillarum 1.75x109 50:1 180 1.3x103 Undefined 
Vibrio anguillarum 1.75x108 5:1 180 0.026x103 Undefined 
Vincenti, (2010) Murine E. coli HfrC 5x107 100:1 15 3.0x103 0.005 
E. coli HfrC 5x107 100:1 30 3.3x106 6.40 
E. coli HfrC 5x107 100:1 60 3.3x106 6.40 
Sjölinder et al. (2008) 
 
Murine Neisseria meningitidis FAM20 nhhA 5x108 100:1 180 Undefined Undefined 
Neisseria meningitidis FAM20 5x108 100:1 180 Undefined Undefined 
Gille et al. (2009) 
 
Human E.coli DH5α* 
 
5x107 50:1 180 Undefined 0.4 
Group B Streptococci BSU98* 5x107 50:1 180 Undefined 0.31 
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Table 4.2: Rate of intracellular killing of bacteria by phagocytes. All values are means 
of rates of the bacterial killing with their standard deviation. A * indicates rate ± SEM, otherwise it 
is standard deviation. All experiments are performed under in vitro conditions. 
 
Bacterial strain Mouse strain/ 
macrophage 
cell line 
Rate constant of 
bacterial killing 
Kk (min-1) 
Reference 
E. coli HfrC J774 0.004 ± 0.0004 * This study 
E.coli M14 Swiss Webster 
mice 
0.017 ± 0.006   * Wells et al., 
(1990) Proteus mirabilis M13 0.020 ± 0.003   * 
E. coli A-D M5 0.016 ± 0.003   * 
E. coli H40 0.026 ± 0.009   * 
Proteus mirabilis H1 0.029 ± 0.003   * 
Salmonella typhimurium Swiss 0.022 ± 0.005 van Dissel et al., 
(1985)  CBA 0.020 ± 0.007 
C57BL/10 0.012 ± 0.003 
E. coli O54 CBA 0.039 van Dissel et al., 
(1987a) E. coli O54 C57BL/10 0.036 
E. coli O2K1 CBA 0.063 
E. coli O2K1 C57BL/10 0.060 
Salmonella typhimurium Peritoneal 
macrophages 
 
0.035 ± 0.015 Langermans et 
al., (1990) 
Listeria monocytogenes 0.026 ± 0.009 
Listeria monocytogenes CBA 0.021 ± 0.004 van Dissel et al., 
(1987b) C57BL/10 0.022 ± 0.005 
Salmonella typhimurium CBA 0.036 ± 0.008 
C57BL/10 0.019 ± 0.009 
Staphylococcus aureus CBA 0.025 ± 0.006 
C57BL/10 0.023 ± 0.004 
E. coli 054 CBA 0.031 ± 0.007 
C57BL/10 0.033 ± 0.008 
Salmonella typhimurium Granulocytes of 
CBA mice 
0.017 ± 0.006 van Dissel et al., 
(1986) 
Granulocytes of 
C57BL/10 mice 
0.007 ± 0.004 
Listeria monocytogenes Granulocytes of 
CBA mice 
0.012 ± 0.003 
Granulocytes of 
C57BL/10 mice 
0.013 ± 0.002 
Staphylococcus aureus  Human 
granulocytes 
 
0.026 Leigh et al., 
(1980) 
E. coli (O54) 0.036 
Staphylococcus aureus   
Human 
neutrophils 
 
0.11 ± 0.02 
 
Hampton et al., 
(1994) E. coli ATCC 25922 0.36 ± 0.06 
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5.0 CHAPTER 5 
5.1. Introduction 
 
In chapter 4 it has been evident from both the GPA and fluorescent data (acridine orange –
crystal violet staining) that LGG-CM plays a role in the activation of macrophage 
enhancing E.coli digestion. In the current chapter we will investigate the possible 
physiological mechanisms which are activated in macrophages to LGG-CM treatment to 
enhance the bacterial digestion process.  
 
Studies have demonstrated that both ROS and RNS play an important role in digesting the 
trapped bacteria in the macrophage phagosomes. This digestion process involves oxidizing 
and damaging bacterial cell wall proteins and DNA, resulting in bacterial killing. Both NO 
and ROS combine to form a potent oxidant peroxynitrite (ONOO-) which has been 
demonstrated to contribute into the bacterial killing process by macrophages (Beckman et 
al., 1992; Ischiropoulos et al., 1992; Evans et al., 1996).  
 
There is evidence that NO and ROS can also work independently in bacterial killing 
process (Nathan and Shiloh, 2000; Fang 2004; Flannagan et al., 2009; Qiu et al., 2009). 
Other free radicals independent mechanisms such as defensins, lysozymes, antimicrobial 
peptides including lactoferrin and condition like reduced pH (approximately 5.5 or lower) 
in the phagosome are also suggested to contribute in bacterial killing process by 
macrophages (Flannagan et al., 2009; Slauch, 2011). 
 
The LGG has shown that it can induce rapid ROS generation in murine intestinal epithelial 
cells (Lin et al., 2009), human (Caco-2, T-84 and HeLa) and rat (IEC-6) intestinal 
epithelial cell lines (Kumar et al., 2007). Farnell et al. (2006) demonstrated an increased 
ROS production from chicken heterophils when they were treated with heat killed Bacillus 
subtilis, Lactococcus Lactis and Lactobacillus acidophilus bacteria. Studies by Ichikawa et 
al. (2012) have shown an increased production of reactive oxygen metabolites from murine 
peritoneal macrophages fed with heat killed LGG. The induction of ROS from 
macrophages have been suggested as beneficial actions of probiotics as ROS is involved in 
the killing of invading microorganisms (Farnell et al., 2006; Flannagan et al., 2009). 
 
Probiotic mediated NO production has also been shown in murine macrophage cell line 
J774 and in human epithelial cell line –T84 as a response to live LGG (Korhonen et al., 
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2001) and in intestinal pig epithelial cell line (IPEC-J2) by several lactobacillus strains 
(Pipenbaher et al., 2009). However, there are studies which have demonstrated that 
probiotic bacteria such as VSL-3 demonstrate the anti-inflammatory response by reducing 
the expression of the iNOS enzyme from in vivo studies (Esposito et al., 2009). Studies 
have been shown to reduce nitrite production (a stable end product of NO) from mouse fed 
with Lactobacillus acidophilus cell-free supernatant (Rishi et al., 2009). Probiotics are 
previously also known to attenuate proinflammatory TNF-α which has known to have a 
profound effect on NO production in intestinal epithelial cells (Madsen et al., 2001; Gopal 
et al., 2001).  
 
Current literature are in agreement with the hypothesis that probiotic bacteria enhances the 
phagocytic activity of macrophage by activating oxidative burst resulting in the increased 
killing of pathogens (Schiffrin et al.,1995,  Donnet –Hughes et al., 1999, Farnell et al., 
2006; Ichikawa et al., 2012; Marranzino et al., 2012). However, the mechanisms 
accounting for the observed beneficial effects remain to be fully elucidated. 
 
The traditional pathways of free radical production are mainly observed through the 
NADPH oxidase (first few hours of infection) and the iNOS (later stages of infection). 
Xanthine oxidase is another source of ROS production (Crane, 2013). However, there are 
controversial reports where one suggests that peritoneal macrophages possess scant amount 
of xanthine oxidase (Jarasch et al., 1986) while the other demonstrates a substantial 
amount of xanthine oxidase in murine peritoneal macrophages (Takao et al., 1996). From 
the literature review, the precise source and mechanism of ROS production for LGG-CM 
mediated bacterial killing is undefined. 
 
The exact mechanism via which the LGG-CM cause their actions is currently not known, 
nor is it clear whether they could regulate ROS generation and mediate bacterial killing as 
seen in the chapter 4. In this study, we have therefore evaluated the influence of cell free 
LGG-CM on ROS and NO production by the J774 macrophage cell line, and further 
evaluated the acute effect of LGG-CM on NO and ROS production during the process of 
macrophage phagocytosis of E.coli in real time. Fluorescence analysis was used to monitor 
ROS or NO generation on a real time basis. Data was analysed using CuSum analysis 
which offers a simple and rapid method for identifying sustained changes in real time 
under experimental situations.  
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The Cumulative sum (CuSum) technique was first proposed by Page, in 1954 (Tam, 2009; 
Hu et al., 2012) but now widely used in several biological fields in investigating medical 
outcomes (Kabir et al., 2013; Cho et al., 2014), quantitative analysis of circadian blood 
pressure profiles (Stanton et al., 1992), monitoring epidemics (Menotti et al., 2009; Hu et 
al., 2012) and in several clinical studies (Knight et al., 2001; Kverka et al., 2007). This is 
however the first study to investigate a real time changes in ROS and NO productions 
using CuSum in in vitro experiments. 
  
In this chapter, the role of both NO and ROS in LGG-CM mediated macrophage digestion 
were also investigated using selective pharmacological inhibitors for NO and ROS. This 
was followed by attempts to delineate precisely which toxic oxidants are primarily 
responsible for the observed LGG-CM mediated phagocytic modulation by using cell 
permeable free radical scavengers such as PEG conjugated SOD and catalase.  
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5.2. Results: Ingestion Phase 
 
In the ingestion phase, the involvement of both NO and free radicals during bacterial 
ingestion was tested by using pharmacological inhibitors and scavengers. The rate of ROS 
and NO production during the ingestion period was also measured using a fluorescence 
microplate reader. 
5.2.1. Effect of ROS inhibitors on bacterial ingestion 
 
Macrophages pretreated with 100 μM apocynin (apo), 100 μM allopurinol (allo) and a 
combination of apocynin and allopurinol (apo+allo) were coincubated with E. coli for 60 
minutes. The recovered bacteria were expressed as log10 CFU ml
-1. Recovered bacteria at 
60 minutes from untreated macrophages (control) were 5.61 ± 0.1.  Macrophages in the 
presence of 75 % LGG-CM ingested significantly less bacteria at 60 minutes co-incubation 
period. Bacteria recovered from the macrophages treated with apocynin, allopurinol, 
apocynin + allopurinol was 5.77 ± 0.09, 5.72 ±0.15, and 5.64 ± 0.17 log10 CFU ml
-1. 
 
We did not observe any significant difference in the bacterial recovery from macrophages 
treated with 75 % LGG-CM when compared to the bacterial recovery from 75 % LGG-CM 
and inhibitor treatments. However, we observed a significant difference in the bacterial 
recovery between control macrophages and macrophages treated with some of the inhibitor 
treatments in the presence of 75 % LGG-CM as shown in Figure 5.1. 
 
Bacteria  recovered from macrophages treated with 75 % LGG, 75 % LGG + apo, 75 % 
LGG+ allo, 75 % LGG (apo+allo) at 60 minutes were 5.19 ± 0.07, 5.22 ± 0.06, 5.14 ± 
0.03, 5.09 ± 0.03 log10 CFU ml
-1 respectively.  
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Figure 5.1: Effect of ROS inhibitors on bacterial ingestion. The effect of NADPH 
oxidase and xanthine oxidase inhibitors on bacterial ingestion were investigated in the presence of 
LGG-CM. Cells were pretreated for an hour with 100 μM apocynin (apo) a NADPH oxidase 
inhibitor; 100 μM allopurinol (allo)- a specific xanthine oxidase inhibitor and 100 μM apocynin-
allopurinol combination (apo+allo).  Recovered bacteria at 60 minutes were expressed as log10 CFU 
ml-1. Experiments were performed at least in duplicate and repeated at least four times. Error bars 
indicate ± standard error of the mean. Statistical analysis was carried out using one way ANOVA 
followed by Dunnett multiple comparison post-hoc tests. Treatments which significantly differed 
with the control are shown with an asterisk [(*p<0.05); (**p<0.01). However, there was no 
difference in the bacterial recovery between treatments and their respective inhibitors during the 
first 60 minutes of incubation with LGG-CM. 
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5.2.2. Effect of free radical scavengers on bacterial ingestion 
 
Macrophages were pre-treated with PEG-conjugated SOD and catalase for 60 minutes. The 
bacterial ingestion was then monitored from control cells ± scavengers and 75 % LGG-CM 
± scavengers. As observed previously, LGG-CM treated macrophages ingested 
significantly less bacteria when compared to the control. 
We also observed significant differences between the bacterial recoveries from control 
macrophages to macrophages treated with SOD on its own and SOD + catalase 
combination (figure 5.2 A). The recovered bacteria from control macrophages were 5.52 ± 
0.07 log10 CFU ml
-1.  The recovered bacteria from the catalase, SOD and catalase + SOD 
treated macrophages was 5.31  ± 0.1 log10 CFU ml
-1 , 5.19  ± 0.07 log10 CFU ml
-1, 5.07  ± 
0.11 log10 CFU ml
-1 respectively. 
In the presence of LGG-CM, macrophages treated with PEG-SOD and PEG-catalase 
significantly reduced bacterial ingestion compared to macrophages treated with LGG-CM 
on its own. Both the PEG-SOD and PEG-catalase treated macrophages yielded similar 
bacterial recovery. However, in combination, they did not have an additive effect and the 
bacterial recovery was non-significant between the scavengers themselves. 
The recovered bacteria from the LGG-CM treated macrophages were 4.88 ± 0.09 log10 
CFU ml-1. The recovered bacteria from LGG-CM + catalase, LGG-CM + SOD and LGG-
CM + (catalase + SOD) treated macrophages were   4.56  ±  0.08  log10 CFU ml
-1 , 4.56  ±  
0.04 log10 CFU ml
-1 and  4.52  ±  0.02 log10 CFU ml
-1 respectively.  
 
 
 
 
 
 
 
 
 
 
 
122 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: Monitoring the effect of free radical scavengers on bacterial ingestion. 
The effect of catalase, superoxide dismutase and catalase + superoxide dismutase combination on 
bacterial ingestion were investigated in the presence of untreated (figure A) and LGG-CM (figure 
B) treated macrophages. Experiments were performed at least in duplicate and repeated at least 
four times. Error bars indicate ± standard error of the mean. Statistical analysis was carried out 
using Graph Pad Prism 3. The Dunnett’s multiple comparison post-hoc tests was performed after 
observing a significant difference from One way ANOVA. Error bars represent ± standard error of 
the mean. An asterisk indicates a significant difference to the control (**p<0.01). 
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5.2.3. Generation of free radicals as a response to menadione and arginine 
 
Macrophages were exposed to 100 μM arginine and 0.5 mM menadione and continuous 
measurements (every 2 minutes) of NO and ROS were made for 60 minutes (ingestion 
period). Menadione and Arginine were used as a positive control for ROS and NO 
production respectively. 
 
 Figure 5.3A and 5.3C show the characteristics of ROS generation from untreated 
macrophages (control) and 0.5 mM menadione treated macrophages (raw data and CuSum 
plot).  The Figure 5.3B and 5.3D represent the characteristics of NO production by J774 
cells over a 60 minute period from untreated and 100 μM arginine treated macrophages 
(raw data and CuSum plot).  
 
There were small differences in the extent of the change of fluorescence readings between 
the control and experimental plates from the raw data. However, the random variation in 
the measurements made these differences difficult to follow when the raw data of 
fluorescence measurements were plotted against time. 
 
To address this, CuSum statistics was used to understand the pattern of real time ROS 
production data. The smoothing of the data in this way elucidated the difference between 
the control and experimental results.  
 
In the Figure 5.3C, the rate or gradient of ROS production from the untreated macrophages 
was zero. However, the gradient of 0.5 mM menadione treated macrophages was 0.3 
fluorescence arbitrary units min-1. The gradient of NO production (figure 5.3D) from the 
untreated cells was 0.05 fluorescence arbitrary units while from 100 μM arginine this was 
found to be 0.29 fluorescence arbitrary units. The gradients are the m values from the 
linear trendline equation y= mx+c derived from CuSum values (see Section 2.11.6 in 
Chapter 2). 
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Figure 5.3: Raw data and CuSum plot for J774 macrophages incubated with 
menadione and arginine. Figure A illustrates the profile of ROS production from control and 
menadione treated macrophages and Fig C represents the corresponding CuSum plots. Figure B 
illustrates the profile of NO production from arginine treated macrophages and Figure D represents 
the corresponding CuSum plots. In figure C and D, menadione and arginine treated macrophages 
demonstrate an increase in free radical production and thereby increased fluorescence values. The 
CuSum plot shows a sharply rising trend with these positive treatments. The measurements were 
made over 60 minutes at two minute intervals. The above graphs are representative of at least 3 
independent experiments (n=4). 
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5.2.4. CuSum gradient of ROS production from macrophages during 
incubation of treatments for 60 minutes 
 
In the next series of experiments, the effect of various dilutions of LGG-CM, LPS, and 
LGG-CM + LPS combination on ROS production was investigated during first 60 minutes 
in J774 murine macrophage cell line by labelling the macrophages with H2DCFDA as 
described in Figure 2.10. 
As shown in Figure 5.4, there was a significant difference in the rate of ROS production 
from macrophages treated with 75 % LGG-CM ± LPS and 100 % LGG-CM ± LPS 
treatments when compared to the control. The rate of ROS production from macrophages 
treated with 75 % LGG-CM, 75% LGG-CM +LPS, and 100 % LGG-CM, 100 % LGG-CM 
+ LPS were 3.27 ± 1.03, 4.00 ± 1.12, 5.2 ±1.06, and 5.13 ± 1.08 fluorescence arbitrary 
units per minute. However, LPS and 10 % LGG-CM ± LPS treatment of the macrophages 
did not differ significantly when compared to untreated macrophages.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: Fluorescence measurement of ROS production during the ingestion 
period. The macrophages were labelled with H2DCFDA and fluorescence measurements were 
taken every 2 minutes for up to 60 minutes. Experiments were repeated at least 7 times (n=4) and 
the rate of ROS production was calculated by CuSum analysis. Error bars indicate ± standard error 
of the mean. Dunnett’s multiple comparison post-hoc tests was used to identify significantly 
differing groups after observing a significant difference from One-way ANOVA. Error bars 
represent ± standard error of the mean. An asterisk indicates a significant difference to control 
(**p<0.01). 
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5.2.5. CuSum gradient of ROS production from macrophages in the presence 
of bacteria during the ingestion period  
 
The effect of LPS, various dilutions of LGG-CM and LGG-CM + LPS combination on 
ROS production was investigated by co-incubating J774 murine macrophage cell line with 
viable E. coli HfrC during first 60 minutes (ingestion phase). 
 
Increased levels of intracellular ROS production was observed from macrophages co-
incubated with bacteria  in the presence of 75 % LGG-CM ± LPS and 100 % LGG-CM ± 
LPS. The LPS and 10 % LGG-CM ± LPS treatment did not significantly influence ROS 
production from the macrophages when compared to the control (Figure 5.5).  
 
Similar results were observed from the macrophages in the presence of 10 % LGG-CM in 
the absence of bacteria (Figure 5.4). The differential level of ROS production from a lower 
concentration of LGG-CM when compared to higher [LGG] is suggestive of a potential 
anti-inflammatory role of LGG-CM at low concentrations. The slope or rate of ROS 
production from macrophages treated with 75 % LGG-CM, 75% LGG-CM +LPS, 100 % 
LGG-CM and 100 % LGG-CM +LPS in the presence of bacteria were 3.4 ± 0.78, 3.7 ± 
0.92, 4.7 ±0.92 and  5.8 ± 1.4 fluorescence arbitrary units per minute.  
 
The rate of ROS production from control macrophages incubated with E. coli and 
macrophages incubated with LPS and E. coli were zero. The slope or rate of ROS 
production from 10 % LGG-CM and 10% LGG-CM +LPS was 0.7 ± 0.29, 1.0 ± 0.56 
fluorescence arbitrary units per minute. 
 
There was no significant difference (p>0.05) in ROS production at 60 minutes from any of 
the treatments on its own (Figure 5.4) and in presence of bacteria (Figure 5.5). 
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Figure 5.5: Fluorescence measurement of ROS production during the ingestion 
period. Macrophages were labelled with H2DCFDA and fluorescence measurements were taken 
every 2 minutes for up to 60 minutes. Experiments were performed in the presence of bacteria. 
Experiments were repeated at least 7 times (n=4) and the slope of ROS production was calculated 
by CUSUM analysis. Error bars indicate ± standard error of the mean. Dunnett’s multiple 
comparison tests was used to identify significantly differing groups after observing a significant 
difference from One-way ANOVA. Error bars represent ± standard error of the mean. An asterisk 
indicates a significant difference to the control [(*p<0.05); (**p<0.01). 
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5.2.6. Visualization of ROS production using a fluorescence microscope 
 
To visualise the ROS production from macrophages treated with LGG-CM, the 
macrophages were first loaded with fluorescent dye H2DCFDA. Various dilutions of LGG-
CM (10 % LGG and 75 % LGG) and 20 μg ml-1 LPS were applied and the images were 
captured using a fluorescence microscope as described in section 2.11. The images were 
then pseudocoloured with Image Hopper 2 software. 
  
In the pseudocoloured images blue represented the coolest fluorescent spot, followed by 
shades of green, yellow, orange and red for brighter intensity. Panel A shows the bright 
field images while panel B and panel C shows the fluorescence images at 30 minutes and 
60 minutes respectively. 
 
 It was evident from the images that macrophages treated with 75 % LGG-CM 
demonstrated higher ROS production both at 30 minutes and 60 minutes  (panel B4 and C4 
in figure 5.6) compared to control (panel B1 and C1), LPS treated (panel B2 and C2) or 10 
% LGG-CM treated macrophages (panel B3 and C3). The bright brick red/orange 
fluorescence from 75 % LGG treated macrophages demonstrate increased ROS production 
when compared to the control (blue/green fluorescence). 
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Figure 5.6: Fluorescence imaging of ROS production from macrophages. The 
macrophages were labelled with H2DCFDA and treated with 20 μg ml
-1 LPS, 10 % LGG-CM and 
75 % LGG-CM for 30 and 60 minutes.  The images are representative of one of the three 
experiments performed. The vertical panels illustrate adjacently placed brightfield (A) and pseudo 
coloured fluorescence images (B and C). 
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5.2.7. CuSum gradient of NO production from macrophages during first 60 
minutes  
 
After observing an increase in ROS production from LGG-CM treated macrophages, we 
next studied the effect of LGG-CM on the extent of NO production. Macrophages were 
labelled with DAFFM-DA. Upon covalent modification by NO, DAFFM forms a 
fluorescent triazolo-fluorescein analog which provides an integrated measure of 
intracellular NO concentration.  
 
In order to study the effect of LGG-CM on NO production by murine macrophages, the 
macrophages were incubated with LPS and various dilutions of LGG-CM ± LPS 
combinations. The gradient of NO production from untreated macrophages, LPS treated 
macrophages and 10 % LGG±LPS treated macrophages were zero in the first 60 minutes.  
 
However, we observed a negative slope in NO production indicating a reduction in NO 
when compared to the control cells. The rate of NO production from the macrophages 
treated with 75 % LGG-CM, 75 % LGG-CM +LPS, 100 % LGG-CM and 100 % LGG-CM 
+LPS were 0.26  ± 0.07, -0.27 ± 0.07, -0.28 ± 0.08 and -0.34 ± 0.08 respectively. The LPS 
did not potentiate the NO production from LGG-CM treated macrophages acutely. 
 
We had previously observed a positive trend in NO production from cells treated with 100 
μM arginine (figure 5.3D). However, in this study, where monitoring NO production from 
macrophages in the presence of LPS and LGG-CM ± LPS, both of the treatments did not 
potentiate NO production. The results indicate a significant reduction in slope (rate) of NO 
production from the higher concentration of LGG-CM treated macrophages (Figure 5.7). 
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Figure 5.7: Fluorescence measurements of NO production during the ingestion 
period. The macrophages were labelled with DAFFM-DA and fluorescence measurements were 
taken every 2 minutes for up to 60 minutes. Experiments were repeated at least 7 times (n=4) and 
the rate of NO production was calculated by CuSum analysis. Error bars indicate ± standard error 
of the mean. Dunnett’s multiple comparison tests was used to identify significantly differing groups 
after observing a significant difference from One-way ANOVA. Error bars represent ± standard 
error of the mean. An asterisk indicates a significant difference to the control [(*p<0.05); 
(**p<0.01). 
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5.2.8. CuSum gradient of NO production from macrophages in the presence 
of bacteria during ingestion period 
 
In order to study the effect of LGG-CM on NO production by murine macrophages in the 
presence of viable E. coli HfrC, macrophages were coincubated with E. coli in the 
presence of LPS and various dilutions of LGG-CM ± LPS combinations. The NO 
production was then investigated by measuring the fluorescence intensity of DAFFM-DA 
every 2 minutes as described in Figure 2.10. 
 
Results indicate a significant reduction in slope (rate) of NO production from 100 % LGG-
CM ± LPS treated macrophages compared to the control. The 75 % LGG-CM ± LPS 
reduced the NO production from the macrophages; however, it was not statistically 
significant (Figure 5.8). 
 
The rate of NO production from macrophages treated with, 75 % LGG-CM, 75 % LGG-
CM + LPS, 100 % LGG-CM, 100 % LGG-CM + LPS in the presence of E. coli were -0.26  
± 0.07, -0.24 ± 0.07, -0.27 ± 0.07, -0.31 ± 0.09 respectively. The LPS did not potentiate the 
NO production in LGG-CM treated macrophages. 
 
Macrophages coincubated with E. coli in the presence of LPS and 10 % LGG-CM ± LPS 
treatments did not significantly differ in NO production compared to the control and the 
gradient was approximately zero.  
 
There was no statistically significant difference in NO production at 60 minutes from any 
of the treatments on its own (Figure 5.7) and in presence of bacteria (Figure 5.8) except 
umtreated macrophages (p<0.05). 
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Figure 5.8: Fluorescence measurements of NO production during the ingestion 
period. The macrophages were labelled with DAFFM-DA and fluorescence measurements were 
taken every 2 minutes for up to 60 minutes in presence of bacteria. Experiments were repeated at 
least 7 times (n=4) and the rate of NO was calculated by CuSum analysis. Error bars indicate ± 
standard error of the mean. Dunnett’s multiple comparison tests was used to identify significantly 
differing groups after observing a significant difference from One-way ANOVA. Error bars 
represent ± standard error of the mean. An asterisk indicate a significant difference to the control 
[(*p<0.05); (**p<0.01)]. 
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5.2.9. Nitric oxide production following acute exposure of LGG and LPS to 
macrophages 
 
To visualise the changes in NO production, unstimulated murine macrophages labelled 
with DAFFM-DA were exposed to 20 μg ml-1 LPS and the NO production was observed in 
a Nikon Eclipse TE2000-U fluorescent microscope equipped with fluorescence filters (ex: 
485nm; em 515nm) using time lapse imaging.  
 
Figure 5.9 shows the time course investigations of effect of LGG-CM and LPS on NO 
production by the macrophages. Images were grabbed every 20 seconds. The images (zero 
through 100 seconds) are in the presence of control media only, whilst images 100 -340 
seconds was in the presence of 20 μg ml-1 LPS, 350-520 seconds in presence of 10 % 
LGG, 520 -680 sec in the presence of sodium nitroprusside (SNP) and 680-860 sec in the 
presence of 75 % LGG. These image sets show that LPS only slightly increase the NO 
production when compared to SNP. The NO production was transient and necessitated the 
investigation to be performed a few seconds after the addition of treatments. 
 
In Figure 5.9, the NO production from control cells ranged from 4.9 ± 0.52 to 15.1 ± 1.05 
fluorescence arbitrary units. The onset of the increase in NO levels peaked just 20 seconds 
after the addition of LPS. However, this was a spike rather than a continuous increase of 
fluorescence production. A similar observation was made with response to the addition of 
10 % LGG from 350 sec -520 sec.  Treatment with LGG did not have a lag phase and a 
spike of DAF-FM oxidation was evident in the images taken at 360 seconds. The 
fluorescence intensity ranged from 3.49 ± 0.4 to 12.96 ± 0.48. The NO production from 
macrophages treated with 1 μM SNP ranged from 3.89 ± 0.49 to 22.51 ± 0.60 fluorescence 
arbitrary units. The fluorescence intensity after addition of SNP peaked within a minute to 
the highest value of 22.51 arbitrary units and this peak was sustained for 20 seconds and 
then dropped back to a nominal value of 6.7 fluorescence units at 680 seconds. The 75 % 
LGG treatment was added at around 690 seconds. The magnitude of fluorescence remained 
fairly constant ranging from 4.4 ± 0.47 to 7.82 ± 0.41 between 690 to 860 seconds. The 
changes in magnitude and the onset of fluorescence intensity varied from cell to cell.  
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Figure 5.9: Fluorescence measurements of NO production from macrophages 
subjected to acute exposure of LGG-CM, LPS and SNP. Figure A is a semi-quantitative 
representation of the images shown in figure B. Experiments was performed under complete 
darkness to avoid any background noise.  In figure A, 47 cells were selected and their fluorescence 
output was measured by grabbing images every 20 seconds. Error bars represents the fluorescence 
output from 47 selected cells. The NO formation was visualised by labelling the macrophages with 
DAFFM-DA. Images are representative of one of 3 experiments. Basal level or nominal 
fluorescence was observed initially in the presence of the control media. The fluorescence intensity 
was high when macrophages were treated with 1 μM SNP.  
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5.3. Results: Digestion phase 
 
In the digestion phase, the involvement of both NO and ROS during bacterial digestion 
was tested by using pharmacological inhibitors and scavengers. The rate of ROS and NO 
production during the digestion period was measured using fluorescence microplate reader. 
 
5.3.1. Effect of ROS inhibitors on bacterial digestion 
 
To establish the potential role of free radicals in the LGG-CM mediated increased bacterial 
digestion rate, the macrophages and bacteria were coincubated for a period of 60 minutes 
in the presence of various pharmacological inhibitors and scavengers. Gentamicin (200 μg 
ml-1) was used to kill the extracellular bacteria (see Section 2.7.4.). The recovered bacteria 
from macrophage lysate at 280 minutes represented any remaining undigested bacteria 
from the macrophages.  
 
Figure 5.10 shows that NADPH oxidase inhibitors apocynin (100 μM) inhibited bacterial 
digestion activity both in control and also in 75% LGG-CM treated macrophages. The 
recovered bacteria from control macrophages at 280 minutes were 5.12 ± 0.04 log10 CFU 
ml-1. However the bacterial recovery from apocynin treated macrophages at 280 minutes 
was 5.57 ± 0.12 log10 CFU ml
-1. Similarly in the presence of 75 % LGG-CM treated 
macrophages, the macrophages treated with apocynin and apocynin + allopurinol 
combination yielded significantly higher bacterial recovery than LGG-CM on its own.  The 
bacterial recovery from LGG-CM + apocynin and LGG-CM + (apocynin+allopurinol) 
combination treated macrophages were 5.17 ± 0.01 log10 CFU ml
-1 and 5.19 ± 0.02 log10 
CFU ml-1 at 280 minutes. 
 
In the control and LGG-CM treated macrophages, allopurinol (xanthine oxidase inhibitor) 
had no effect on the bacterial recovery at 280 minutes. We also did not observe any 
summative effect on the bacterial recovery from apocynin and allopurinol combination 
treatments in the presence of LGG-CM when compared to apocynin on its own. 
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Figure 5.10: Role of ROS in bacterial digestion in the presence of LGG-CM. The effect 
of NADPH oxidase inhibitors on bacterial digestion was investigated in the presence of LGG-CM. 
Cells were pretreated for an hour with 100 μM apocynin (apo); 100 μM allopurinol (allo); 100 μM  
apocynin and allopurinol combination (apo + allo). Recovered bacteria at 280 minutes were 
expressed as log10 CFU ml
-1. Experiments were performed at least in duplicate and repeated at least 
three times. Error bars indicate ± standard error of the mean. Statistical analysis was carried out 
using Graph pad Prism 3. Statistical analysis was performed using One-way ANOVA followed by 
Dunnett multiple comparison post-hoc test.  An asterisk (*) indicates a significant difference 
between the treatments and the control. A ($) indicates a significant difference between inhibitors 
and 75 % LGG-CM treated macrophages. 
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5.3.2. Effect of free radical scavengers catalase and SOD on bacterial 
digestion 
 
The effect of the free radical scavengers PEG-SOD and PEG-CAT were investigated on 
bacterial digestion by macrophages from both control and LGG-CM   treated macrophages 
at 280 minutes.  
 
The bacterial recovery from the control macrophages was 5.19 ± 0.02 log10 CFU ml
-1. The 
bacterial recovery from catalase, SOD and catalase+SOD treated macrophages similar to 
control were  5.19 ± 0.02 log10 CFU ml
-1, 5.13 ± 0.02 log10 CFU ml
-1 and  5.13 ± 0.08 log10 
CFU ml-1.  Although these values are fairly similar to control, however as shown in figure 
5.2, that macrophages ingest less bacteria in the presence of ROS scavengers.  Hence any 
increase of E. coli recovery from ROS scavengers treated macrophages at 280 minutes, 
could be masked due the fact of initial lower uptake of bacteria to ROS scavengers. 
 
The LGG-CM + catalase and LGG-CM + (Catalase + SOD) combination treatment of 
macrophages demonstrated a significant increase in bacterial number (shown as a dollar 
sign in Figure 5.11) compared to LGG-CM on its own.  There was no additive effect on the 
bacterial recovery when catalase and SOD were applied in combination. The SOD appears 
to have small influence on inhibiting digestion in LGG-CM treated macrophages. This 
could be due to the nature of the data as the error bar seems to have masked the effect of 
SOD.  The bacterial recovery from 75 % LGG-CM treated macrophages at 280 minutes 
was significantly less (4.35 ± 0.09 log10 CFU ml
-1).   The bacterial recovery from LGG-
CM + catalase, LGG-CM+SOD and  LGG-CM + (catalase +SOD) combination treated 
macrophages were 4.78 ± 0.03 log10 CFU ml
-1, 4.66 ± 0.14 and 4.79 ± 0.04 log10 CFU ml
-1.  
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Figure 5.11: Effect of free radical scavengers on bacterial digestion. The effect of 
superoxide dismutase (SOD) and catalase (CAT) on bacterial digestion was investigated in the 
presence of LGG-CM. After bacterial ingestion, the macrophages were allowed to digest bacteria 
for 280 minutes in the presence of PEG conjugated free radical scavengers. Recovered bacteria 
were expressed as log10 CFU ml
-1. Experiments were performed at least in duplicate and repeated at 
least three times. Error bars indicate ± standard error of the mean. Statistical analysis was carried 
out using Graph Pad Prism 3. The Dunnett’s multiple comparison post-hoc tests was performed 
after observing a significant difference from One way ANOVA. An asterisk (*) indicates 
significant difference between the treatments and the control. A significant difference in the 
bacterial recovery was also observed between LGG-CM treated macrophages and LGG-CM treated 
either with catalase or with SOD + catalase groups (P<0.05) shown as $.  
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5.3.3. Effect of nitric oxide inhibitor on bacterial digestion 
 
To investigate if NO has any effect on LGG-CM mediated bacterial killing, the 
macrophages and bacteria were coincubated for a period of 60 minutes in the presence of 
L-NMMA, after which gentamicin was used to kill the extracellular bacteria. The 
recovered bacteria at 280 minutes represented any remaining undigested bacteria from the 
macrophages. Figure 5.12 shows that blocking the iNOS activity of the macrophages using 
100 μM L-NMMA had significant effect on the bacterial digestion by macrophages. 
The bacterial recovery from the control and LGG-CM treated macrophages at 280 minutes 
were 5.04 ± 0.09 and 4.44 ± 0.16 log10 CFU ml
-1. The bacterial recovery from L-NMMA 
treated macrophages was 5.5 ± 0.06 log10 CFU ml
-1. The bacterial recovery from LGG-CM 
treated macrophages in presence of L-NMMA was 5.21± 0.02 log10 CFU ml
-1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12: Role of NO in bacterial digestion in the presence of LGG-CM. The effect 
of iNOS inhibitors on bacterial digestion were investigated in the presence of LGG-CM. 
Macrophages was pretreated for an hour with 100 μM L-NMMA. Recovered bacteria at 280 
minutes were expressed as log10 CFU ml
-1. Experiments were performed in duplicate and repeated 
atleast three times. Error bars indicate ± standard error of the mean. Statistical analysis was carried 
out using Graph Pad Prism 3. The Dunnett’s multiple comparison post-hoc tests was performed 
after observing a significant difference from one-way ANOVA. An asterisk (*) indicates 
significant difference between the treatments and control. Significant difference in the bacterial 
recovery was also observed between LGG-CM treated cells and LGG-CM + L-NMMA is shown as 
$ as indicated by two-tailed unpaired t-test. 
 
 
Co
ntr
ol
Co
ntr
ol+
LN
MM
A
75
 %
 LG
G
75
 %
 LG
G 
+ L
NM
MA
4.0
4.5
5.0
5.5
6.0
*
**
$
R
ec
o
ve
re
d
 b
ac
te
ri
a 
at
 2
80
 m
in
lo
g
10
C
FU
 m
l-1
141 
 
5.3.4. Effect of nitric oxide inhibitor and NADPH oxidase inhibitor 
combination on bacterial digestion 
 
To investigate the effect of both apocynin and L-NMMA combination on bacterial 
digestion, the macrophages and bacteria were coincubated for a period of 60 minutes in 
presence of the control ± inhibitors and 75 % LGG-CM ± inhibitors. After killing the 
extracellular bacteria by gentamicin, the macrophages were further incubated for 280 
minutes. The recovered bacteria at 280 minutes represented any remaining undigested 
bacteria from the macrophages. Figure 5.13 shows that blocking the iNOS and NADPH 
oxidase activity of the macrophages using 100 μM L-NMMA and 100 μM apocynin 
combinations had a significant effect on bacterial killing from 75 % LGG-CM treated 
macrophages. From figure 5.13, the bacterial recovery from the control and LGG-CM 
treated macrophages at 280 minutes was 5.04 ± 0.09 and 4.44 ± 0.16 log10 CFU ml
-1. The 
LGG-CM treated macrophages at 280 minutes demonstrated significantly less bacteria at 
280 minutes from unpaired t-test. The bacterial recovery from L-NMMA + Apo treated 
macrophages was 5.63 ± 0.15. The bacterial recovery from LGG-CM treated macrophages 
in the presence of L-NMMA +Apo inhibitors was 5.19 ± 0.06 log10 CFU ml
-1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.13: Role of NO+ROS inhibitor combination in bacterial digestion in the 
presence of LGG-CM. The effect of iNOS + NADPH oxidase inhibitors on bacterial digestion 
were investigated in the presence of LGG-CM. Experiments were performed in duplicate and 
repeated three times. Error bars indicate ± standard error of the mean. Statistical analysis was 
carried out using Graph Pad Prism 3. The Dunnett’s multiple comparison post-hoc tests was 
performed after observing a significant difference from One way ANOVA. An asterisk (*) 
indicates significant difference between the treatments and control.   Significant difference in the 
bacterial recovery was also observed between LGG-CM treated cells and LGG-CM + (L-NMMA + 
apo) (P<0.05) shown as $ from a two-tailed unpaired t-test. 
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5.3.5. Effect of menadione on ROS production from macrophages 
 
Menadione was used as a positive control for monitoring ROS production by macrophages. 
The macrophages were either incubated for 60 minutes or 280 minutes with 0.5 mM 
menadione. Fluorescence readings were taken every 2 minutes and the rate of ROS 
generation from menadione was calculated as described in section 2.11.6. The rate of ROS 
production from menadione treated macrophages was 0.24 ± 0.05 min-1 (n=3 experiments) 
during the first 60 minutes (figure 5.14A). However, the rate of ROS production from 
menadione treated macrophages (3 experiments) was 0.5 ± 0.12 min-1 at 280 minutes 
incubation period (figure 5.14B). The rate of ROS production during 280 minute 
incubation almost doubled when compared to the rates during the first 60 minutes of 
incubation. However, it was not statistically different (p=0.1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.14: Effect of menadione on ROS production by macrophages. The effect of 
menadione on ROS production by macrophages was investigated by incubating the macrophages 
for 60 minutes and 280 minutes. Experiments were repeated at least three times (n=4). Error bars 
indicate ± standard error of the mean. Statistical analysis was carried out by two-tailed unpaired t-
test using Graph pad Prism 3. An asterisk indicates a significant difference to the control 
[(*p<0.05); (**p<0.01). 
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5.3.6. Effect of arginine on NO production from macrophages 
 
Arginine was used as a positive control for monitoring NO production by macrophages. 
Arginine is an essential substrate for iNOS enzyme. Macrophages were either incubated 
for 60 minutes or 280 minutes with 100 μM arginine and the fluorescence readings were 
taken every 2 minutes. The rate of NO generation from arginine was calculated as 
described in section 2.11.6. The average rate of NO production from macrophages treated 
with 100 µM arginine during the first 60 minutes of incubation was 0.23 ± 0.03 min-1 
(figure 5.15A). The average rate of NO production from macrophages incubated with 
arginine for 280 minutes was 0.17 ± 0.02 min-1 (Figure 5.15 B). The rate of NO production 
decreased slightly when compared to the ingestion period. However this decrease in NO 
production during the 280 minutes incubation period was statistically non-significant 
(P=0.06). This decrease in NO production might possibly be due to the reduced arginine 
substrate availability for iNOS over a period of time, as arginine is consumed for NO 
generation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.15: Effect of arginine on NO production by macrophages. The effect of 
arginine on NO production by macrophages was investigated by incubating the macrophages for 60 
minutes and 280 minutes. Experiments were repeated at least 3 times. Error bars indicate ± 
standard error of the mean. Statistical analysis was carried out by two-tailed unpaired t-test using 
Graph pad Prism 3. An asterisk indicate a significant difference to the control [(***p<0.001); 
(**p<0.01) 
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5.3.7. Analysing the effect of LGG-CM mediated ROS production by 
macrophages during the digestion period  
 
Macrophages exhibited an increased digestion rate in the presence of a high concentration 
of LGG-CM (see figure 4.4). Monitoring the bacterial recovery using ROS inhibitors and 
scavengers also demonstrated the importance of LGG-CM mediated ROS production in 
bacterial killing, as the inhibition of ROS production resulted in an increased number of 
bacterial recovery from the macrophages (see figure 5.10 and 5.11). To further validate the 
above findings, ROS production was monitored acutely and continuously in real time for a 
period of 280 minutes. Figure 5.16A in the panel represents an example of raw data of 
ROS production and figure B represents its corresponding CuSum lines.  
The variation of ROS generation in the raw data makes it very difficult to detect 
differences between the patterns of ROS production from the various treatments. Figure B 
shows the CuSum analysis of the same data from Figure A plotted as CuSum, using the 
overall average for the ROS production in the control wells as the target. These 
experiments were performed in quadruplicate and repeated at least 3 times. The CuSum 
values in figure B are based on 2 minute intervals, but only 10 minute points are plotted for 
clarity. The graph demonstrates the gradient, or slope, from 75 % or 100 % LGG-CM 
treated macrophages were higher when compared to the control or cells treated with only 
10 % LGG-CM.  
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Figure 5.16: Raw data and CuSum plots of ROS production from murine 
macrophages in the presence of LGG-CM. Figure A shows a representative example of raw 
data for ROS production recorded over 280 minutes for control cells and cells exposed to various 
concentrations of LGG-CM, 20 μg ml-1 LPS and LGG-CM + LPS combinations. Figure B 
represents the same data expressed as CuSum values.  
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5.3.8. CuSum gradient of ROS production from macrophages during the 
incubation of treatments for 280 minutes 
 
The ROS production from LGG-CM treated macrophages were measured every 2 minutes 
for up to 280 minutes using a fluorescence microplate reader.  From Figure 5.17, increased 
levels of intracellular ROS production were observed from macrophages coincubated with 
bacteria  in the presence of 75 % LGG-CM ± LPS and 100 % LGG-CM ± LPS. However, 
the rate of ROS production decreased at least by 2 times compared to the rate of ROS 
production during the first 60 minutes (Fig 5.4).   
The LPS on its own and 10 % LGG-CM ± LPS treatment for 280 minutes did not affect 
ROS production from the macrophages (Figure 5.17). The differential level of ROS 
production from a lower concentration of LGG-CM is suggestive of a potential anti-
inflammatory role of LGG-CM at low concentrations. The rate of ROS production from 
the control macrophages, LPS, 10 % LGG-CM and 10 % LGG-CM + LPS treated 
macrophages were almost zero. The slope or rate of ROS production from macrophages 
treated with, 75 % LGG-CM, 75 % LGG-CM + LPS, 100 % LGG-CM and 100 % LGG-
CM + LPS were 1.3 ± 0.3, 1.4 ± 0.4, 2.1 ±0.5, and 1.8 ± 0.5 fluorescence arbitrary units 
min-1. 
 
 
 
 
 
 
 
 
 
 
Figure 5.17: Fluorescence measurements of rate of ROS production during 
digestion period. Macrophages were labelled with H2DCFDA and fluorescence measurements 
were taken every 2 minutes for up to 280 minutes. Experiments were performed in the absence of 
bacteria. Experiments were repeated at least 5 times (n=4) and the rate of ROS production was 
calculated by the fluorescence values from 60 minutes to 280 minutes by CuSum analysis. Error 
bars indicate ± standard error of the mean. Statistical analysis was carried out by using One-way 
ANOVA followed by Dunnett’s multiple comparison tests. An asterisk (*) indicates a significant 
difference between the treatments and the control [(*) (P<0.05); (**) (P<0.01)]. 
co
ntr
ol
LP
S
10
%
LG
G
10
%
LG
G+
LP
S
75
%
LG
G
75
%
LG
G+
LP
S
10
0%
LG
G
10
0%
LG
G+
LP
S
-2
0
2
4
6
8
*    **   **
R
at
e 
of
 R
O
S
 p
ro
du
ct
io
n
du
ri
ng
 d
ig
es
ti
on
 p
er
io
d
(R
FU
)
147 
 
5.3.9. CuSum gradient of ROS production from macrophages in the presence 
of bacteria during the digestion period 
The ROS production from LGG-CM treated macrophages coincubated with viable E. coli 
HfrC were measured every 2 minutes for up to 280 minutes using a fluorescence 
microplate reader as described in Section 2.11.4. Figure 5.18 demonstrates the effect of 
LGG-CM on the extent of ROS production by macrophages during the bacterial digestion 
period. The rate of ROS production from the control macrophages incubated with E. coli 
and macrophages incubated with LPS and E. coli were 0.06 ± 0.09 and 0.19 ± 0.25 
respectively. The slope or rate of ROS production from 10 % LGG-CM and 10 % LGG-
CM + LPS were 0.34 ± 0.16 and 0.99 ± 0.47 fluorescence arbitrary units min-1. The slope 
or rate of ROS production from macrophages treated with the 75 % LGG-CM, 75 % LGG-
CM +LPS, 100 % LGG-CM and 100 % LGG-CM +LPS in presence of bacteria were 1.53 
± 0.34, 1.40  ± 0.35, 1.55 ± 0.49 and  1.73 ± 0.58 fluorescence arbitrary units min-1. 
However, the rate of ROS production decreased at least by 2 times compared to the rate of 
ROS production during the ingestion period (Fig 5.5).  There was no statistically 
significant difference in ROS production from any of the treatments on its own (Figure 
5.17) and in presence of bacteria (Figure 5.18). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.18: Fluorescence measurements of the rate of ROS production during the 
digestion period in presence of bacteria. Macrophages were labelled with H2DCFDA and 
fluorescence measurements were taken every 2 minutes for up to 280 minutes. Experiments were 
performed in the presence of bacteria. Experiments were repeated at least 5 times (n=4) and the rate 
of ROS production was calculated by the fluorescence values from 60 minutes to 280 minutes by 
CuSum analysis. Error bars indicate ± standard error of the mean. Statistical analysis was carried 
out by using ANOVA followed by Dunnett’s multiple comparison tests. An asterisk (*) indicates a 
significant difference between the treatments and the control [* (P<0.05)]. 
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5.3.10. CuSum gradient of NO production from macrophages during the 
incubation of treatments for 280 minutes  
 
The LGG-CM treated macrophages demonstrated only a basal effect on NO production at 
24 hours from Griess assay (Figure 3.7). To further investigate whether LGG-CM had any 
effect on NO production during 280 minutes of treatment incubation period, the 
macrophages were labelled with NO specific dye DAFFM-DA and the fluorescence 
measurements were performed using a fluorescence microplate reader. Figure 5.19 
demonstrates the effect of LGG-CM on the rate of NO production by macrophages during 
280 minutes of treatment incubation period. The slope of the control and 10 % LGG + LPS 
was zero. The rate of NO production from LPS and 10 % LGG were 0.02 ±0.05 and -0.01 
±0.03 respectively. The rate of NO reduction from 75 % LGG, 75 % LGG+LPS, 100 % 
LGG and 100 % LGG-CM + LPS were -0.25 ± 0.08, -0.25 ± 0.07, -0.29 ± 0.07 and -0.33 ± 
0.08 fluorescence arbitrary units min-1. The rate of NO production from 100 μM arginine 
was 0.14±0.02 fluorescence arbitrary unit min-1. 
  
 
 
 
 
 
 
 
 
 
 
Figure 5.19: Fluorescence measurements of rate of NO production during the 
digestion period. Macrophages were labelled with DAFFM-DA and fluorescence measurements 
were taken every 2 minutes for up to 280 minutes. Experiments were repeated at least 3 times (n=4) 
and the rate of NO production was calculated by the fluorescence values from 60 minutes to 280 
minutes by CuSum analysis. Error bars indicate ± standard error of the mean. Statistical analysis 
was carried out by using One way ANOVA followed by Dunnett’s multiple comparison tests. 
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5.3.11. CuSum gradient of NO production from macrophages in presence of 
bacteria during the digestion period 
 
The NO production from LGG-CM treated macrophages coincubated with viable E. coli 
was measured every 2 minutes for up to 280 minutes. From Figure 5.20, there was no 
difference in NO production from macrophages coincubated with E. coli in the presence of 
LPS or 10 % LGG-CM. Both LPS and LGG-CM ± LPS produced NO to a similar extent as 
those from untreated macrophages. The gradient of NO production from untreated 
macrophages, LPS treated macrophages, 10 % LGG and 10 % LGG-CM +LPS treated 
macrophages in the presence of E. coli were 0.06 ±0.08, 0.11 ± 0.02, 0.09 ± 0.04 and 0.11± 
0.04 fluorescence arbitrary units min-1. However, we observed a negative slope in NO 
production from a higher concentration of LGG-CM treated macrophages in the presence 
of bacteria indicating a reduction in NO when compared to the control cells. The rate of 
reduction of NO production from macrophages treated with 75 % LGG-CM, 75 % LGG-
CM +LPS, 100 % LGG-CM and 100 % LGG-CM +LPS in presence of bacteria were -0.24  
± 0.04, -0.20 ± 0.07, -0.29 ± 0.05 and -0.35 ± 0.09 fluorescence arbitrary units min-1 
respectively. The LPS did not potentiate the NO production in LGG-CM treated 
macrophages. There was no statistically significant difference in NO production from any 
of the treatments on its own (Figure 5.19) and in presence of bacteria (Figure 5.20). 
 
 
 
 
 
 
 
 
  
Figure 5.20: Fluorescence measurements of the rate of NO production during the 
bacterial digestion period. Macrophages were labelled with DAFFM-DA and fluorescence 
measurements were taken every 2 minutes for up to 280 minutes. Experiments were performed in 
presence of bacteria. Experiments were repeated at least 3 times (n=4) and the extent of NO 
production was calculated by the fluorescence values from 60 minutes to 280 minutes by CuSum 
analysis. Error bars indicate ± standard error of the mean. Statistical analysis was carried out by 
using One-way ANOVA followed by Dunnett’s multiple comparison tests.  
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5.4. NADPH Oxidase expression to LGG-CM 
 
Experiments were performed to investigate the effect of LGG-CM on NADPH oxidase 
expression. Two subunits of NADPH oxidase p47 phox and gp91 phox were investigated 
in the presence of LPS and various dilutions of LGG-CM at 2 hours, 6 hours and 24 hours. 
 
5.4.1. Effect of LGG-CM on the expression of p47 phox at 2 hours. 
 
Figure 5.21A shows the percent change in expression of p47 phox from untreated 
macrophages, LPS and various dilutions of LGG-CM ± LPS with respect to the control at 2 
hours incubation period. The figure 5.21B shows the p47 phox protein bands from various 
treatments. The sequence in the bands (left to right) is the same as in figure 5.21A. The 
protein β-actin was used as a loading control to ensure that treatments were loaded equally 
across the wells and were used as a guide for effective protein transfer (Fig 5.21C). 
 
The expression of p47 phox in J774 macrophages was very low at 2 hours. The figure 5.21 
shown is from one successive experiment. We also could not detect the expression of p47 
phox at 24 hours from macrophages. However, at 6 hours of incubation period we were 
successful in detecting the expression of p47phox as the protein expression was high 
compared to the 2 hours of incubation period (Fig 5.22). 
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Figure 5.21: Effect of LGG-CM on the expression of p47 phox at 2 hours incubation. 
A confluent monolayer of macrophages was treated with various concentrations of LGG-CM and 
LGG-CM + 20 μg ml-1 LPS combination. The result represents one experiment’s data demonstrated 
as the percent change in percent area with respect to the control (A). Image J was used to analyse 
the bands of p47 protein expression (B). The β-actin expression was used as a control to indicate 
the sample loading efficiency(C). The western blot bands shown in figure B for p47phox represents 
the protein expression as a response to various treatments which are in the same series as in the 
graph A. 
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5.4.2. Effect of LGG-CM on the expression of p47phox at 6 hours 
 
It was challenging to detect the p47 expression at the initial 2 hours of incubation with 
LGG-CM (see figure 5.21). The next attempt was to investigate the effect of LGG-CM on 
the p47phox expression (cytosolic subunit of NADPH oxidase) at 6 hours of incubation.  
 
A confluent monolayer of macrophages was treated with various concentrations of LGG-
CM, LPS (20 μg ml-1) and LGG-CM+LPS combination for 6 hours. Figure 5.22A shows 
the percent change in the expression of p47 phox from untreated macrophages, LPS and 
various dilutions of LGG-CM ± LPS with respect to the control at 6 hours. The figure 
5.22B shows the p47 phox protein bands from various treatments. The sequence in the 
bands (left to right) is the same as in figure 5.22A. The figure 5.22C represents the 
expression of β-actin protein from the macrophages incubated with the respective 
treatments and was used to indicate protein loading efficiency. 
 
We observed a significant increase in the expression of p47 phox from macrophages 
treated with 75 % LGG-CM ± LPS when compared to untreated macrophages. A low 
concentration of LGG-CM ± LPS and LPS expressed p47phox to same extent as untreated 
macrophages. 100 % LGG-CM ± LPS treated macrophages demonstrated an enhanced 
expression of p47 phox but was not statistically different from the control at 6 hours. 
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Figure 5.22: Effect of LGG-CM on the expression of p47 phox at 6 hours incubation 
in macrophages.  The result represents the percent change in percent area with respect to the 
control (A). Image J was used to analyse the bands of p47 protein expression (B). The β-actin 
expression was used as a control to indicate the sample loading efficiency (C). The graph 
represents the mean of 3 independent experiments.  Error bars indicate ± standard error of the 
mean. Statistical analysis was performed using One-way ANOVA followed by Dunnett’s multiple 
comparison post-hoc tests.  An asterisk  (*) indicates a significant difference to control 
(**p<0.01).The western blot bands shown in figure B for p47phox represents the protein 
expression as a response to various treatments which are in the same series as in the graph A. 
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5.4.3. Effect of LGG-CM on the expression of gp91phox at 2 hours 
  
These experiments were performed to investigate time dependent changes in the NADPH 
oxidase subunits expression in the presence of LGG-CM. We observed the expression of 
protein subunits gp91 phox (Figure 5.23) after a 2 hour incubation period of the 
macrophages with LPS and various dilutions of LGG-CM ± LPS. 
 
Figure 5.23A shows the percent change in the expression of gp91 phox from untreated 
macrophages, LPS and various dilutions of LGG-CM ± LPS with respect to the control at 2 
hours. The figure 5.23B shows the gp91 phox protein bands from various treatments. The 
sequence in the bands (left to right) is the same as in figure 5.23A. The figure 5.23C 
represents the expression of β-actin protein from macrophages incubated with the 
respective treatments.  
 
The LPS and various dilutions of LGG ± LPS treated macrophages expressed gp91 phox 
protein to a similar extent. There was no significant change in expression of gp91 phox 
from macrophages treated with any of the treatments with the control at 2 hours of 
incubation.  
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Figure 5.23: Effect of LGG-CM on the expression of gp91 phox at 2 hours 
incubation.  The macrophages were treated with various concentrations of LGG-CM and LGG-
CM + LPS (20 µg ml-1) combination for 2 hours. The result represents the percent change in 
percent area with respect to control (A). Image J was used to analyse the bands of protein 
expression (B). The β-actin expression was used as a control to indicate the sample loading 
uniformity. The graph represents the mean of 3 independent experiments.  The western blot bands 
shown in figure B for gp91phox represents the protein expression as a response to various 
treatments which are in the same series as in the graph A. Error bars indicate ± standard error of the 
mean. Statistical analysis was performed using one -way ANOVA. There was no significant 
difference between the treatments.  
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5.4.4. Effect of LGG-CM on the expression of gp91 phox at 6 hours 
  
We had previously observed a non-significant difference in gp91phox NADPH oxidase 
subunit expression at 2 hours incubation in the presence of various dilutions of LGG-CM 
(Figure 5.23). A confluent monolayer of macrophages was treated with various 
concentrations of LGG-CM, LPS (20 μg ml-1) and LGG-CM+LPS combination for 6 
hours. Following 6 hours incubation, cells were lysed and the protein concentration of cell 
lysate was determined by BCA assay. After separating the protein on 8 % gel, the proteins 
were transferred to a PVDF membrane and incubated with a gp91 specific primary 
antibody followed by incubation with a goat-antimouse secondary antibody.    
 
Figure 5.24A shows the percent change in the expression of gp91 phox from untreated 
macrophages, LPS and various dilutions of LGG-CM ± LPS with respect to the control at 6 
hours. The figure 5.24 B shows the gp91 phox protein bands from various treatments. The 
sequence in the bands (left to right) is the same as in figure 5.24A. The figure 5.24C 
represents the expression of β-actin protein from the macrophages incubated with 
respective treatments and was used to indicate protein loading efficiency. 
 
From figure 5.24, there was a significant increase in the expression of gp91 phox from the 
macrophages treated with 75 % LGG-CM ± LPS and 100 % LGG-CM ± LPS when 
compared to control macrophages. A low concentration of LGG-CM ± LPS and LPS 
expressed gp91phox to the same extent as control macrophages.  
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Figure 5.24: Effect of LGG-CM on the expression of gp91 phox at 6 hours 
incubation in macrophages. The result represents the percent change in percent area with 
respect to the control (A). Image J was used to analyse the bands of gp91phox protein expression 
(B). The β-actin expression was used as a control to indicate the sample loading consistency (C). 
The graph A represents the mean of 3 independent experiments.  The western blot bands shown in 
figure B for gp91phox represents the protein expression as a response to various treatments which 
are in the same series as in the graph A. Error bars indicate ± standard error of the mean. Statistical 
analysis was performed using One-way ANOVA followed by Dunnett’s multiple comparison post-
hoc tests.  An asterisk (**) indicates a significant difference to the control (p<0.01). 
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5.4.5. Effect of LGG-CM on the expression of gp91 phox at 24 hours 
 
A significantly increased expression of gp91 phox and p47 phox subunits of NADPH 
oxidase was observed when the macrophages were incubated with LGG-CM for 6 hours 
(see Figure 5.22 and 5.24). These results are supportive with the observations made with 
respect to an increased bacterial digestion rate from macrophages (Figure 4.4) and 
increased rate of ROS production in the presence of a high concentration of LGG-CM from 
macrophages (Figure 5.18).  
 
To further monitor the changes in the NADPH oxidase activity at 24 hours, a confluent 
monolayer of macrophages were treated with various concentrations of LGG-CM, LPS (20 
μg ml-1) and LGG-CM+LPS combination. Following 24 hours incubation, cells were lysed 
and the protein concentration of cell lysate was determined by BCA assay. After separating 
the protein on 8 % gel, the proteins were transferred to a PVDF membrane and incubated 
with a gp91phox specific primary antibody followed by incubation with a goat-antimouse 
secondary antibody (see Section 2.12 for methods).  
 
From Figure 5.25, we found that at 24 hours there was no difference in the gp91phox 
expression between control, and LPS and LGG-CM ± LPS, treated macrophages. 
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Figure 5.25: Effect of LGG-CM on the expression of gp91phox at 24 hours 
incubation in macrophages. The result represents the percent change in percent area with 
respect to the control (A). Image J was used to analyse the bands of gp91phox protein expression 
(B). The β-actin expression was used as a control to indicate the sample loading efficiency (C). The 
graph represents the mean of 3 independent experiments. The western blot bands shown in figure B 
for gp91phox represents the protein expression as a response to various treatments which are in the 
same series as in the graph A.  Error bars indicate ± standard error of the mean. Statistical analysis 
was performed using One-way ANOVA and there was no significant difference between the 
treatments. 
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 5.3. Discussion 
 
In chapter 4, the LGG-CM has been shown to have increased the rate of E.coli digestion. 
Both NO and ROS are known to be involved in macrophage digestion.  In this chapter role 
of NO and ROS to LGG-CM induced increased digestion by macrophages was further 
investigated by using various ROS scavengers and inhibitors for ROS and NO production. 
The ROS and NO productions from macrophages were also monitored using fluorescence 
microplate reader. The results indicated that ROS is involved in the process of increased 
bacterial digestion rate and is produced by NADPH oxidase. To further support these 
findings western blotting was performed to investigate the expression of NADPH oxidase 
subunits. 
We observed that the treatment of macrophages with higher concentrations of LGG-CM 
significantly increased the rate of ROS production both in the presence and absence of E. 
coli.  Higher concentrations of LGG-CM significantly reduced the rate of NO production 
both in the presence and absence of E. coli. Expressions of NADPH oxidase protein 
subunits gp91 and p47 phox were found to be enhanced significantly to higher 
concentration of LGG-CM treatments at 6 hours.  
Macrophages phagocytosis has been shown to be associated with the activation of 
phagocyte NADPH oxidase and iNOS. The NADPH oxidase is a membrane associated 
enzyme that catalyses the production of superoxide (O2
.-) which can be metabolised into a 
variety of other ROS. The steady state concentration of O2
.- and H2O2 in phagosome was 
found to be 25 μM and 2 μM respectively (Winterbourn et al., 2006). Studies have shown 
that phagocytes produce approximately around 2 μM O2
.- even at pH 4.5. The E.coli 
membrane damage is normally observed at approximately 0.5 μM O2
.- concentration 
(Imlay., 2009). The E. coli DNA and other intracellular protein damage were observed at 
approximately 0.5 μM H2O2 (Slauch, 2011). Thus, ROS produced from activated 
macrophages acts as a potential antibacterial agent. 
The iNOS activates the production of NO from arginine. Unlike superoxide, NO is 
synthesized on the cytoplasmic side of phagosomes, but it has the ability to diffuse across 
membranes to reach intraphagosomal targets (Denicola et al., 1996) where it encounters 
ROS. In the intraphagosomal environment, ROS and NO can undergo either spontaneous 
or catalytic conversion to a range of intermediate compounds such as nitrite (NO2
-), nitrate 
(NO3
-), dinitrogentrioxide (N2O3) and dinitrogen tetroxide (N2O4) (Darrah et al., 2000; 
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Aktan 2004). The combination of NO and O2
.- to form peroxynitrite (ONOO-) from murine 
macrophages has previously been shown as potently bactericidal to Rhodococcus equi 
(Darrah et al., 2000). 
In this study, the NADPH oxidase inhibitor apocynin (apo) and xanthine oxidase inhibitor 
allopurinol (allo) were used to investigate the role of free radicals on E.coli ingestion by 
macrophages to LGG-CM treatment. There was no significant difference in bacterial 
recovery at 60 minutes between LGG-CM treated macrophages and macrophages treated 
with LGG-CM in the presence of apocynin, allopurinol and apo+allo combination (Figure 
5.1). These results support the work by Takao et al. (1996) where murine peritoneal 
macrophages had no effect on Candida parapsilosis ingestion when treated with 
allopurinol (xanthine oxidase inhibitor) and Diphenyleneiodonium (DPI) (NADPH oxidase 
inhibitor).  
 
In our study cell permeable free radical scavengers such as polyethylene glycol (PEG) 
conjugated SOD, PEG-conjugated catalase and PEG-conjugated SOD + catalase 
combination were used to investigate the effect of free radicals produced by LGG-CM on 
bacterial ingestion by macrophages. These experiments demonstrated a significant 
reduction in bacterial ingestion between 75 % LGG-CM and 75 % LGG-CM and 
scavenger combinations, indicating the role of free radicals in bacterial ingestion (Figure 
5.2). However, Takao et al., (1996) found that phagocytosis of Candida parapsilosis by 
murine peritoneal macrophages was unaffected by the antioxidant activity of SOD and/or 
catalase. The difference in the macrophage response observed in our study compared to 
Takao et al., may be mainly due to the use of PEG conjugated SOD and catalase.  The 
PEG-Catalase and PEG-SOD binds to the cell membrane and rapidly penetrates into the 
cell, whereas, unconjugated SOD and catalase has limited cellular penetration (Beckman et 
al., 1998). Thus, the PEG conjugated SOD and catalase scavengers can even neutralise the 
intracellular ROS as they can easily penetrate the macrophage. In our study, macrophages 
in the presence of scavengers demonstrated a significant reduction in the bacterial 
ingestion compared to either the control or the LGG-CM treated cells.  
 
The further reduction in the bacterial recovery in the presence of ROS scavengers from 
control macrophages indicates its involvement in the normal phagocytic process. The ROS 
are known to play a key role in phagocyte chemotaxis. During chemotaxis, actin 
polymerisation occurs within the leading edge of the cell membrane driving up-gradient 
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protrusion, whereas myosin activity in the uropod detaches the rear of the cell. These 
include a localised polymerisation of F-actin at the site of the cell cortex closest to the 
chemoattractant source, a morphological change characterised by cell elongation, and the 
formation of pseudopodia. The ROS has been shown to be involved in the coordination of 
these polarised events for the directional migration of macrophages and neutrophils 
(Gresham et al., 1988; Fialkow et al., 2003, Kuiper et al., 2011; Sakai et al., 2012). 
 
In this study, bacterial digestion was found to be unaffected by SOD only treatments both 
in the control or the LGG-CM treated macrophages at 280 minutes.  The catalase on its 
own and in combination with SOD significantly inhibited LGG-CM induced bacterial 
digestion. However, we did not observe an additional effect on bacterial digestion from 
LGG-CM treated macrophages coincubated with the catalase and SOD combination 
(Figure 5.11). Brummer & Stevens, (1989) found that SOD inhibited the killing of C. 
parapsilosis but the catalase did not. They found that C. parapsilosis was resistant to 
killing at physiological concentrations of H2O2 and the killing mechanism did not appear to 
involve hydroxyl radicals. However, the main drawback of their study was that they did 
not study the bacterial killing in the presence of SOD + catalase combination.  Studies by 
Takao et al. (1996) found that the killing of C. parapsilosis by murine peritoneal 
macrophages IC-21 was inhibited by pretreatment with SOD. Catalase did not affect the 
bacterial killing in their studies. However, they found that the SOD+catalase combination 
potentiated the inhibitory effect of SOD.  
 
We have found that the higher concentration of LGG-CM significantly increased the rate 
of ROS production in the macrophages during both the bacterial ingestion and digestion 
period. This finding is similar to a number of previous studies which have also shown an 
increased ROS production in macrophages and also in epithelial cells to live probiotic 
treatments (Farnell et al., 2006; Kumar et al., 2007). Farnell et al. (2006) demonstrated a 
significant increase in the oxidative burst from chicken heterophils treated with Bacillus 
subtilis, Lactococcus lactis and Lactobacillus acidophilus bacteria. Donnet –Hughes et al. 
(1999) also observed an enhanced respiratory burst and phagocytic activity from peripheral 
blood leukocytes in the presence of 107 CFU ml-1 live L. johnsonii. 
 
During the first 60 minutes of incubation, both 75 % LGG-CM and 100 % LGG-CM 
treated macrophages (both in the presence and absence of E.coli and/or LPS) produced a 
massive amount of ROS. However, macrophages treated with LPS, live E. coli and a low 
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concentration of LGG (10 % LGG) had no effect on ROS production from the 
macrophages (see Figure 5.4 and 5.5). The ROS measurements from the macrophages 
during the digestion period from the same treatments showed a diminished rate, but still 
significantly higher than the rate of ROS production from the control macrophages. The 
rate of ROS produced from the macrophages were approximately 2 times less during the 
digestion period when compared to ROS produced during the bacterial ingestion period 
(see Figure 5.17 and 5.18). This increase in ROS production from macrophages was found 
to be due to enhanced expression of NADPH oxidase subunits as a response to higher 
concentration of LGG-CM treatment. 
We observed that the macrophages treated with L-NMMA demonstrated a significant 
reduction in their ability to kill bacteria (Figure 5.12). This result indicates that even the 
basal level of NO plays a vital role in bacterial killing by both LGG-CM treated and the 
control macrophages. This effect might be partly due to the synergistic effect of ROS and 
NO due to formation of their combination product, namely, peroxynitrite. Complete 
inhibition of NO production from L-NMMA might block the production of peroxynitrite 
and thereby partly, weaken the ability of macrophages to kill bacteria. There is evidence 
that both reactive oxygen and nitrogen intermediates are involved in bacterial killing, 
which is mediated by peroxynitrite (Darrah et al., 2000; Brennan et al., 2004).  
We were not successful in measuring any nitrite by Griess assay within 4 hours of 
treatments due to it’s sensitivity limit in the culture media is in micromolar range (Sun et 
al., 2003).  This issue was resolved by using a fluorophore DAFFM-DA to measure NO.  It 
was found that the limit of detection of NO by DAF-FM DA in vitro was approximately 3 
nM (Kojima et al., 1998).  In order to study the effect of LGG-CM on NO production, the 
macrophages were incubated with LPS, various dilutions of LGG-CM and combination of 
LGG-CM and LPS, both in the presence and absence of E. coli for 60 minutes. A 
significant reduction in the rate of NO level was observed from the macrophages treated 
with a higher concentration of LGG-CM relative to the control macrophages. The LPS and 
10 % LGG-CM alone or in combination, did not have any effect on the NO production by 
macrophages. This finding remained unchanged by the addition of E. coli in the treatments. 
However, we observed a significant increase in NO production from macrophages treated 
with 100 μM arginine compared to the control macrophages (see Figure 5.15).  
The rate of NO production was further investigated until 280 minutes in the presence of 
above treatments. It was also observed that the higher concentration of LGG-CM brought 
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about a significant reduction in the rate of NO production (see Figure 5.19 and 5.20) from 
the macrophages during the further 280 minutes of incubation time.  
There is evidence that NO possibly is not an essential contributor in the control of the acute 
phase of Acinetobacter Baumannii infections in mice (Qiu et al., 2009). Weinberg et al. 
(1995) demonstrated negligible expression of iNOS mRNA in the first few hours from 
human blood monocytes and peritoneal macrophages to LPS treatments. Study by Hattori 
et al. (1996), observed that iNOS mRNA, was barely detectable in unstimulated J774 
macrophages.  However, it became detectable after 4 hours, when stimulated with 1 μg ml-
1 LPS. Similar conclusion was also drawn by Stuehr & Marletta (1985) who showed that 
maximum NO production was achieved in murine macrophages approximately after 10 
hours of incubation with the LPS. They observed that within 10 to 12 hours of the 
macrophage incubation with LPS, the nitrite production increased by 5 to 6 times 
compared to the control macrophages.  
The kinetics of ROS production in our study is quite similar to the findings of Pearson et 
al. (1982). They have shown that an increased respiratory burst occurs within 1 hour of 
initial phagocytosis of serum-opsonized Leishmania donovani promastigotes by the human 
monocyte derived macrophages. Vanderven et al. (2009) also demonstrated a similar 
kinetics of ROS production in macrophages.  In their study ROS production rate was 
peaked between 20 to 30 minutes after ingestion of oxidation sensitive fluorochrome 
coated microbeads by macrophages.  
 
Thus, from our findings and existing literature, we can conclude that the J774 macrophages 
treated with a higher concentration of LGG-CM modulate bacterial phagocytosis by 
modulating free radicals production. We observed an enhanced NADPH oxidase activity at 
6 hours (which is essential for bacterial killing in the acute phase), which is consistent with 
increased rate of ROS production from higher concentration of LGG-CM (75 % and 100 % 
LGG-CM). In this study, we did not observe a significant difference in NADPH oxidase 
expression at 2 hours to LGG-CM treatments (see Figure 5.23). Although we observed an 
enhanced rate of acute ROS production from the macrophages in response to higher 
concentration of LGG-CM treatments, this could be due to phosphorylation of the enzyme 
subunits (Li & Shah., 2004; Ray & Shah., 2005). Thus we have not have seen any 
increased expression of gp91phox within 2 hours. The antibody used in our study to detect 
gp91phox was not able to differentiate the phosphorylated and non-phosphorylated state of 
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enzyme subunits and could be therefore used only for overall relative quantitative 
expression of these proteins.  
 
Due to the nature of experimental protocols, monitoring ROS production by macrophages 
using a microplate reader could not be performed for up to 24 hours. In our study 24 hours 
treatment of macrophage by LGG-CM have failed to produce any increase in expression of 
NADPH enzyme.  This could be due to activation of a protective antioxidant mechanism 
activated by LGG-CM to reduce the host tissue damage.  The excessive ROS production 
acutely from macrophages might be beneficial for bacterial killing by macrophages but can 
potentially damage the host if it continues for longer duration.  
5.4 Chapter Summary 
 
Free radical production during phagocytosis has significant implications for immune 
functions. In light of the established role for ROS as a physiological signalling molecule 
and the emerging role of LGG-CM induced ROS production in macrophage phagocytic 
activity, this study has investigated the potential regulatory role of LGG-CM in 
physiological interactions between the host macrophage and the bacteria. Higher 
concentration of LGG-CM treated macrophages demonstrated a decreased rate of NO 
production during the bacterial ingestion and digestion period of macrophage 
phagocytosis. However, macrophages treated with a high concentration of LGG-CM 
demonstrated a significantly increased rate of ROS production both during the bacterial 
ingestion and digestion periods. The rate at which ROS was produced due to LGG-CM 
treatment during the initial 60 minutes treatment is significantly higher than the rate of 
ROS production after 60 minutes to 280 minutes of incubation. The increased ROS 
production was found to be due to increased expression of NADPH oxidase components to 
LGG-CM treatments. Thus, we conclude that the effect of LGG-CM observed is more 
acute and is elegantly balanced, during the first few hours of bacterial contact with the 
macrophages. This physiological modulation of free radicals production and enhanced 
bacterial digestion by LGG-CM by modulating the NADPH oxidase activity is an added 
advantage to the host during innate immune responses.  
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6.0. CHAPTER 6 General Discussion 
 
There is an increasing interest in the field of probiotics to understand the mechanism of 
probiotic action. This section will address the analysis of the experimental techniques 
employed in this research and explore the scope, novelty and limitations of the research 
findings and further understand the mechanism of LGG mediated immunomodulation. 
The J774 murine macrophage cell line is an immortalised cell line established from female 
BALB/c mice. The cell-line has been widely used in studies of macrophage bacterial 
interactions for a variety of microorganisms including Brucella abortus (Ko and Splitter, 
2003), Mycobacterium tuberculosis (Zhang et al., 2005), Cryptococcus neoformans 
(Mukherjee et al., 1995) and E. coli (Vincenti, 2010) and also responds to probiotic 
bacteria from human origin (Morita et al., 2002). This cell line is also known to respond to 
LPS treatment and produce NO (Hattori et al., 1996; Korhonen et al., 2002). 
 
6.1. Experimental methodology: advantages and limitations 
6.1.1. Gentamicin protection assay  
Gentamicin protection assay, or gentamicin survival assay, is usually used for the 
measurement of bacterial ingestion by eukaryotic cells (Srivastava & Isberg, 2002; 
Edwards & Massey, 2011). The method is generally used to study bacterial macrophage 
interactions because of its simplicity and sensitivity relative to techniques such as Giemsa 
staining or direct microscopic observation. The principle of the assay is based on the 
concept that gentamicin cannot penetrate eukaryotic cells. Once the bacteria have been 
ingested by the macrophage; the intracellular phagosomal bacteria are protected from the 
antibacterial effect of extracellular gentamicin.  Non-internalised but adhered or 
extracellular bacteria will be exposed to gentamicin and killed. After removal of 
gentamicin, the eukaryotic cells are lysed to release intracellular bacteria which are then 
enumerated by colony counting technique (Elsinghorst, 1994; Mandell, 1973; Srivastava & 
Isberg, 2002; Edwards & Massey, 2011). 
Based on the current understanding of the bacterial macrophage interactions, in this thesis 
it is considered appropriate to use the term ‘ingestion’ to specify bacterial entry into the 
macrophages. Several studies have used the term ‘invasion’ to indicate bacterial uptake. 
However, it seems inappropriate in this study as the bacterial target E.coli HfrC is a non 
pathogenic laboratory strain. In the present study gentamicin protection assay was adopted 
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with some modifications.  In the experimental setup the macrophage phagocytosis of E. 
coli was divided into two different stages-  
1. Ingestion of bacteria and  
2. Digestion of bacteria 
 
 
Gentamicin protection assay is highly sensitive and a small fluctuation of experimental 
conditions can interrupt with bacterial phagocytosis. Various factors need to be monitored 
and maintained in optimum conditions during the gentamicin protection assay. These 
factors include pH, temperature, CO2 level, macrophage-bacterial co-incubation time, 
multiplicity of infection (MOI) and antibiotic concentration.  
In our experiments the ingestion studies were performed at two time points. The bacterial 
ingestion was studied at 30 minutes and 60 minutes.  Similar to Vincenti’s report (2010) 
we also observed that macrophages needed at least 30 minutes co-incubation with E. coli 
to recover any countable number of ingested bacteria. Studies by De Koning-Ward et al. 
(1998) have found that 30 to 60 minutes was sufficient for bacteria to be ingested by 
macrophages without a significant number being digested. Our results are in agreement 
with this finding that there is no significant difference of E. coli recovery between 30 
minutes and 60 minutes of incubation. The bacterial killing by macrophages is a 
culmination of the bacterial ability to bind to the surface of macrophages and the 
macrophage ability to ingest and finally kill the bacteria within the phagosome. These 
ingestion and digestion steps can occur as independent steps in sequence and therefore can 
be easily distinguished by careful experimental procedures.  
The J774 macrophages were maintained at a temperature of approximately 370C. It was 
really important to maintain the media in the 24 well plates at approximately 370C as 
changes in temperature would significantly affect the process of phagocytosis (Li et al., 
2002). A study by Peterson et al., (1976) demonstrated a significant reduction of 
Staphylococcus aureus and S. epidermidis ingestion by human leukocytes when the 
incubation temperature was raised from 370C to 410C.  Similarly, Li et al., (2002) showed 
that phagocytosis of M. tuberculosis by human macrophages was significantly decreased 
when the incubation temperature was reduced to 230C and 300C. 
Generally, gentamicin protection assay uses a MOI of about 10 bacteria per eukaryotic cell 
(see Table 4.1).  In the present study the MOI was optimised by using a number of MOI to 
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suit the J774 cell line (Elsinghorst, 1994). Several pilot experiments were performed at a 
higher MOI (100:1) which yielded inconsistent bacterial recovery in our study. This was 
assumed to be due to the increased susceptibility of macrophages to bacteria at higher 
bacterial inoculums which in turn lead macrophages rendering to detach easily during the 
washing steps. At this MOI, we also observed an increase in the background levels of 
bacteria. This was possibly due to release of E. coli from the dead macrophages. 
Therefore, modification to the gentamicin protection assay was essential in order to 
retrieve the actual bacterial count. Following this, experiments were performed at a lower 
MOI of 10:1. However, at this MOI, the macrophages treated with LGG-CM yielded a 
very low bacterial count. The next attempt was to use a MOI of 50:1 as mentioned in Gille 
et al. (2009). This MOI was found to be a balanced standard bacterium to macrophage 
ratio without affecting macrophage viability at least during the time course of the 
experiment. The background bacterial recovery observed from plating the extracellular 
medium was negligible. This could be due to the effect of lower concentration of 
gentamicin (20 µg ml-1) in the media which had killed any accidental release of bacteria 
from any morbid cells. Lower concentration of gentamicin would also ensure no further 
bacterial replication in the media.  
The gentamicin is a broad-spectrum antibiotic that exerts its bactericidal activity by 
selectively binding to the bacterial ribosome and interfering with protein synthesis (Magnet 
and Blanchard, 2005). The minimum inhibitor concentration (MIC) for E. coli ATCC 
25922 and E. coli LU2 from literature was found to be 0.5 mg L-1 (Isaksson et al., 1988). 
The gentamicin concentration used in this study was found to be an important factor for the 
reproducibility of the data.  A higher concentration (200 µg ml-1) of gentamicin was 
initially used for approximately 10 minutes to kill most of the extracellular bacteria as in 
Gille et al. 2009. Following this initial killing, 20 µg ml-1 gentamicin was constantly 
maintained in the medium until the macrophages were lysed. This lower concentration of 
gentamicin was found to be essential to maintain macrophage health and its attachment 
capability during the time-course of the experiment.  This was also found to be necessary 
to recover live E. coli reproducibly from the lysate. The killing of extracellular bacteria in 
our experiments was confirmed by direct microscopic observation and also by the 
inoculation of an extracellular medium on to nutrient agar plates. 
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Observations of the inability of the gentamicin and other antibiotics to kill the intracellular 
bacteria were used in early studies investigating the invasion of host cells by bacteria 
(Vaudaux & Waldvogel, 1979; De Melo & Pechere, 1988; Hardt et al., 1998). However, 
there are reports suggesting that gentamicin added to the extracellular media can actually 
cross the cell membrane and kill the internal bacteria (Ohya et al., 1998; Eze et al., 2000; 
Tsang et al., 2000).  Gentamicin is thought to enter eukaryotic cells through pinocytosis. It 
is shown to accumulate within the pinocytotic endosomes, reaching the phagosomes by 
fusion of the endosomes with the pathogen-containing phagosomes (Drevets et al., 1994). 
However, studies by Menashe et al. (2008) demonstrated that gentamicin at a 
concentration of between 15 and 150 μg ml−1 did not kill intracellular Salmonella.  After 
infecting the macrophages with Salmonella, the cells were treated with gentamicin for one 
hour. When 50 μg ml−1 or a lower concentration of gentamicin was used, the intracellular 
viable bacterial counts did not change significantly. Higher antibiotic concentrations (up to 
150 μg ml−1) resulted in a log reduction in the viable counts (P < 0.01) at 60 minutes. Their 
study did not increase the antibiotic concentration beyond 150 μg ml−1, as gentamicin at 
higher concentrations and a longer incubation period changed the morphology of the host 
cells (Menashe et al., 2008).  
Studies have demonstrated that the antimicrobial activity of aminoglycosides is pH 
dependent and is strongly inhibited at a low pH (Menashe et al, 2008). Low pH changes 
the electrostatic potential across the bacterial cytoplasmic membrane, and this electrostatic 
potential is crucial for the uptake of aminoglycosides into the bacterial cell (Eisenberg et 
al, 1984; Xiong et al., 1996; Taber et al, 1987).  It has been observed that the bacteria-
containing phagosomes acidify within less than 60 minutes after their formation (Rathman 
et al., 1996). Thus, the low pH in phagosomes could affect both the uptake of 
aminoglycosides into the bacterial cell and their antibacterial activity. Indeed, a previous 
observation indicated that a direct increase in the pH of the phagosomes was sufficient to 
significantly increase the intracellular killing effect of Staphylococcus aureus by the 
aminoglycoside amikacin (Maurin and Raoult, 1994).  
Studies by Kim et al., (2006b) estimated the number of internalised Salmonella enterica 
serovar typhimurium by employing bacteriophage SP6, a Salmonella specific lytic 
bacteriophage, by immunostaining and fluorescence microscopy. They demonstrated that 
gentamicin at a concentration of more than 20 µg ml-1 can accumulate inside the 
macrophage influencing the bacterial number. However, they concluded that gentamicin 
might still be useful at concentrations upto 20 µg ml-1 but not above (Kim et al., 2006b). 
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Thus, we can summarise that gentamicin can still be used at a high concentration but not 
for an extended period of time. Using a lower concentration of gentamicin after 60 minutes 
also ensures the minimal or negligible role of gentamicin in intracellular bacterial killing. 
Several other approaches are used in different studies to remove the extracellular bacteria. 
This includes the use of complement and bacteriophages. The use of complement is least 
satisfactory because it facilitates phagocytosis. On the other hand bacteriophages lyse the 
cell wall of susceptible bacteria by their lytic enzymes (Shaw et al., 1983; Kim et al, 
2006b). However, this needs the bacteriophage recognising specific receptors and attaching 
to the surface of bacteria. This poses a problem when the bacteriophage fails to eradicate 
all the extracellular bacteria as any remaining bacteria can easily multiply in the nutritive 
macrophage culture medium. The rapid development of phage resistant bacteria was shown 
to be difficult to eradicate with this method. Studies by Kim et al., (2006b) used the 
bacteriophages to eradicate Salmonella by replacing the media containing SP6 
bacteriophage every 2 hours to remove any phage resistant Salmonella. They concluded by 
saying that this problem can be overcome by employing a cocktail of different types of 
lytic phages. Another method to overcome these technical difficulties is by utilising the 
bacteria that are unable to replicate in the media used to maintain the macrophages (Straley 
and Harmon, 1984). However, challenges may still exist as the above system might just 
provide bacteriostatic conditions as one won’t be efficiently able to remove bacteria 
adhered to macrophages.  
A study by Tabrizi and Robins-Browne, (1993) quantified the bactericidal capacity of 
phagocytes by removing the extracellular bacteria from the reaction mixture before 
intracellular bacteria were released by macrophage cell lysis. Gentamicin was used to kill 
the extracellular bacteria. However they enzymatically inactivated the antibiotic using the 
enzyme gentamicin acetyl transferase (GAT). This reduced the number of washing steps 
and therefore reduced the probability of the inadvertent removal of macrophages from the 
reaction mixture. 
To summarise, these assays are variable on a day to day basis. This variability is attributed 
to an overall physiological state of both prokaryotic and eukaryotic cells (Elsinghorst, 
1994). The uptake of gentamicin by bacteria is influenced by the bacterial membrane 
potential, cell membrane integrity and it also requires active protein synthesis. Several 
environmental conditions such as low pH, low oxygen and the accumulation of metabolic 
products in the cultured media may render an antibiotic less effective (Davis et al., 1987). 
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This is evident from the variation in the bacterial recovery observed in previous studies as 
shown in Table 4.1).  
 
6.1.2. Use of Pharmacological inhibitors and scavengers  
 
In this study a number of pharmacological inhibitors and scavengers were used in the 
gentamicin protection assay to identify the effect of LGG-CM on ROS and NO production 
during bacterial macrophage interactions. The ROS inhibitors used were apocynin (an 
NADPH oxidase inhibitor) and allopurinol (a xanthine oxidase inhibitor) and L-NMMA 
was used to inhibit NO production. Cell permeable SOD and catalase (PEG conjugated) 
were used to scavenge both extra and intracellular free radicals from the macrophages.   
 
Apocynin is a reversible inhibitor of NADPH oxidase.  Preincubation of human primary 
macrophages with apocynin has been shown to prevent both membrane translocation of 
p47phox and superoxide production by human primary macrophages (Ye et al., 2011). It 
has been reported that apocynin does not act directly as an inhibitor of NADPH oxidase; it 
must be pre-activated by hydrogen peroxide or peroxidase for its effect (Simons et al., 
1990). Phagocytic cells, such as macrophages, have a low level of hydrogen peroxide as 
well as myeloperoxidase (Kumar et al., 2004; Tseng & Kung, 2012) and hence apocynin 
does not require to be activated in these cells.  
Apocynin has been shown to inhibit ROS production in both phagocytic and non-
phagocytic cells (Stefanska & Pawliczak, 2008).  However, a study by Vejrazka et al. 
(2005) using apocynin to inhibit NADPH oxidase activity, found that treatment with 
apocynin, surprisingly bought about a significant increase in ROS production from 
vascular fibroblasts. Their study concluded that apocynin inhibits ROS production in 
phagocytes such as macrophages, but stimulates ROS production in non-phagocytic cells 
since they do not have any constitutive peroxidase activity.  
On the other hand, studies have also proved the inhibitory effects of apocynin on ROS 
formation in non-phagocytes as well (Holland et al., 2001; Beswick et al., 2001; Thabut et 
al., 2002). The conditions, under which these experiments were performed, however, were 
different. Cells or tissues were treated with apocynin several hours, or even several days 
before ROS measurement began. It can be assumed that the slower production of H2O2 by 
non-phagocytes was sufficient in these cases, and that the peroxidase activity was probably 
173 
 
replaced by the pseudo-peroxidase effect of iron and other transition metals present as 
ubiquitous contaminants (Vejrazka et al., 2005).  
 
In summary, the activation of apocynin depends on its oxidation by H2O2 in the presence 
of a peroxidase activity, either externally added or produced by macrophages. It is known 
that symmetrical 5, 5′ dimer (that can be formed in such a reaction) is a potent inhibitor of 
NADPH oxidase assembly (Johnson et al., 2002).  Thus, the effect of apocynin varies 
amongst various experimental conditions and should be carefully monitored and tailored if 
it is used as a ROS inhibitor. In our study, macrophages were pre-treated with apocynin for 
60 minutes prior to the addition of bacteria while investigating the role of NADPH oxidase 
mediated ROS production on bacterial phagocytosis.  
The L-NMMA competitively inhibits the generation of NO from arginine and is a useful 
tool for the inhibition of NO mediated effects. It is cell-permeable and is an L-arginine 
analog that acts as a competitive inhibitor of all three isoforms of NOS and is readily 
available. It is probably still the most widely used, investigative tool in elucidating the 
potential role of iNOS. Studies by McCall et al. (1991) have found that L-NMMA (100 
μM) needs a preincubation period of 50 minutes to achieve its full inhibitory activity in 
both J774 murine macrophages and rat peritoneal neutrophils. In this study, the 
macrophages were preincubated with 100 μM L-NMMA for 60 minutes prior to the 
addition of bacteria while investigating the role of NO on bacterial killing by gentamicin 
protection assay. The fact that L-NMMA undergoes slow processing at the active site of 
NOS being metabolised several times to inactivate the enzyme, probably contributes to the 
necessity of the preincubation period (Olken and Marletta, 1993).  
 
In macrophages, iNOS is thought to account for most of the observed NO dependent 
microbial killing (Stuehr and Nathan 1989; Green et al., 1990; Schapiro et al., 2003). 
Study by Lorsbach et al. (1993) showed that iNOS m- RNA was not detected until 4 hours 
after induction with LPS and 2 hours after induction with LPS and interferon-γ in murine 
macrophages. Given the time course of our study it is unlikely that iNOS could account for 
the observed macrophage mediated bacterial ingestion and digestion in our model. 
However, it is difficult to rule out that the basal level of NOS potentiating the bactericidal 
activity, perhaps via the formation of peroxynitrite (Zhu et al., 1992; Evans et al., 1996; 
Darrah et al., 2000; Brennan et al., 2004). 
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Allopurinol is a selective inhibitor of xanthine oxidase (Das et al., 1987; Moorhouse et al., 
1987; Takao et al., 1996). Allopurinol was used in this study to investigate the role of 
xanthine oxidase in bacterial killing by J774 macrophages. Xanthine oxidase is one of the 
sources of ROS in the biological system, however a previous study shows that peritoneal 
macrophages contain a scant amount of xanthine oxidase (Jarasch et al., 1986) and might 
not exist at the biologically important concentrations.  
 
At a low concentration, allopurinol is a substrate and a competitive inhibitor of enzyme 
xanthine oxidase and at higher concentration; it is a non-competitive inhibitor (Pacher et 
al., 2006). In vitro studies by Joh et al. (1994) have shown that allopurinol (100 μM) 
completely inhibits the activity of xanthine oxidase (Joh et al., 1994). Consistent with the 
studies by Joh et al. (1994), experiments to investigate bacterial ingestion and digestion in 
the presence of allopurinol were performed after preincubating the inhibitor (allopurinol) 
with macrophages for 60 minutes. 
 
In this study we have used PEG conjugated SOD and catalase to scavenge ROS. The 
enzyme SOD catalyses the production of H2O2 from superoxide which is then split into 
water and oxygen by the enzyme catalase. The PEG conjugation of SOD and catalase 
enhances the cell association of these enzymes in a manner which increases cellular 
enzyme activities and provides prolonged protection from intracellular proteases (Beckman 
et al., 1988). The PEG conjugation of these enzymes brings about an effective scavenging 
of free radical activity both in vivo and in vitro (Carter et al., 2004; Franchini et al., 2013). 
 
6.1.3. Use of fluorescent dye to measure ROS and NO 
 
Macrophages were grown on an optically accessible surface, such as glass bottomed cell 
culture wells or 96 well plates. The black 96 well plates were used, as the background 
fluorescence levels because of auto-fluorescence is low in black 96 well plates. The use of 
black 96 well plates also resolves the cross-talk in fluorescence measurements in adjacent 
wells and results in better sensitivity.  
 
For ROS measurements, the macrophages were labelled with H2DCFDA, a dye which has 
been widely used to monitor intracellular ROS production in general from intact cells 
(Kalyanaraman et al., 2012; Winterbourn, 2014). A loading concentration of 5 μM was 
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used as it gave consistent results and is similar to that which has previously been used in 
human intestinal epithelial cells (Lin et al., 2009). At this concentration the fluorescent dye 
was non-toxic and suitable for detecting the signals with negligible background noise. 
Experiments were performed using a medium without phenol red as it reduces the 
interference of fluorescent dyes.  
 
The H2DCFDA is cell permeable and is hydrolysed intracellularly to the DCFH anion 
which after two electron oxidation results in the formation of fluorescent 
dichlorofluorescein (DCF). The fluorescent intensity of DCF is directly proportional to 
intracellular ROS generation (Klien et al., 2012). Although the fluorescence dye 
H2DCFDA has been widely used to measure oxidative bursts in phagocytes such as 
macrophages and neutrophils (Zielinska et al., 2001; Caldefie-Chézet et al., 2002), there 
are reports that peroxynitrite can also interfere with the formation of DCF in cellular 
systems (Possel et al., 1997; Crow,1997; Wang and Joseph 1999; Kalyanaraman et al., 
2012) and therefore the probe H2DCFDA is mainly used as a marker of general ROS 
production rather than as a specific marker of any one of the ROS products (Gomes et al., 
2005). The advantages, pitfalls and limitations of these fluorescent dyes have previously 
been well discussed in a number of reports, but this dye is still considered as a convenient 
fluorescent probe for measuring the general aspects of intracellular ROS production 
(Halliwell & Whiteman, 2004; Dikalov et al., 2007; Kalyanaraman et al., 2012; Dikalov & 
Harrison 2014; Winterbourn 2014).   
 
Reliable measurements of NO and its derivatives in biological systems presents significant 
challenges due to its short half life. The majority of studies investigating the role of RNS 
during bacterial macrophage interactions mainly concentrate on the stable end products of 
NO such as nitrite and nitrate (Sun et al., 2003). The NO does not fluorescence itself and it 
needs to be labelled with NO specific fluorophores such as DAFFM-DA. In our study, the 
requisite incubation time for the DAF probes with macrophages was 45 minutes at 5 μM 
concentration. Earlier studies have also demonstrated that the requisite incubation time for 
DAF probes was less than 2 hours (Nakatsubo et al., 1998). The vast majority of studies 
incorporating the use of DAF’s have only reported relative changes in the fluorescent 
signal (Nagy et al., 2004; Planchet et al., 2006; Nyberg et al., 2010).  The diacetate 
derivative of DAFFM has some advantages over another commonly used NO sensing 
fluorescence probe DAF-2. The main advantage is that the spectra of NO adduct of 
DAFFM-DA are independent of pH above 5.5 and it is more photostable than DAF-2. 
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These fluorescent probes may be used to measure nanomolar levels of NO both in vitro 
and in vivo (Namin et al., 2013). The detection limits of DAFFM-DA is ˜ 3nM compared to 
DAF-2 which is ˜ 5 nM. 
 
 6.1.4. Use of Griess assay to measure nitric oxide. 
 
This is a widely used technique used as an index of integrated NO production estimated 
from determining the concentrations of nitrite and nitrate end products. In this study we 
could not detect nitrite accumulation within the first 5 to 6 hours of macrophage incubation 
with various treatments. However, nitrite production from macrophages as a response to 
various treatments was easily detectable at 24 hours. This could also be attributed to the 
sensitivity of Griess assay. The two main limitations of Griess assay is the sensitivity limit 
and experiment duration. Detecting nitrite production from macrophages requires an 
incubation time of approximately 9 to 40 hours (Nakatsubo et al., 1998).  There is a 
variation in the reported sensitivity limit for Griess assay in the literature. In biological 
fluids the sensitivity limit for Griess assay is about 0.4 to 300 μM (Green et al., 1982; Pratt 
et al., 1995; Sun et al., 2003).  
 
6.1.5. Strength of Cusum analysis 
 
In this study, CuSum analysis has provided useful evidence regarding the acute change of 
the rate of free radicals generation from pre-existing levels. The interpretation is most 
robust when detecting a change, or irregular fluctuations, or shifts in free radical 
production (Stanton et al., 1992). The CuSum method is quite simple as it perceives the 
variation without assuming any functional form of the data. If the measured fluorescence 
value of free radical production from the experiment is equal to the target value (average 
fluorescence from untreated cells) the slope would be zero. But if the measured 
fluorescence value of free radical production from the experiment is greater than the target 
value, the slope will be a positive and vice versa. The greater the difference between the 
measured fluorescence value and the target value, the greater the slope will be. The slope 
of the plot over any given time period (the change in the CuSum over that period divided 
by the period duration) indicates the average deviation of free radicals generation from the 
mean control ROS generation during that period. The plot facilitates the calculation of the 
relative rate of ROS production and the derivation between the treatments.  
177 
 
6.2. General discussion on experimental findings 
 
The results in this thesis have demonstrated the role of LGG-CM on the modulation of 
macrophage phagocytic activity. The MTT assay demonstrates that LGG-CM is non-toxic 
to the J774 macrophage cell line. It also has no acute antibacterial activity on E. coli.  
There are reports suggesting that, the antibacterial activity of LGG-CM was mainly 
because of low pH.  However, in this study LGG-CM was neutralised to pH 7.4 ± 0.2 and 
no antibacterial activity was observed at this pH. In this study macrophage phagocytosis 
was investigated separately as ingestion (uptake) and a digestion (killing) phase.  The 
LGG-CM treated J774 macrophages demonstrated a significant reduction of E.coli 
ingestion. Reduced bacterial uptake was also observed when the macrophages were 
incubated with LPS. However, the bacterial digestion rate by macrophages was found to be 
enhanced when the macrophages were incubated with a higher concentration of LGG-CM. 
The LPS had no effect on the bacterial digestion rate by the macrophages. The present 
study also explored the role of ROS and NO generation in both the ingestion and digestion 
phases of phagocytosis modulated by LGG-CM. This was investigated by using a number 
of pharmacological inhibitors of ROS such as apocynin, allopurinol; NO inhibitor L-
NMMA and also cell permeable free radicals scavengers PEG-SOD and PEG-catalase. 
The results from our experiments have demonstrated that LGG-CM increased the E.coli 
digestion rate by enhancing ROS production. Enhanced ROS production to LGG-CM was 
found to be due to an increase in the expression of NADPH oxidase subunits in J774 
macrophages.  
 
6.2.1. Variation of Bacterial ingestion by macrophages 
 
Studies monitoring the bacterial ingestion by macrophages at 30 and 60 minutes in the 
presence of LPS demonstrated a lower bacterial ingestion. The LPS mediated reduction in 
bacterial ingestion by macrophages has been shown previously (Eder et al., 2009; 
Sivagnanam et al., 2010). The Gram negative bacteria possess LPS in its outer cell 
membrane component and are recognised by TLR-4 on the macrophages. Thus, when the 
macrophages are exposed to LPS and live bacteria, there is the possibility of competition 
for TLR-4 receptors on the macrophages (Hornef et al., 2003; Dunzendorfer et al., 2004).  
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A possible similar mechanism could explain the lower bacterial ingestion in the presence 
of LGG-CM treated macrophages. A growing amount of evidence indicates that LGG-CM 
contains a number of components, or factors, which are released either from the cell 
membrane or secreted constitutively from the bacteria (Oelschlaeger, 2010). However, it is 
not known if any of the secreted components of LGG could compete for TLR-4 receptors 
and hence the reduced uptake of E. coli in the presence of LGG-CM.  Generally, 
recognition of Gram positive bacterial cell wall components by innate immune cells occurs 
through TLR-2 (Yoshimura et al., 1999). Thus one possible mechanism of reduction in 
bacterial ingestion in the presence of LGG-CM in the present study may be due to the non-
specific inhibition of certain receptors by components of LGG-CM instead of receptor 
competition.  However, there are studies where probiotic bacterial components have been 
shown to block bacterial binding sites in mice (Aiba et al., 1998) and humans (Rolfe 2000; 
Hamilton –Miller 2003; Wang et al., 2004). But the mechanism is yet to be established. 
 
The lower recovery of bacteria in the presence of the LGG-CM might also be due to the 
down-regulation of macrophage signalling mechanisms involved in phagocytosis rendering 
the macrophages to a less active state. It is quite challenging to argue that reduced bacterial 
ingestion could be due to the down-regulation of the activation state of macrophages as we 
have seen a significant difference in the acute ROS production to LGG-CM treated 
macrophages. Therefore, in this study, reduced bacterial ingestion in the presence of LGG-
CM might be attributed to the activities of LGG components at receptor level (Roselli et 
al., 2006; Wong et al., 2013). 
 
Pharmacologic inhibitors such as apocynin and allopurinol had no effect on bacterial 
ingestion. Apocynin and allopurinol block the activities of the enzymes namely, NADPH 
oxidase and xanthine oxidase and, thereby, prevents ROS production. However, these 
inhibitors would not be able to stop ROS production from macrophages completely since 
the arachidonic acid pathway also contributes to ROS production in macrophages 
(Griendling et al., 2000; Sakuma et al., 2012) and could maintain a basal level of ROS 
production to regulate its physiological functions such as calcium regulation (Klebanoff 
2005).  Interestingly, in this study, macrophages in the presence of PEG-SOD and PEG-
catalase treatments demonstrated a significant further reduction in bacterial ingestion. This 
can be attributed to the effectiveness of cell permeable PEG-SOD and PEG-catalase to 
scavenge the free radicals from any source and thereby resulting in reduced bacterial 
recovery. 
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6.2.2. Role of LGG-CM induced ROS in bacterial digestion 
 
In the present study an increased rate of E.coli digestion was observed when macrophages 
were treated with LGG-CM.  This increased rate of digestion is found to be due to 
enhanced ROS production in the LGG-CM response.  
 
In this study, the macrophages increased ROS production in response to LGG-CM is 
primarily due to the activation of NADPH oxidase. Phosphorylation of p47 phox is shown 
to be essential for NADPH oxidase activation in phagocytes such as neutrophils (Li & 
Shah, 2004).  Ray and Shah, (2005) suggested that unphosphorylated p47 phox would have 
inhibitory effects on NADPH oxidase activity. Phosphorylation of p47 phox relieved these 
inhibitory effects and at the same time increased NADPH oxidase activity.  
 
In the present study NADPH oxidase subunits gp91 phox and p47 phox were measured at 
different time points.  We did not observe any significant change in the gp91 phox and p47 
phox expression in the first 2 hours of incubation with LGG-CM treatments; wherein at 6 
hours of incubation time, LGG-CM treated macrophages demonstrated a significant 
increase in the expression of gp91 phox and p47 phox compared to untreated macrophages. 
This is in line with the findings from previous studies that NADPH oxidase activation 
occurs over the short term through phosphorylation of the enzyme subunits and over the 
long term by increased subunit expression (Li and Shah., 2004; Ray and Shah., 2005). We 
also observed no significant difference of gp91 phox and p47 phox expression between the 
control and the LGG-CM treated cells at 24 hours. 
 
CuSum data analysis also demonstrated that there is a variable rate of ROS production 
from macrophages during the first hour (ingestion period) and also approximately 280 
minutes of LGG-CM treatment (digestion period). Despite the sustained elevation of ROS 
production observed in the presence of LGG-CM compared to the control cells throughout 
the experiments, there is a differential rate of ROS production between these two phases.  
When the macrophages were treated with a higher concentration of LGG-CM, the ROS 
production rate during the first hour of treatment was approximately 2 times higher than 
the ROS production rate during the next 280 minutes. Similarly, from the macrophages 
treated with the positive control menadione (0.5 mM), the rate of ROS production from the 
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macrophages almost doubled during same period of incubation when compared to the rate 
of ROS production during first 60 minutes.  
 
In this study the LGG-CM mediated ROS production in the macrophages appears to 
happen in a highly controlled manner where the macrophages probably regulate ROS 
production by oscillating the ROS production. This sort of ROS regulation has been 
previously demonstrated in plant root hairs and guard cells and also during pollen stigma 
interactions (Monshausen et al., 2007; Takeda et al., 2008; McInnis et al., 2006; Jammes et 
al., 2009).   Detection of the oscillating pattern of ROS signals in plants clearly supports 
our current findings where our raw data for free radical production demonstrates an 
oscillatory pattern.  It has been postulated that maintaining a nontoxic steady-state level of 
ROS, while allowing for the transient accumulation of ROS in particular subcellular 
locations, could have a physiological significance and could act as signals (Mittler et al., 
2004). 
 
Excessive ROS generation causes oxidative stress which has been implicated in many 
disease processes (Veal et al., 2007). Disproportionate, or prolonged, ROS generation may 
result in the non-specific oxidation of biomolecules and contribute to tissue injury. High 
ROS production has also been implicated as a cause of the deleterious suppression of 
NFκβ mediated cell survival factors (Storz & Toker 2003). In gut epithelial cells, LGG has 
been shown to induce an increased ROS production through NADPH activation.  However, 
this increase in ROS has been suggested to play a role as an anti-inflammatory by 
inhibiting NFκβ through oxidative inactivation of the key regulatory enzyme Ubc12 
(Kumar et al., 2007; Lin et al., 2009). A similar suppression of NFκβ activation was also 
demonstrated in liver cells to probiotic treatment (Li et al., 2003). This suppression was 
due to the reduced activity of Jun N-terminal kinase (JNK); a regulatory enzyme found to 
be modulated by ROS (Zhang & Chen, 2004).  It seems that ROS mediated suppression of 
NFκβ may account to regulate physiological inflammatory susceptibility of the cells to 
probiotic bacteria. 
 
6.2.3. Modulation of NO by LGG 
 
In this study, we investigated the role of LGG-CM on NO production by J774 
macrophages acutely and also after 24 hours of treatments. Macrophages treated with 
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LGG-CM for 24 hours produced a basal low level of NO. This is consistent with a study by 
Pipenbaher et al. (2009) where several live Lactobacilli demonstrated a low basal level of 
NO production from pig alveolar macrophages. 
 
In our study, the macrophages produced a massive amount of NO to LPS treatment at 24 
hours. However, when LGG-CM was added to LPS, there was dose dependent reduction of 
NO production by macrophages at 24 hours. A low level of NO plays an important role by 
protecting the intestinal mucosa and resolving gut inflammation (Brown, 2003; Pipenbaher 
et al., 2009). Under pathogenic stress, or as a response to inflammatory stimuli, 
macrophages induce increased NO production from iNOS (Korhonen et al., 2001). Over 
expression of NO has been found to be involved in condition such as ulcerative colitis 
(Alican and Kubes 1996).  Numerous studies have shown that the chronic inflammation 
associated with IBD is due to the prolonged activation of iNOS and thereby NO 
production. The NO produced is further known to contribute to tissue injury (Rachmilewitz 
et al., 1995). Studies by Toumi et al. (2014) have shown that probiotic supplementation 
reduced NO production and iNOS expression in colitic mice. 
 
In the present study a reduced rate of NO production was observed acutely from 
macrophages when treated with the higher concentration of LGG-CM. Previous studies 
have reported differential kinetics of ROS and NO production by macrophages in response 
to parasite infections.  A study by Gantt et al. (2001) detected the ROS production (within 
40 minutes) occurring early after Leishmania chagasi phagocytosis, whereas the effect of 
NO occurred later (48–72 hours after infection) from murine and human macrophages.  
 
These observations are consistent with our studies where we also observed a rapid ROS 
production from macrophages, but failed to detect any enhanced NO production. The 
reduction in the rate of NO production from the higher concentration of LGG-CM treated 
macrophages in our study is probably due to the inactivation of NO by ROS. Interestingly, 
there is evidence in the central nervous system that SOD could increase the toxic effects of 
NO by inhibiting the superoxide mediated inactivation of NO (Oury et al., 1992). The NO 
can react rapidly with superoxide to generate the stable peroxynitrite anions. This pattern 
of elevated levels of ROS leading to a decrease in NO bioavailability has been described in 
endothelial cells (Hsieh et al., 2014). The scavenging of superoxide by SOD has also been 
shown to increase the half-life of the endothelium-derived relaxing factor (NO) and to 
preserve the biological activity of NO measured by platelet aggregation (Gryglewski et al., 
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1986; Rubanyi et al., 1986). Thus, it is likely that the acute reduced rate of NO production 
to LGG-CM, in our study, is probably due to the enhanced ROS generation in the 
macrophages.  
 
It has been shown that peroxynitrite might further decrease iNOS expression by nitration 
reactions (Connelly et al., 2001; Aktan 2004). Peroxynitrite has been shown to oxidise the 
iNOS cofactor BH4 into inactive dihydro-L-biopterin and, thereby, results in NOS 
reactions being uncoupled (Milstien & Katusic, 1999; Kopincova et al., 2011). Uncoupling 
of the iNOS further enhance ROS production as NADPH consumption increases 
independently of L-arginine oxidation reactions. Thus, it seems NO and ROS together 
determines the fate and reactions of their own production or inhibition. Thus, the 
production of low level NO, after 24 hours of treatment, could be a balancing act of LGG-
CM between  NO and ROS production to regulate the homeostatic mechanism of 
macrophage phagocytosis and the prevention of collateral tissue injury. A summary figure 
of modulation of macrophage phagocytosis by LGG-CM has been shown in figure 6.1. 
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6.3. Recap and Conclusions 
 
This section provides an overview of the research by restating the objectives along with a 
description on how they have been met. The first chapter was concerned with introducing 
the background knowledge of the research question and sets the background for the 
research through establishing the aims and objectives. The subsequent chapters were 
designed to achieve these objectives and thereby meet the aims of our project. This study 
was set out to explore the effect of cell free LGG-CM on bacterial macrophage 
interactions. This study has also sought to understand the mechanisms involved in LGG-
CM mediated bacterial-macrophage interactions, particularly with respect to LGG-CM 
mediated ROS production from macrophages. Major findings in the course of achieving 
these objectives have been listed below. The final section in this chapter states how this 
research generates a platform for future work for the advancement of knowledge.  
 
From the literature review in chapter 1 we found that probiotic bacteria have been shown 
to demonstrate immunomodulatory activity, however the functional properties attributing 
these effects were unclear. The research, therefore, aimed to investigate the effect of 
probiotic conditioned media from a single probiotic strain Lactobacillus rhamnosus GG on 
immune cells like macrophages and understand the bacterial-macrophage interactions.  
 
The research aimed at investigating and understanding the following:  
1. The effect of cell-free LGG-CM on bacterial phagocytosis by macrophages 
2. The physiological mechanisms attributed by LGG-CM in modulating macrophage 
phagocytosis with respect to free radical production. 
Understanding the LGG-CM mediated immunomodulatory activity enables the host to 
achieve the probiotic health benefits in a more informed manner. The step by step 
conclusion approach reiterates the objectives set out in Chapter 1 and describes vital 
findings during the process of accomplishing these objectives towards meeting the purpose 
or aim of the research. 
 
6.3.1. Understanding the role of probiotics as immunomodulatory agents  
 
The Objective 1 is achieved through the literature review conducted in Chapter 1. The 
literature review on the effect of probiotics and their influence on the immune system 
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mainly concentrated on the effect of LGG-CM on immune cells such as macrophages at 
the component level. Information was also gathered on macrophages and their defence 
mechanisms such as iNOS and NADPH oxidase. The literature review was then oriented 
towards the role of free radicals in macrophage phagocytosis. Attempts have been made to 
summarise the literature in the form of table to provide more collective information. Each 
section in the literature review chapter (to achieve Objective 1) has a vast diversity in the 
terms of details included.  Careful decisions were made to include or exclude the topics in 
the introductory chapter as this form the basis for the future five chapter objectives. The 
major findings from the literature review was that although an enormous amount of data is 
available to demonstrate probiotics modulates phagocytosis, there is no specific mounting 
evidence on the physiological modulation of the whole process. This study fills the gap in 
the existing literature by explaining the functional mechanisms behind the observed 
probiotic mediated phagocytic modulation by using LGG- CM.  
 
6.3.2. Designing various approaches to investigate the bacterial macrophage 
interactions. 
 
The achieve Objective 2, various experimental techniques were established which were 
paramount to achieving the rest of the objectives. This chapter described the 
methodological framework for preparing cell free LGG-CM, experiments to perform 
macrophage and bacterial cell-viability studies and methods to determine the effect of 
LGG-CM on NO production by J774 murine macrophages. The background knowledge 
such as the principle of an experimental technique and steps involved in general, are 
described for a number of microbiological and immunological methods used to monitor 
bacterial ingestion and digestion, along with the experimental techniques to modulate free 
radical production. The methods adapted in this thesis provide an efficient way to monitor 
changes in the bacterial number and free radical production from macrophages. These also 
helped to determine the effect of LGG-CM induced free radical production on bacterial 
number recovered from macrophages both during ingestion and digestion periods. The 
developed fluorescence microplate reader technique for the continuous monitoring of free 
radical production (real time kinetic approach) along with the CuSum technique, adds a 
significant knowledge and tool for measuring free radicals. Specifically, data reliability 
was significantly improved as the overall assay protocol employed multiple techniques to 
support any findings. This multiparameter accessing protocols increases the accuracy of 
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the findings rather than simple measurements taken from the single type of experimental 
measurements.   
 
6.3.3. Determining the effect of LGG-CM on cell viability and nitric oxide 
production. 
 
The preliminary, but most important step, of the present study performed to achieve 
Objective 3 and 4 was preparing an effective cell free LGG-CM. The main findings from 
this section is that LGG-CM do not demonstrate antibacterial activity, at least on our 
model bacterium E.coli HfrC. Findings from macrophage viability assays also 
demonstrated that LGG-CM at a concentration and duration utilised in the experiment do 
not demonstrate toxic effects. A key advance in knowledge in this study with respect to 
NO production from macrophages at 24 hours is the observed dual effect of LGG-CM on 
NO production. 
 
6.3.4 Determining the effect of LGG-CM on bacterial ingestion and digestion 
 
This work was performed in order to achieve Objective 5. The methods developed by 
modifying existing protocol in this thesis helped in understanding the effect of LGG-CM 
on the bacterial uptake by macrophages. Bacterial recovery by gentamicin protection assay 
was monitored both during bacterial ingestion and digestion. Gentamicin protection assay 
performed in the presence of LGG-CM demonstrated that LGG-CM treated macrophages 
ingest significantly less bacteria. A higher concentration of LGG-CM demonstrated 
enhanced bacterial digestion rate. 
 
6.3.5 Determining the effect of LGG-CM on physiological mechanisms 
 
To achieve Objective 6, experiments were performed in the presence and absence of 
pharmacological inhibitors and free radical production was monitored on a real-time 
approach by fluorescently labelling the macrophages with ROS or NO specific 
fluorophores. Studies monitoring free radical production have demonstrated increased ROS 
production and decreased NO production from macrophages treated with LGG-CM during 
bacterial phagocytosis. 
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Western blotting results during the first 6 hours of LGG-CM treated macrophages 
demonstrated an enhanced expression of NADPH oxidase subunits. These results 
supported the increased rate of ROS production observed in presence of high concentration 
of LGG-CM. Bacterial killing monitored in the presence of ROS and NO inhibitors, also 
supports the role of ROS and basal NO mediated bacterial killing in the presence of LGG-
CM. Taken together; LGG-CM modulates E. coli phagocytosis by modulating free radical 
production in J774 murine macrophages. 
 
6.3.6. Summary 
 
In conclusion, we have observed that the LGG-CM treated macrophages modulate 
macrophage phagocytosis by enhancing bacterial digestion. We have investigated the role 
of LGG-CM in the regulation of ROS and NO production in macrophages during 
phagocytosis. It has been clear that LGG-CM may have some soluble components which 
activate macrophage to significantly increase the rate of ROS production both in presence 
and absence of E. coli. In contrast, macrophages treated with high concentration of LGG-
CM demonstrated a significant decrease in the rate of NO production. This skewing 
modulation of ROS and NO production is probably beneficial to the host as excessive 
production of NO might not only be useful to accelerate bacterial killing mechanism but 
could also potentially damage the host tissue. Here we have also shown for the first time 
that by using CuSum it has become possible to detect subtle changes in the trend in free 
radical production from macrophages treated with various treatments and thus can be used 
as a successful tool in analysing noisy in vitro data.  The ability of probiotic to 
differentially regulate NO and ROS generation may have clinical implications in several 
pathological conditions associated with bacterial infection and may prove useful in 
improving intestinal homeostasis. 
 
6.4. Future work 
 
1. This study demonstrated that the LGG-CM modulates the macrophage 
phagocytosis and thereby could be used as a potential immunomodulating agent. 
However, in this study, work was not carried out on isolation, identification and 
quantification of the active components in LGG-CM. In future work, considerable 
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attention has to be given to identifying and quantifying the active components from 
the LGG-CM. 
 
2.  It is not known if the LGG-CM can also activate bacterial digestion in the 
macrophages from human origin. Therefore the effects of LGG-CM should be 
investigated from both in vitro using human primary cell line and also in vivo in 
animal models.  
 
3. Future work should also consider the use of pathogenic bacteria instead of a non-
pathogenic E. coli HfrC to see if the LGG-CM can potentiate pathogenic bacterial 
digestion as well. 
 
4. Our study demonstrated the potential role of LGG-CM mediated ROS and NO 
production in macrophage phagocytosis. An important aspect that should be 
considered in the future is to detect and analyse the potential role of peroxynitrite 
(combined product of ROS and NO) during bacterial macrophage interactions. 
Peroxynitrite is known to have potent bactericidal effect. It is not known if 
concentration of peroxynitrite plays a role into this effect.  It would be interesting 
to see if low peroxynitrite level has any protective or anti-inflammatory effect.  
Future work therefore needs to be directed towards identifying the role of 
peroxynitrite mediated phagocytosis and physiological regulatory mechanisms in 
the presence of the LGG-CM.  
 
5. Increase in ROS has also been suggested to play a role as an anti-inflammatory 
agent by inhibiting NFκβ through oxidative inactivation of the key regulatory 
enzyme Ubc12.  We have found that LGG increased ROS production through 
NADPH activation.  It would be interesting to see if this increase in ROS to LGG-
CM treatment has a role as anti-inflammatory along with its bacterial killing effect.  
 
6. In this study, the raw data for free radical production demonstrated an oscillatory 
pattern. More work is needed to investigate whether this pattern is also observed in 
other non-immune cells such as epithelial cells, as these are also known to produce 
free radicals to LGG treatments. 
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7. Pattern of NADPH oxidase expression to LGG-CM treatments need to be 
investigated. It is not known if NADPH oxidase expression can be regulated on a 
switch on and off basis for skewing of ROS production. 
 
8. The LGG-CM antibacterial role needs to be further investigated at acidic pH range 
since in this study we have observed no antibacterial activity of LGG-CM to E.coli 
at neutral pH. 
 
9. Finally, it is important to highlight the extended necessary amount of preparation 
time and the demanding number of agar plates and other equipments necessary for 
gentamicin protection assay. In future, this work can be improved by employing 
alternative techniques such as flow cytometer and also by improving the acridine 
orange crystal-violet staining technique. A higher magnification lens would 
possibly enable one to enumerate the fluorescently labelled bacteria with in the 
macrophages. This would also simplify the steps involved in the tedious and time 
consuming gentamicin protection assay. 
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Appendix A 
List of chemicals 
Acridine orange hydrochloride (Sigma 318337) 
Acrylamide/bis solution (Biorad 161-0156) 
Allopurinol (Sigma A8003) 
Ammoniun persulphate (Sigma A3678) 
Apocynin Santa Cruz Biotechnology (CAS 498-02-2) 
Autoradiography film (Ultracruz SC-201696) 
BCA (Thermoscientific-Pierce BCA protein assay kit-23225) 
Blocking buffer (10 ml of 10 x wash buffer, 100 μl Tween-20, 5 % non-fat dried milk, 90 
ml ultrapure water). 
Carestream® Kodak® autoradiography GBX developer  
Carestream® Kodak® autoradiography GBX fixer.  
DAFFM-DA   (Santa Cruz biotechnology SC-205940). 
de Man, Rogosa and Sharpe (MRS) broth (OXOID CM0359) 
 Dimethyl sulfoxide (Sigma D8418 >= 99.9 % purity) 
DMEM (1000 mg L-1 glucose, 4 mM L-glutamine and 110 mg L-1 sodium pyruvate Gibco 
31885) 
ECL lumiglo reserveTM 547101 KPL 
FBS (Sigma F6178) 
Gentamicin sulphate (Sigma G1264) 
Glycerol (Fischer Scientific G/0650/17) 
Glycine (Sigma G8898) 
gp91phox antibody (Santa Cruz biotechnology SC130543) 
H2DCFDA-AM (Molecular probes, D399). 
L-Arginine hydrochloride (Sigma A92600) 
L-NMMA (Sigma M7033) 
Lysis buffer (10 x) [(100 mM tris –HCl pH 7.4, 10 % SDS, 1.5 M NaCl)] 
Menadione (Santa Cruz biotechnology CAS 58-27-5) 
MTT (Cell proliferation Kit, Roche, 1465007) 
N-Napthylethylene-diamine (S222488)  
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Nutrient agar media (Oxoid, CM0003)  
Nutrient broth (Oxoid, CM0001)  
p47phox antibody (Santa Cruz biotechnology SC17845) 
PEG conjugated Catalase (Sigma C4963) 
PEG conjugated SOD (Sigma S9549)  
Penicillin-streptomycin (Gibco 10378-016) 
 Phosphate buffered saline (Sigma P4417) 
Protease cocktail inhibitor (Sigma P8340) 
Sodium dodecyl sulphate (Sigma L3771) 
Sodium chloride (Sigma S3014) 
Sodium nitrite (Sigma 237213) 
Sodium nitroprusside dehydrate (SNP) Sigma 31444 
Sodium orthovanadate (Sigma S6508) 
Sulfanilamide (Sigma S9251)  
Tank Buffer (1x) (0.025 M Tris-HCl, 0.192 M Glycine, 0.1 % SDS) 
TEMED (SigmaGE17-1312-01) 
Tris-HCL (Sigma RES3098T-B7) 
Trypan blue (Sigma T6146) 
Tween 20 (Sigma P1379) 
Wash buffer (10 mM Tri-HCl pH 7.5, 100 mM NaCl, 0.1 % Tween-20) 
β-actin antibody (Santa Cruz biotechnology SC47778) 
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Poster presentations 
 
2010 Y. Seenappanahalli Nanjundaiah, Z. Ali, D. A. Wright & M. Sarker The influence 
of a cell -free      probiotic supernatant on bacterial macrophage interactions. 5 
Febraury 2010 
North East Postgraduate research Conference, King’s road centre, Newcastle 
university, 
 
2011 Y.S. Nanjundaiah, Z.Ali, D.A.Wright, M.Sarker. The influence of a cell-free 
probiotic supernatant on bacterial macrophage interactions. 17 May 2011  
TFI research Day, Teesside University, Middlesbrough 
 
2012  Yashaswini Seenappanahalli Nanjundaiah, Ali Z., Wright D.A., Sarker M.H. 
Influence of cell-free probiotic supernatant on bacterial macrophage interactions 8 
May 2012 
Vitae yorkshire and North East hub Public engagement conference and competition 
at the Royal York hotel, York. 
 
2012 Y. Seenappanahalli Nanjundaiah, Z. Ali, D. A. Wright & M. Sarker. The influence 
of cell free probiotic supernatant on bacterial macrophage interactions. 5-8 Sep2012 
European congress of Immunology, 5-8 September 2012, Glasgow, Scotland 
Immunology Volume 137, Issue Supplement s1, Article first published online: 12 
SEP 2012 
 
2012 Y.S. Nanjundaiah, Z.Ali, D.A.Wright, M.Sarker. Influence of probiotic supernatant 
on macrophage phagocytic activity. 26 October 2012 
North East Postgraduate research Conference. 
 
2013 Y.S. Nanjundaiah, Z.Ali, D.A.Wright, M.Sarker. Differential Immunomodulatory 
properties of cell free probiotic supernatant: relevance of phagocytosis and free 
radical production by macrophages. 28 October 2013 
North East Postgraduate research Conference, Hancock museum, Newcastle 
upontyne. 
 
2014 Mosharraf H. Sarker, Yashaswini S. Nanjundaiah, David A wright, Nasima S. 
Chowdhury and Anwar R Baydoun. Modulation of E. coli phagocytosis by LGG 
conditioned medium in macrophage J774 cells. International scientific conference 
on Probiotics and Prebiotics, Budapest, Hungary.24th-26th June 2014 
 
2015 Y.S. Nanjundaiah, D.Wright, L.O, Hare, A.Baydoun, Z.Khaled & M. Sarker. 
Probiotic Lactobacillus rhamnosus GG conditioned media enhances acute ROS 
production, but reduces nitric oxide in J774 macrophages.Physiology 2015, 6th-8th 
July. Motorpoint Arena, Cardiff 
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Oral presentations 
 
 
2012 Y.S. Nanjundaiah, Z.Ali, D.A.Wright, M.Sarker.  The influence of cell free 
probiotic supernatant on bacterial macrophage interactions. 15 May 2012 
research Day, Teesside University, Middlesbrough 
 
2013 
 
Yashaswini Seenappanahalli Nanjundaiah, Ali Z., Wright D.A., Sarker M.H.  
Immunomodulatory effects of cell free probiotic supernatant on murine 
macrophages. 21 May 2013. Annual research day and postgraduate symposium best 
oral communication  award 
TFI research Day, Teesside University, Middlesbrough 
 
2014 Yashaswini Seenappanahalli Nanjundaiah, Ali Z., Wright D.A., Sarker M.H. 
Modulation of E. coli phagocytosis by murine macrophages in the presence of 
probiotic conditioned medium is mediated by NADPH-oxidase activity. 31 October 
2014 
 
2014 Yashaswini S.Nanjundaiah, David A. Wright, Nasima S. Chowdhury, Anwar R. 
Baydoun & Mosharraf H.Sarker. Modulation of macrophage phagocytosis by 
probiotic bacteria in vitro. Invited Lecture, 4th Biennial conference of South Asian 
Association of physiologists and 3rd National convention of Bangladesh society of 
Physiologists, 5-7 December 2014, Dhaka, Bangladesh 
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1. Yashaswini Seenappanahalli Nanjundaiah, Anwar R Baydoun, Zahangir Khaled, 
David A Wright, Liam O’Hare, Mosharraf Sarker. Lactobacillus rhamnosus GG 
conditioned media enhances acute free radical production in J774 murine 
macrophages. (Submitted to Free radical Biology and Medicine) 
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Mosharraf Sarker. Lactobacillus rhamnosus GG conditioned medium enhances 
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